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ABSTRACT OF THE DISSERTATION
Neuroprotective Functions of Docosahexaenoic Acid and
Epidermal Fatty Acid Binding Protein
by
Manuel Luis Montero
Doctor of Philosophy, Graduate Program in Physiology
Loma Linda University, September, 2018
Dr. Marino A. De León, Chairperson

Lipotoxicity (LTx) is involved in mostly every process of neuronal injury. Using
NGFDPC12 cells we show that palmitic acid (PA) induces the expression of stress
response genes HIF-1α and BNIP3, increases the accumulation of reactive oxygen
species, and decreases cell viability by apoptosis. Inhibition of cathepsins does not
rescue neurons from PA-LTx but inhibition of necroptosis and promotion of autophagy
do. DHA decreases the expression of HIF-1α and BNIP3 and rescues PA-induced cell
death by inhibiting apoptosis and necroptosis. Besides DHA stimulates the mRNA
expression, phosphorylation and conjugation of autophagy controlling proteins.
Inhibiting autophagy during DHA treatment decreases its capacity to rescue cells form
PA-LTx. PA-induced ROS also stimulate the expression of EFABP that could be
prevented by co-treating the cells with the antioxidant N-Acetyl-Cystein during PA-LTx.
Conversely lowering EFABP expression by siRNA increases the accumulation of ROS
and decreases cell viability but stimulating PPARβ and PPARγ with direct agonists
increases the expression of EFABP and increases cell viability during PA-LTx.
As a parallel study .5% [O2] hypoxia induces the expression of the same stress
response genes and triggered apoptosis in NGFDPC12 cells just like PA-LTx. Hypoxia

xiii

disrupts the architecture of NGFDPC12 cells microscopically by diminishing the body
size, reducing the confluency, thinning the neurites and producing apoptotic bodies. The
decrease in cell viability can be prevented with an array of different concentration of
DHA and the autophagy promoter rapamycin just like in PA-LTx. Pre-treatment of
NGFDPC12 cells with DHA and EPA (another PUFA) increases cell viability under
hypoxia. As in PA-LTx hypoxia also induces ROS and can be prevented with antioxidant
MCI-186. The mRNA and protein level of FABP5 are also increased under hypoxia and
can be prevented by co-treatment with antioxidant. Lastly the hypoxia-induced
expression of EFABP can be inhibited by antagonizing PPARγ.
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CHAPTER ONE
INTRODUCTION

Lipids
Lipids are major and important components of the brain and the central nervous
system (CNS). Due to the complex shape and prominent extension of the plasma
membranes neurons and glial cells have a high cell membrane to cytoplasmic ratio
(Bourre et al. 1992). The cell membrane is a linear mosaic of a fluid lipid bilayer having
as main components saturated and unsaturated fatty acids, cholesterols and others
hydrophobic molecules (Zerouga et al. 1991). Lipids are also important nutrients to the
brain because of its availability during hypoglycemia and because of its high caloric
value (Choi et al. 2003). Lipids are also important as biologically active substances either
by direct participation in signal transduction or modulation of metabolic functions by
lipids metabolites. Free fatty acids (FA) are classified according to the amount of double
bonds in their chain. Saturated fatty acids by definition are fatty acid saturated of
hydrogen atoms in their chain and by definition devoid of carbon-carbon double bonds
(e.g. stearic acid). Monounsaturated fatty acids have one carbon-carbon double bond in
their chain (e.g. oleic acid). And those fatty acid that have two or more carbon-carbon
double bonds are called polyunsaturated fatty acids (e.g. DHA). Not all fatty acids can be
synthesized endogenously and for this reason some of them have to be acquired from the
diet. More important for the present study polyunsaturated fatty acids with double bonds
at the n3 and n6 position are essential fatty acids and need to be supplied because
mammals lack the enzymes Δ3-desaturase and Δ6-desaturase respectively. The most
well studied polyunsaturated fatty acids, n-3 and n-6, are represented by
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Docosahexaenoic acid and Arachidonic acid respectively. They are major component in
the brain (Sastry 1985). It’s well established the role of ARA through the body during
time of injury and stress when it is released from the cell membrane by phospholipase A2
and metabolized into other bioactive substances such as prostaglandins by enzymes like
cyclooxygenases, leading to various physiological functions (Bazan et al. 1993, Stella et
al. 1995, Oomagari et al. 1991). In general FA are essential nutrients used in a myriad
array of cellular processes. They are the building blocks of glycerophospholipids and
sphingolipids to build all biological membranes. As the more caloric dense nutrient of
our diet lipids are used as storehouse for triacylglycerol to be broken down during
starvation. They are used to modify proteins for signal transduction and immune
recognition (Afshordel et al. 2015). During neurogenesis and nerve regeneration
increased amount of fatty acids are needed to synthesize and expand the neurite network
which is the hallmark of the nervous system. Thus, we can conclude that the normal
function of the nervous system is dependent on the healthy metabolism of fatty acids.

FABP
Given that the blood is an aqueous media FAs cannot be solubilized easily and
need the assistance of albumin to be carried in the blood to its destination (Richieri et al.
1993). In the blood lipids form complexes with lipoprotein to signal their fate and
modulate fat metabolism or the metabolism of the tissue where they are taken to (JacomeSosa & Parks 2014, Picq et al. 2010, Voshol et al. 2009). Once inside the cell fatty acids
and fatty acids binding proteins complexes signal for nuclear hormone receptors like
peroxisome proliferator-activated receptor (PPAR) for gene expression and protein
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regulation (Atshaves et al. 2010, Schroeder et al. 2008).
The interactions of FABPs and their ligands are quite complex. FABPs show a
variety of ligand specificity, but many FABPs have a general tendency to bind to longchain PUFAs more strongly than to short-chain saturated fatty acids (Zimmerman et al.
2001). For example, FABP7 shows higher predilection for long PUFAs such as
eicosapentanoic acid (EPA; 20:5), DHA (22:6), and ARA (24:4), but low binding affinity
to the saturated fatty acids like lauric acid (12:0), palmitic acid (16:0), and stearic acid
(18:2), while FABP3 has higher affinity to shorter PUFAs, like oleic acid (18:1), and
linolenic acid (18:2) than long PUFAs, like EPA and DHA (Balendiran et al. 2000).
FABP5 binds not only to long PUFAs but also to eicosanoids such as 5 (S)- and 15 (S)hydroperoxyeicosatetraenoic acid (HPETE), which are ARA metabolites, with moderate
binding affinities (Kane et al. 1996).
FABP5 (or epidermal fatty acid binding protein, EFABP) in particular, is the one
expressed the most in the developing brain (Liu et al. 2000, Owada et al. 1996b). In the
adult brain, FABP5 expression is observed in both neurons and glia in a region specific
manner with various intensities (Owada 2008). FABP5 is induced by peripheral nerve
injury, indicating its potential role on neuroregeneration (Owada et al. 1996a, De Leon et
al. 1996). Although significant expression of FABP5 is observed in the developing brain,
FABP5-knockout mice are viable and show no significant deficit in the brain at neither
macro- nor microscopic level (Owada et al. 2002). But it’s been reported that FABP5
knockout mice have reduced neurogenesis in the hippocampus (Matsumata et al. 2012).
FABP5 have been observed to regulate cognitive function such as learning and memory
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through the degradation of endocannabinoid anandamide and the PPARβ/δ activation (Yu
et al. 2014).
Our group has published important observations about FABP5 in neurogenesis,
differentiation and neuroprotection. De Leon et al published the findings that fatty acid
binding protein 5 is induced in neurons of the dorsal root ganglia after peripheral nerve
injury in the sciatic nerve (De Leon et al. 1996). Liu, et al reported that FABP5 (DA11)
expression coincides with axon growth and neuronal differentiation during central
nervous tissue development. There was a correlation in time and space evidenced by
Northern blots, Western blots and immune- cytochemistry. (Liu et al. 1997). Allen et al.
reported that depletion of a fatty acid binding protein impairs neurite outgrowth in PC12
cells during differentiation with nerve growth factor (Allen et al. 2000). Along these
lines, Allen et al. described the same phenomenon in retinal ganglion cells by showing
induction and axonal localization of FABP5 during differentiation and axon growth
(Allen et al. 2001). More recently Liu et al. showed that DHA increases FABP5
expression and FABP5 mediates DHA/EPA enhanced neurite outgrowth in PC12 cells
(Liu et al. 2008). Further, Liu et al. reported that FABP5 protects nerve growth factor
differentiated PC12 cells from lipotoxic injury when PPARβ and PPARγ are stimulated
resulting in decrease ROS and increased cell viability (Liu et al. 2015).

DHA
DHA is a highly polyunsaturated fatty acid of the ω-3 series with 22 carbon atoms
and six cis double bonds. This chemical arrangement gives DHA the curved (kinked or
bent) structure that is key to its capacity to increase the fluidity of membranes (Stillwell
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& Wassall 2003, Hashimoto et al. 1999). In a diverse array of experiments increasing
membrane fluidity resulted in increased drug permeability (Roach et al. 2004), carrier
mediated transport (Wu & Robinson 1999), activities of membrane-bound enzymes
(Keeffe et al. 1980), and enhanced neurotransmission (Clarke et al. 1999). The common
biochemical event to all these processes is the microaggregation and conformational
change of receptors and enzymes at the membrane surface. The strongest inducer of
membrane fluidity is ω-3 polyunsaturated fatty acid specially DHA (Hashimoto et al.
1999, Onuki et al. 2006). Yehuda et al. (Yehuda et al. 1997) showed that
polyunsaturated fatty acids affect brain functions by modifying membrane fluidity,
activity of membrane-bound enzymes, number and affinity of receptors, functions of ion
channels, production and activity of neurotransmitter, and signal transduction. Moreover,
an increased incorporation of DHA into synaptic membranes reportedly improves signal
transduction involving phospholipase A2 and/or C (Jones et al. 1997), enhances
glutaminergic (Kim et al. 2011) and dopaminergic (Zimmer et al. 1998) synaptic
activities, and enhances [3H]-noradrenaline release in SH-SY5Y cultured cells (Mathieu
et al. 2010). Lastly Hashimoto et al. (Hashimoto et al. 2006) has reported that
neurobehavioral effects, particularly avoidance-related memory function, are associated
with neuronal plasma membrane fluidity.
DHA has antioxidant properties. This might sound counterintuitive because DHA
is highly polyunsaturated and an increase in the number of double bonds renders cells
more susceptible to damage by oxidation (Saito & Nakatsugawa 1994). It is published
that the concentration of Arachidonic acid (ω-6 polyunsaturated fatty acid) is positively
correlated with the levels of lipid peroxidation; however, the concentration of DHA was
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negatively correlated with levels of lipid peroxidation. Based on these findings the
authors concluded that the molar ratio of DHA/AA acted as an indicator of antioxidant
defense (Bondy & Orozco 1994). Also working as an indirect antioxidant oral
administration of DHA increase the enzyme activity of catalase, glutathione peroxidase
(GPx) and glutathione reductase (GR) (Hossain et al. 1999).
Dietary supplementation with DHA restores neurotransmitter release and
impairment in expression of long term potentiation (Fujita et al. 2001). N-Methyl-DAspartate (NMDA) receptor is key for the induction of long term potentiation. Inhibitors
of NMDAR such as AP5 (Morris 1989) stop the induction of long term potentiation in
the hippocampus. Transgenic mice with increased NMDAR expression, showed
increased memory (Tang et al. 2001). DHA increased the mRNA expression of the
NMDA receptor in the hippocampus of DHA fed rats compared to control (Hashimoto et
al. 2017). Therefore DHA seems to be important for memory consolidation because it
increases the expression and/or activation of mostly every key protein involved in long
term potentiation like BDNF (brain derived neurotrophic factor) (Bhatia et al. 2011),
NR2B (a subcomponent of the NMDA receptor) (Dyall et al. 2007), and TrKB (tyrosine
protein kinase B) involved in differentiation and survival of specific neuronal population
(Bhatia et al. 2011). Taken together DHA directly or indirectly regulates the expression
of various genes and may exert increasing effects on learning and memory.
Moreover DHA elevated the number of Tuj-1-positive neurons (marker of neural
stem cells) taken from the dentate gyrus of the hippocampus when compared with that of
control after 4 or 7 days of cultures from 15 day old rat embryos (Kawakita et al. 2006).
The DHA treated cells were morphologically more mature and numerous than that of
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control. This observation is worth noting because the dentate gyrus is critical for
forming and storing spatial memories. It is one of the regions of the brain where neuronal
progenitor cells constantly produced new neurons (neurogenesis), which then integrate
into the new neuronal network and form new synapses with other neurons (Gross 2000).
The proposed mechanism is that DHA stimulated the differentiation of neuronal stem
cells into neurons by inducing the exit from cell cycle and suppressing cell death.
Another mechanism by which DHA exerts its effect is by modifying lipid-raft
domain in the cell membrane. Lipid rafts or caveolae are specialized membrane
structures composed of saturated fatty acids and cholesterol-rich membrane-invaginated
floating microdomains. The enrichment of DHA in these lipid-raft domains induces the
expulsion of cholesterol and saturated fatty acids, and renders it more fluid for better
protein-protein and lipid-protein interaction that facilitates specific signal transduction
(Eckert PE. Manipulation of lipid rafts in neuronal cells. Open Biol J. 2010;3:32-38).
Lipid rafts are involved in intracellular trafficking of proteins and lipids, secretoryendocytic pathways, signal transduction, inflammatory and proteolytic signals (TsuiPierchala et al. 2002).
DHA is now recognized as an important signaling molecule, particularly in brain
function. EPA, (20:5, n-3) the precursor of DHA, can act as a substrate for the AAcascade enzyme, producing alternatives eicosanoids such as 3-series prostanoids and 5series leukotrienes, which are considered to be anti-inflammatory and/or less proinflammatory than AA-derived metabolites (Moreno 2009). Recently DHA-derived
mediators (docosanoids) have been reported in brain circuity. The best well known is
neuroprotective D-1 (NPD1), formed from free DHA through 15-lipoxygenase-1 (15-
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LOX-1) (Bazan et al. 2011). NPD1 has been reported to decrease Aβ42 release in
Alzheimer’s disease (Lukiw et al. 2005), and to downregulate inflammatory signaling,
amyloidogenic APP cleavage and apoptosis (Chen et al. 2012). It’s been described that
NPD1 interacts with peroxisome-proliferator activated receptor-γ (PPARγ), and induces
the expression of genes which control lipoprotein metabolism, adipogenesis and insulin
sensitivity (Tontonoz & Spiegelman 2008, Zhao et al. 2011). The induction of these
proteins enhances survival of neurons under circumstances of chronic ischemia and
Alzheimer’s disease. Many other DHA-derived docosanoids metabolites like oxylipines,
neuroprostanes, protectines, maresines and resolvines have already been identified but
their specific function remains unknown (Galano et al. 2018).
Our group has reported diverse effect of DHA on neurons during differentiation,
lipotoxicity and spinal cord injury. Almaguel et al reported that NGFDPC12 cells cotreated with PA and DHA (PA+DHA) from the start exhibited increased cell viability.
Interestingly, NGFDPC12 cells pre-incubated in DHA for 12 hours before PA treatment
(there was no DHA during PA treatment) showed a moderate decrease in viability when
compared to control cells and cells undergoing lipotoxicity without previous DHA
treatment. DHA decreased the morphological features of apoptosis as well as apoptotic
nuclei during lipotoxicity. Also, DHA co-treatment inhibited the PA-induced apoptotic
cleavage of PARP and Lamin-B. More over DHA stabilized mitochondrial membrane
potential. The PA-LTx induced apoptosis and reversal with DHA was also tested in
primary rat cortical cells (Almaguel et al. 2009). In another series of experiment
Almaguel et al. published again that DHA keeps the integrity of lysosomal membranes
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during PA-LTx and prevents cathepsin-L over spilling from the lysosomes (Almaguel et
al. 2010).
Using Sprague-Dawley rats Figueroa et al. (Figueroa et al. 2012) showed that
injection of DHA through the tail vein before spinal cord injury ameliorates functional
locomotor deficits and inhibits the apoptotic pathway but not necessarily the
inflammatory pathway. In 2013 Figueroa et al. also published that spinal cord injury
triggers a robust alteration in the cord PUFA neurolipidome, which was characterized by
a marked docosahexaenoic acid (DHA) deficiency. Pre-treated animals with DHA
exhibited lower sensory deficits, better autonomic bladder recovery, and early
improvements in locomotion that persisted for at least 8 weeks after trauma (Figueroa et
al. 2013a). In another work done the same year Figueroa et al. showed that ω-3 PUFAs
provides significant antinociceptive benefits and attenuated the development of belowlevel thermal hyperalgesia. Also, metabolomic profiling revealed that DHA led to
accumulation of novel N-acyl ethanolamines precursors including the glycerophosphocontaining docosahexaenoyl ethanolamine (DHEA), docosapentaenoyl ethanolamine
(DPEA), and eicosapentaenoyl ethanolamine (EPEA) (Figueroa et al. 2013b). And lastly
in 2014 Figueroa et al. used Sprague-Dawley rats to identify and define the dominant
metabolic pathways targeted by dietary long chain ω-3 poly unsaturated fatty acids. They
reported that the spinal cord metabolome of animals fed with long chain ω-3 PUFA
exhibited increases in the level of antioxidant/ anti-inflammatory amino acids and
peptides metabolites (Figueroa & De Leon 2014).
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Autophagy
Autophagy is the degradative mechanism with higher capacity in the cell.
Contrary to ubiquitin-proteasome degradation, autophagy is a lysosomal degradation
pathway that is able to target large protein aggregates and even entire organelles. It is not
restricted to protein degradation but breaks down lipids, DNA and RNA so that they can
be recycled for energy or building materials (Wirawan et al. 2012). Autophagy is
generally considered to be a pro-survival pathway protecting cells under stress or poor
nutrient conditions. In this way autophagy provides new pools of amino acids, fatty acids
and nucleosides for anabolic process and drives a continuous flow of materials in the cell
(Rabinowitz & White 2010). Autophagy preserves the health of cells and tissues by
replacing old, outdated and damaged cellular components and even whole organelles with
new ones. During starvation, hypoxia or high oxidative stress it provides an internal
source of nutrients for energy generation and survival. Autophagy is particularly
important in neurons because they are non-dividing cells and are more sensitive to
accumulation of toxic components (Hara et al. 2006). Second, the brain needs a constant
supply of energy even under conditions of stress like ischemia, starvation or infection.
It’s well known that inhibition of autophagy causes neurodegeneration in mature neurons
indicating that autophagy may regulate neuronal homeostasis (Komatsu et al. 2006).
Many stress signals stimulate both autophagy and apoptosis and at the same time
autophagy and apoptosis are regulating each other. The Bcl-2-binding factor Beclin-1
(ATG6) is the central protein controlling this process (Glick et al. 2010). Beclin-1
associates with VPS34 (vacuolar protein sorting 34) and initiates the isolation of double
membrane to start autophagy. This Beclin-1/VPS34 complex is inhibited when bound by
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Bcl-2 mainly or Bcl-X. In the situation that c-Jun N-terminal kinases (JNK) is activated,
which causes Bcl-2 phosphorylation, frees Beclin-1 to form active Beclin-1/VPS34
complex and initiate autophagy. Another control of autophagy is the activation of DAPK
(death associated protein kinase), which causes the phosphorylation of Beclin-1 and also
frees Beclin-1 to form active Beclin-1/VPS34 complex to initiate autophagy (Todde et al.
2009). Autophagy is able to inhibit apoptosis, by means of reducing damaged
mitochondria (mitophagy) or pro-apoptotic proteins (Green & Levine 2014). When the
intensity of stress overcome the capability of autophagy, the apoptosis-stimulated
caspases may digest essential autophagy proteins and disable autophagy pathway (Long
& Ryan 2012) or Bcl-2 is inactivated and not able to inhibit Bak and Bax leading to
apoptosis (Mizushima & Levine 2010). There is a line of thought regarding autophagy as
a cell death mechanism. This rational comes from the fact that autophagy inhibitors
sometimes stimulate cell survival (Zhang et al. 2009b). The main reason is that the
regulation of autophagy is context dependent. Autophagy inhibitor Bafilomaycin-1 works
by neutralizing (inhibiting the acidification) lysosomal pH and 3-methyladenine (3-MA),
a PI3K inhibitor, by modulating mTOR activity. When a stress is severe or ATP
deficiency is prolonged, the integrity of lysosomes or autophagolysosomes will be
impaired and the vesicle contents of autolysome may be spilled into the cytoplasm, i.e.
hyperautophagy. At this point, reducing hydrolazes/cathepsins activity by increasing pH
(in the case of Bafilomaycin-1) or decreasing additional autolysome formation (in the
case of 3-MA) may provide cells temporary protective effect.
Additionally, the nutrient environment may affect the effect of 3-MA. It is shown
that 3-MA promotes autophagy under nutrient-rich conditions, whereas 3-MA inhibits
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starvation-induced autophagy. These results are attributed to differential effects on class I
versus class III PI3K (Wu et al. 2010). Therefore, the mere accumulation of autophagic
vesicles when cells were dying cannot be interpreted as an evidence of autophagic cell
death (ACD), this may actually reflect death accompanied by the block of autophagic
flux with its concomitant accumulation of vacuoles rather than death mediated by
autophagy itself (Marino et al. 2014). Under stress, the cell will ramp up the autophagic
flux to get rid of harmful products in an effort to cope with the challenge. But if the
damaged products cannot be degraded, the apoptotic or necroptotic machinery (that has
some autophagic features like cathepsins activation) will prevail.
Moreover, most of the research done where autophagy was described as a cell
death process mechanism is either using cancer cells or tumor models where the specific
microenvironment of starvation and hypoxia inside of the tumor promote the increase in
survival genes, proteins and autophagy (Xie & Klionsky 2007). However, in mammals
ACD is one mechanism of cell death through a non-apoptotic or necrotic pathway that is
documented in pathological or drug-induced conditions (Zhu et al. 2007).
Autophagy morphology is often evident in cells going through programed cell
death because it shares some of the machinery with apoptosis and necroptosis (Lu et al.
2011). This tightly controlled interaction within the death-inducing signaling complex
comprises FADD, RIP1, caspase 8 and some of the catalytic proteins for autophagy,
ATG5:ATG12 and ATG16 (Bell et al. 2008). The constant inhibition of necroptosis by
basal caspase 8 maintains a basal level of autophagy and the constant basal level of
autophagy will digest caspase 8 to inhibit the apoptotic cascade. By inhibiting Beclin-1
by Bcl-2 the cell secures that neither necroptosis nor enhanced autophagy take place (Luo
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& Rubinsztein 2010, Maiuri et al. 2007). In a T-cell model lacking caspase 8 and FADD
the cell develops a hyperautophagic morphology and dies from necroptosis, which could
be prevented with necroptosis inhibitor and deletion of RIP3K, (Lu et al. 2011).

Lipotoxicity
Overweight and obesity are rampant in United States of America. According to
the CDC 34% of the population are obese and over two thirds are overweight and/or
obese in the United States (https://www.cdc.gov/obesity/data/adult.html, accessed May
2018). Consumption of a diet rich in fats increases the levels of saturated fatty acids in
serum (Gambino et al. 2016) and brain particularly the hypothalamus (Posey et al. 2009).
The most abundant saturated fatty acid in the diet is Palmitic Acid and the one most
elevated after an oral fat load (Gambino et al. 2016). When the storing capacity of
adipocytes has reached its maximum, lipids are distributed to other organs triggering
lipotoxicity. This over spilling of lipid to the peripheral tissue promotes visceral obesity
and the onset of type 2 diabetes mellitus among other diseases (Guilherme et al. 2008,
Unger & Scherer 2010).
The accumulation of Palmitic Acid and its metabolites in the hypothalamus
induces inflammation in the tissue and cell stress at endoplasmic reticulum level with a
decrease in insulin signaling, metabolic derangement and more weight gain and obesity
(Benoit et al. 2009) (Posey et al. 2009). In cultured hypothalamic neuropeptide Y cells
exposed to palmitic acid a decreased in insulin signaling could be observed as evidenced
by reduced insulin-stimulated phosphor Akt and increased caspase-3 protein levels
(Mayer & Belsham 2010). It’s been also reported that this 16 carbon free fatty acid in
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hypothalamic neurons in vitro increases the mRNA expression of pro-inflammatory
cytokines IL-6, TNF-α, and IL-1β, the classical endoplasmic reticulum markers Chop,
Bax/Bax, increased Bax/Bcl-2 ratio, and Grp78 among others protein involved in the
unfolded protein response. (Dalvi et al. 2017, McFadden et al. 2014, Ye et al. 2016). The
palmitic acid metabolite ceramide is associated with insulin resistance and apoptosis in
hypothalamic neurons in Zucker diabetic rats (Chavez et al. 2003, Contreras et al. 2014).
The detrimental effects of FFA and PA in particular are not only observed in
neuronal tissue. Gao et al (Gao et al. 2014) described that palmitate impairs endothelial
function through COX-2 up-regulation and COX-2-dependent ROS over-production in
mouse aortic endothelial cells. Palmitic acid triggers inflammation through activation of
toll-like receptor-dependent IKKα-NF-κB signaling in human endothelial cells (Maloney
et al. 2009), increases endoplasmic reticulum stress and apoptosis in mouse endothelial
cells (Li et al. 2013), and promotes ROS formation from mitochondrial electron transport
chain and NADPH oxidase in rat skeletal muscle (Lambertucci et al. 2008). In diabetic
and obese individuals, increased saturated fatty acids stimulate prostaglandin production
(Hellmann et al. 2013). FFAs activate protein kinase C and reduces endotheliumdependent relaxations in rat aortas (Li et al. 2011) while inhibition of protein kinase C or
adenosine monophosphate-activated kinase attenuates the stimulatory effect of PA on
ROS production in human endothelial cells (Mugabo et al. 2011). In addition, PA lowers
nitric oxide (NO) bioavailability through reducing the phosphorylation of Akt and eNOS
(Tian et al. 2012).
Palmitic acid also induces reactive oxygen species (ROS) production with lose of
mitochondrial membrane potential (Δψm) and mitochondrial induced cell death
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(Lambertucci et al. 2008, Koshkin et al. 2008). In pancreatic β-cell lines lipotoxicity
induces the Ca-dependent assembly of the mitochondrial permeability transition pore
(MTP). Palmitate was significantly a more efficient inducer of MPT than the unsaturated
FA oleate, although upon acute application both caused similar MPT activation.
Treatment with antioxidants, inhibitors of the ceramide pathway, or modifiers of
membrane fluidity did not protect β-cell mitochondria from FA exposure. However,
significant protection was provided by co-application of the unsaturated FA oleate in a
phosphatidylinositol 3-kinase-dependent manner (Koshkin et al. 2008).
According to the center for disease control (https://www.cdc.gov/stroke/facts.htm
accessed April 2018) every year more than 795,000 people have a stroke. About 610,000
of these are first or new strokes and 140,000 will die of stroke each year. The cost to the
United States is estimated at $34 billion each year and is a leading cause of serious longterm disability and immobility in more than half of the stroke survivors. The cardinal
features observed during stroke or traumatic brain injury are glutamate release, increased
intracellular Ca2+ levels, phospholipids degradation, local accumulation of free fatty
acids, free radical formation and lipid peroxidation (White et al. 2000). FFAs play an
important role in what is called the delayed phase of neuronal injury. FFAs accumulate
in response to ischemia-hypoxia as a consequence of lecithinases and phospholipases
activation with concomitant membrane degradation (Bazan et al. 1971) (Belayev et al.
2004). After injury the fatty acids with the higher concentration expressed in the CSF are
C16:0˃C18:0˃C18:1˃C20:4˃C22:6 (Sun et al. 1994). This accumulation is central to
the delayed phase that induces apoptosis in the area of the penumbra days later after the
original insult (Sun & Gilboe 1994).
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Our group has published that palmitic acid at concentrations comparable to those
found following traumatic brain injury, trigger cell death. NGFDPC12 cells exposed to
oleic and arachidonic acids display normal cell survival. However, when cells are
exposed to stearic and palmitic acids, there is a dramatic loss of cell viability that is
apoptotic as assessed by morphological analysis, and activation of caspase-8 and caspase3-like activities (Ulloth et al. 2003). We also have published that in NGFDPC12 cells
PA induces reactive oxygen species, alteration of the mitochondrial transmembrane
potential, and increase in the mRNA levels cell death-associated proteins BNIP3 and
FAS receptor (Almaguel et al. 2009). A year later Almaguel et al. published that PA
induces lysosomal membrane permeabilization before mitochondrial membrane
permeabilization and cathepsin L activation in NGFDPC12 cells (Almaguel et al. 2010).
In 2011 Padilla et al. reported that in Schwann cells hyperglycemia magnifies cell
dysfunction during PA-LTx as measured by a decrease in Ca2+ and an increase in
endoplasmic reticulum stress signature genes CHOP, XBP1 and GRP78 with cell death
measured by Annexin V/7AAD (Padilla et al. 2011).

Apoptosis
Apoptosis is one of several types of programmed cell death and is described by its
microscopical morphological characteristics like nuclear condensation and fragmentation
(pyknosis and karyorrhexis respectively), blebbing of the plasma membrane and at the
end apoptotic bodies (Marino et al. 2014). Besides morphological changes there are
some biochemical events that execute apoptosis. Mitochondrial outer membrane
permeabilization (MOMP), activation of the effector caspases like caspase 3, caspase 6,
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and caspase 7 and the activation of catabolic hydrolases that degrades the DNA in the
nucleus (Galluzzi et al. 2009). In physiological terms the whole events of apoptosis are
rarely seen because apoptotic cells are engulfed and degraded by phagocytic cells before
the full apoptotic phenotype can be displayed (Galluzzi et al. 2009).
Depending on the kind of trigger apoptosis is described in two categories albeit
the final outcome is the same. Extrinsic apoptotic pathway occurs in response to
stimulation of the death receptors, which are CD95 (also known as FAS), tumor necrosis
factor receptor 1 or TNF-related apoptosis-inducing ligand receptor (TRAILR). This
results in the recruitment of several proteins, including FAS-associated death domain
(FADD), TNFR1-associated death domain (TRADD) and caspase 8. Activated caspase 8
then proteolytically activates downstream effector caspases or truncates the BH3 (BCL-2
homology 3)-only protein BID (BH3-interacting domain death agonist), which coactivates the intrinsic pathway of apoptosis by translocating to mitochondria.
On the other hand, the intrinsic apoptosis pathway is mainly a mitochondrial
triggered event. Any stimulus that destabilizes the mitochondria membrane potential
induces the mitochondrial membrane permeabilization pore with its concomitant
cytochrome C release from the intermembrane space. Once cytochrome C is in the
cytosol it triggers the assembly of a caspase-activating complex between caspase 9 and
apoptotic protease-activating factor 1 (APAF1; the apoptosome). Mitochondrial outer
membrane permeabilization (MOMP) can be triggered by the activation of BH3-only
proteins following their mobilization from other subcellular compartments and their posttranslational modification (such as phosphorylation or proteolysis) or transcriptional
upregulation (for instance in response to p53 activation) (Vousden & Lane 2007). BH3-
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only proteins generally stimulate MOMP by inducing the oligomerization of Bcl-2associated X protein (BAX) and/or Bcl-2 antagonist or killer (BAK) in the outer
mitochondrial membrane, an in this way forming channels that mediate the liberation of
soluble proteins from the mitochondrial intermembrane space (Adams & Cory 2007,
Galonek & Hardwick 2006). Another intrinsic trigger for apoptosis is DNA damage that
stimulates the transactivation of genes encoding pro-apoptotic proteins such as NOXA
and PUMA (p53 upregulated modulator of apoptosis) by p53, or activated caspase 2 in a
p53-dependent manner. Caspase 2 may then induce MOMP and activate other caspases,
such as caspase 3, directly. It is worth noting that some of the protein released from the
mitochondria can also induced caspase independent cell death. Proteins like apoptosisinducing factor (AIF) and endonuclease G (EndoG) can promote caspase-independent
cell death (Kroemer & Martin 2005) that can be due to lysosomal membrane
permeabilization (LMP) and release of cathepsin proteases into the cytosol (Boya &
Kroemer 2008). In turn cathepsins can also trigger MOMP, thereby stimulating the
intrinsic apoptotic pathway (Boya & Kroemer 2008).

Necrosis / Necroptosis
Distinct from apoptosis, the morphology of necrosis is characterized by cell
swelling, plasma membrane permeabilization and finally rupture with spilling of
intracellular products inducing inflammation (Vandenabeele et al. 2010b). Some have
described necrosis with features of lysosomal degradation, release of lysosomal
hydrolases and increased breakdown of the cell membrane and organelles (Boya &
Kroemer 2008). Different from apoptosis, the nuclei of necrotic cells remains largely
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intact (Vandenabeele et al. 2010b). As a surprised to the field of cell death Vercammen
et al. (Vercammen et al. 1998) showed that classical death receptors could induce
necrosis upon inhibition of apoptosis by the caspase inhibitor, zVAD-fmk. Later on,
others reported that this kind of cell death involved the activation of kinases of the
receptor interacting protein (RIP) family, RIP1 and RIP3 (Holler et al. 2000, He et al.
2009, Zhang et al. 2009a). In 2005 Degterev et al. (Degterev et al. 2005) discovered that
necrostatin-1 was a potent inhibitor of this kind of programmed necrosis cell death and it
was given the name necroptosis.
The best characterized signal for necroptosis is the tumor necrosis factor receptor
1 (TNFR1), which induces the assembly of a cytoplasmic complex (TNFR1 complex1)
composed of TNFR-associated death domain (TRADD), cellular inhibitor of apoptosis 1
(cIAP1), cIAP2 and as we mentioned before receptor interacting protein kinase 1 (RIP1
or RIPK1) (Chan et al. 2003). Once the complex I is formed, RIP1 might be targeted for
ubiquitylation by cIAP and for deubiquitylation by cylindromatosis (CYLD) and A20
(another name TNFAIP3) (Csomos et al. 2009, Rothe et al. 1995). The two possible
outcomes are ubiquitylated RIP1 promoting the activation of nuclear factor-κB (NF-κB
system) that activates cytoprotective genes and facilitates cell survival or deubiquitylated
RIP1 functioning as a cell death-inducing kinase. If the TNFR1 is internalized, it
combines with TRADD, FAS-associated protein with a death domain (FADD) and
caspase 8 forming what is called complex II (Micheau & Tschopp 2003, Christofferson &
Yuan 2010). In a normal physiological situation once the complex II is formed, caspase
8 becomes activated triggering the pro-apoptotic caspase. Caspase 8 inactivates RIP1 and
RIP3 by proteolytic cleavage and initiates the pro-apoptotic caspase cascade (Feng et al.
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2007). If caspase 8 is deleted, depleted or inhibited, complex II cannot enter the
apoptotic mode and TNFR1 ligation results in RIP1 physically and functionally
interacting with RIP3 forming the necrosome complex and inducing (at least in some cell
types) programmed necrosis or necroptosis (Vercammen et al. 1998).
Necrostatin 1 abolishes the assembly of the RIP1–RIP3 complex, suggesting that
the kinase activity of RIP1 is required for necrosome formation. Necroptosis depends on
a tightly regulated mutual relationship between RIP1 and RIP3 kinase activities,
involving the autophosphorylation of RIP1 on Ser161 and direct or indirect RIP3mediated phosphorylation of RIP1 (He et al. 2009). The inhibition of RIP1 by
necrostatin 1 truncates (in most systems) the RIP1-RIP3 interaction and abolishes
necroptosis. There are some examples where RIP1 was not required for the execution of
necroptosis. In a murine model cytomegalovirus infection was shown to induce RIP3dependent but RIP1 independent necroptosis (Upton et al. 2010). Overexpression of
catalytically active RIP3 can trigger necroptosis irrespective of the presence of RIP1
(Zhang et al. 2009a). According to Vandenabeele ((Vandenabeele et al. 2010b) the RIP1
independent necroptosis is always induced in a virus infected model in vivo or in vitro.
We infer that because (as we will show in chapter 2) the type of necroptosis we induced
with the PA and zVAD combination is the classical necrosome dependent cascade,
necrostatin 1 is able to block it and increase cell survival.
ROS also seem to play a role in necroptosis cell death. Although ROS production
is not necessary for all cases of TNF-induced necrosis, the kinase activity of RIP3 might
link TNFR1, mitochondria functional status and ROS production. RIP3 interacts with
several metabolic enzymes like glycogen phophorylase (PYGL), glutamate-ammonia
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ligase (GLUL) and glutamate dehydrogenase (GLUD1) (Vandenabeele et al. 2010a).
These enzymes are directly involved in the metabolism of energy substrates and
indirectly induce the production of ROS resulting in unbalance redox status. Knock
down of any of these enzymes attenuates TNF plus zVAD.fmk-mediated ROS production
and necroptosis (Zhang et al. 2009a). We propose that PA-LTx-dependent ROS induces
the cellular signaling necessary for complex II formation and as we will see in chapter 2
the presence of zVAD.fmk will tip the scale for necroptosis. ROS can react with
polyunsaturated fatty acids in cellular membranes to generate reactive aldehydes (such as
4-hydroxynonenal), they in turn can oxidase proteins and lipids in organelles and
membranes, thereby affecting their structure and function (Benedetti et al. 1980). In
mitochondria, the products of lipid peroxidation inhibit oxidative phosphorylation, alters
the permeability of the inner membrane, disrupts the mitochondrial Δψ and reduce the
Ca2+ buffering capacity, thus contributing to necrosis (Orrenius et al. 2007). And what
might be the final outcome, destabilization of cellular membranes due to lipid
peroxidation (including the plasma, lysosomal and ER membranes) results in a leakage of
proteases or an elevation of cytosolic Ca2+ concentrations, two events that take place in
necrotic cell death (Benedetti et al. 1980). Taking all of this information into
consideration we conclude that inhibition of necroptosis (in this present study by the
RIP1 inhibitor necrostatin-1) can confer consistent neuroprotection, suggesting that
necroptosis may constitute a promising target for treating nerve injury.

Hypoxia
The brain utilizes 20-25% of all oxygen consumed by the body (Hoiland et al.
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2016). The neurons or the central nervous system in general have no capacity to store
substrates for ATP production because it doesn’t store glucose nor oxygen to be used on
demand. Therefore disruption of cerebral blood flow rapidly results in a hypoxic or
anoxic state that triggers an array of mechanism leading to cell death (Guo et al. 2011).
The classical description of CNS injury during hypoxia (Dirnagl et al. 1999) is a sharp
decrease in pH, glutamate excitotoxicity, production of oxygen free radicals and
oxidative stress, with acute necrosis with inflammation followed by prolonged periods of
delayed cell death by apoptosis. Mitochondria respiratory dysfunction results in
decreased ATP and the formation of reactive oxygen species. On the other hand,
excitatory neurotransmitters, such as glutamate, bind to a variety of receptors allowing
for an influx of calcium ions with depolarization (Nathaniel et al. 2015). Because
glutamate reuptake is an energy driven process, the lack of ATP availability during
hypoxia allows for glutamate to persist more time in the neural cleft and induce more
influx of calcium and toxicity. Also because of lack of ATP the Na+/Ca2+ pump fails to
extrude Ca2+ out and the resultant high intracellular Ca2+ triggers a series of events that
end up in mitochondrial dysfunction and cell death (Thushara Vijayakumar et al. 2016).
This accidental and not-regulated type of cell death cannot be prevented or modulated.
This type of cell death will induce the release of DAMPs (damage-associated molecular
patterns) that eventually will have a toxic effects on surrounding cells that survived the
initial insult and will make the primary injury bigger (van der Kooij et al. 2010). The
main forms of delayed or regulated cell death under hypoxia are apoptosis and to a lesser
extent necroptosis of which we already spoke about in their respective sections of this
introduction. The main mediator of hypoxia induced endotoxicity is the activation of
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HIF-1α (hypoxia inducible factor-1α) that induces the activation of stress response
protein or cell death pathways. HIF-1α is part of the heterodimer Hypoxia Inducible
Factor (HIF). Under normoxia conditions HIF-1α is hydroxylated by proline
hydroxylases and targeted for proteasome degradation via von Hippel Lindau E3
ubiquitine ligase complex. Under hypoxia conditions, proline hydroxylase is not able to
hydroxylate HIF-1α rendering it stable and able to interact with HIF-β becoming a
heterodimer that stimulates the expression of hundreds of Hypoxia Response Elementscontaining genes (Bargiela et al. 2018).
HIF-1α induces the expression and interacts with BNIP3 (Bcl-2 adenovirus E1B
19-kDa interacting protein 3) (Bellot et al. 2009). This interaction at the early stages of
the injury hinders the capacity of Bcl-2 to inhibit the master protein controlling
autophagy, Beclin-1 also known as ATG6 (Kim et al. 2013). Once Bcl-2 is inhibited
Beclin-1 could be phosphorylated and the Beclin1-Vps34-ATGs-LC3 complex can be
assembled (Codogno et al. 2011). This interaction has preference when ATP is available
and takes place near the ER membrane. As we will demonstrate in chapter 4 this is the
route for survival in our model. When the availability of oxygen and energy is low and
the amount of reactive oxygen species is high the interaction of HIF-1α with BNIP3
during cell injury and stress will tip the cell machinery into cell death. This other
mechanism is spatially separated and takes place in the vicinity of the mitochondria. This
time HIF-1α+BNIP3 will prevent the interaction of Bcl-2 in another domain with proapoptotic protein Bax (Bcl-2-associated X protein) and Bak (Bcl-2 antagonist/killer 1)
(Ravagnan et al. 2002). The activation of these proteins at the mitochondrial membrane
elicit the formation of the mitochondrial transition pore with cytochrome C release from
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the mitochondria. Cytochrome C release will form the complex (apoptosome) with
deoxy-ATP, apoptotic peptidase-activating factor 1 (APAF-1) and caspase-9 leading to
the downstream activation of the executioner caspase-3 (Li et al. 1997).
It’s been well known for many years the benefits of polyunsaturated fatty acids in
the whole body and nervous system. In the heart eicosapentaenoic acid protects
cardiomyoblasts from lipotoxicity in an autophagy dependent manner (Hsu et al. 2018).
In new born piglets DHA reduced oxidative stress and lipid peroxidation following
hypoxia-ischemia in new born piglets (Huun et al. 2018). In a model of traumatic brain
injury in rats DHA provided neuroprotection via activating Nrf2-ARE signaling (Zhu et
al. 2018). In this case DHA decreased the expression of Bax and cleavage of caspase-3
and increased the activity of Bcl-2. In the section of DHA we discussed more of the
effect of DHA and what our lab already has published in regard to polyunsaturated fatty
acids.
It is our purpose in chapter four to test the effect of DHA in NGFDPC12 cells
subjected to a subacute 48 hours hypoxia at .5% [O2] concentration. We hypothesize that
DHA will stimulate the protective response by inducing LC3 and autophagy. There is
activation of phospholipases during hypoxia, particularly phospholipase A2 (PLA2).
PLA2 releases free fatty acids from the membranes and add the effect of lipotoxicity with
peroxidation of other molecules to the already dire condition of the stressed cell. By
stimulating autophagy DHA helps the cell to eliminate damage proteins, organelles and
even mitochondria and prevent the cascade of cytochrome C release with activation of
caspases or the induction of necroptosis when oxygen concentration is low and ATP is
not available. We believe that the mechanism induced by DHA and the proteins it
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activates are targets for therapeutic options during CNS injury by hypoxia, trauma or
degenerative disease.

Hypothesis and Goals
In light of the implications for neuronal lipotoxicity, understanding the
mechanisms of PA-induced cell death is key to develop a strategy for neuroprotection. A
better comprehension of the cell death events taking place during PA-LTx and hypoxia
gives us an opportunity to tackle key proteins and pathways that can be modulated for a
better outcome. DHA inhibiting apoptosis and necroptosis and inducing autophagy is a
novel finding and gives great significance to our project. The long term goal of this study
is to elucidate the mechanisms by which DHA induces its neuroprotective effect, so we
can identify key players and exploit the manipulation for neuronal cell survival. The
objective of this research is to understand how DHA divert the cell from apoptosis/
necroptosis into autophagy. The central hypothesis is that the presence of DHA in an
augmented concentration will make the membranes more fluid, allow the activation of
pro-autophagy proteins and facilitate the formation of the autophagofore during PA-LTx,
hypoxia or another ROS producing environment. The rational of the study is that the
unique chemical properties of polyunsaturated fatty acid gives DHA the capacity to keep
the autophagic flux in the cell. We will focus on the capacity of DHA to inhibit or induce
the main proteins involved in the cell’s fate during PA lipotoxicity.
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Abstract
Lipotoxicity (LTx) leads to cellular dysfunction and cell death and has been
proposed to be an underlying process during traumatic and hypoxic injuries and
neurodegenerative conditions in the nervous system. The objective of this study is to
identify cellular LTx mechanisms and examine whether autophagy mediates the
neuroprotective function of docosahexaenoic acid (DHA). Nerve growth factordifferentiated pheochromocytoma (NGFDPC12) cells exposed to palmitic acid (PA)
show a significant PA-induced lipotoxicity (PA-LTx), evidenced by induction of
apoptosis and increased HIF-1α and BNIP3 gene expression. Treating NGFDPC12 cells
undergoing PA-LTx with the pan-caspase inhibitor ZVAD was not protective, and shifted
the process from apoptosis to necroptosis confirmed with the appearance of the signature
necroptotic Topo I protein cleavage fragments and inhibition with necrostatin-1. In
addition, co-treatment with necrostatin-1 and rapamycin (autophagy promoter), exhibited
greater protection against PA-LTx compared to necrostatin-1 alone. Treatment with DHA
showed a full protection against PA-LTx, and reduced levels of HIF-1α and BNIP3
transcripts. DHA neuroprotection was accompanied with phosphorylation of beclin-1,
appearance of LC3-II, and upregulation of Atg7 and Atg12 genes, which are associated
with induction of autophagy. Further, DHA-induced protection was suppressed by the
lysosomotropic agent chloroquine that has been shown to inhibit the autophagic process.
Our findings suggest that DHA elicits neuroprotection by stimulating autophagy and
inhibiting apoptosis and necroptosis. Protection of cells vulnerable to PA-LTx may
require combinatory interventions that target multiple cell death pathways.
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Introduction
Lipids play essential roles in membrane structure, signal transduction and energy
usage/storage. However, non-adipose cells exposed to lipids overload exhibit lipotoxicity
(LTx), with detrimental consequences including cell death in vitro or in vivo (Ulloth et al.
2003) (Scheff & Dhillon 2004) (Leroy et al. 2008) (Listenberger & Schaffer 2002). The
mechanisms underlying LTx-induced cell death are not well understood in nerve cells,
and there are no adequate treatments to block its detrimental cellular effects. This is
important considering the significant increase in the levels of free fatty acid (FFA)
following traumatic brain injury (TBI), spinal cord injury (SCI), hypoxic-ischemic insults
in the central nervous system (CNS) and peripheral nervous system (PNS), and during
chronic obesity (Dhillon et al. 1997) (Rodriguez de Turco et al. 2002). Our previous
reports showed that saturated fatty acid overload, palmitic acid (PA) in particular, triggers
apoptosis in nerve growth factor-differentiated PC12 (NGFDPC12) cells, primary rat
cortical cells, and Schwann cells (Ulloth et al. 2003) (Almaguel et al. 2009) (Padilla et al.
2011). We also reported that treatment with DHA suppressed PA-LTx but inhibition of
caspases with the pan-caspase inhibitor carbobenzoxy – valyl – alanyl – aspartyl - [Omethyl] - fluoromethylketone (ZVAD) did not prevent the loss of cell viability resulting
from PA-LTx (Ulloth et al. 2003). We concluded that PA-LTx involves caspaseindependent cell death and reasoned that a mechanistic understanding of this process
could provide novel insights into the protective effects of DHA against lipotoxicity
(Ulloth et al., 2003).
Recent studies have shown that stressful conditions that prevent caspases
activation may trigger cells to switch to necroptotic cell death (Galluzzi et al. 2014).
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Necroptosis is driven by the kinases RIP1 and RIP3 (Receptor Interacting Proteins 1 and
3) which together with MLKL (mixed lineage kinase domain-like) forms the
necroptosome. Upon phosphorylation in the necroptosome, MLKL forms pores in the
plasma membrane, triggering release of intracellular contents and lysosomal membrane
permeability (LMP), leading to cytoplasmic degradation (Meng et al. 2016) (Su et al.
2016) (Holler et al. 2000).
Plasma membrane permeabilization is a biochemical hallmark in which
necroptosis, primary necrosis and secondary necrosis converge, leading to the release of
intracellular damaged-associated molecular patterns (DAMPS) into the extracellular
milieu, resulting in a pro-inflammatory immune response (Vanden Berghe et al. 2010).
Under normal cell growth conditions, apoptosis and necroptosis are in a mutual inhibitory
state. During apoptosis, caspase-8 cleaves and inactivates RIP3, preventing necroptosis
from occurring (Newton et al. 2014) (Feltham et al. 2017). Due to its non-inflammatory
properties and highly organized and efficient cell demise program, apoptosis is the
preferred mode of death for the cell, both under normal and pathological states. However,
in recent years necroptosis has emerged as a key pro-inflammatory mode of cell death in
the pathogenesis of human disease, from renal ischemic reperfusion injury, cardiac
hypoxic injury, to hypoxic, traumatic, seizure, and degenerative brain injury (Linkermann
et al. 2012) (Smith et al. 2007) (Oerlemans et al. 2012) (Northington et al. 2011) (Zhu et
al. 2011).
Autophagy is a critical cellular process that eliminates damaged and harmful
intracellular molecules, even organelles, in order to maintain homeostasis and survival in
the presence of stress (Wirawan et al. 2012) (Green & Levine 2014). Autophagy is
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regulated by ATG (autophagy-related) proteins and redistribution of LC3 (microtubuleassociated protein 1 light chain 3). Further, the appearance of lipidated LC3, i.e. LC3-II,
is considered a biochemical hallmark of autophagy. During hypoxia, nutrient depletion,
or growth factor deprivation, autophagy is critical for maintaining cellular ATP and
macromolecular recycling and, therefore, can represent a pro-survival pathway (Bray et
al. 2012, Degenhardt et al. 2006). This process has been observed in primary mice
cortical cells where autophagy was correlated with recovery and cell survival after
hypoxia/reoxygenation injury (Zhang et al. 2013). There is increasing amount of
evidence supporting an interplay between autophagy, apoptosis, and necroptosis (Long &
Ryan 2012). Whether the cell survives or dies by a particular cell death modality in the
presence of an environmental stressor depends on the severity of cellular damage, the
energy/ATP availability, and the levels of endogenous inhibitors of specific survival/cell
death pathways. For instance, low ATP levels may stimulate autophagy to decrease
energy expenditure and avoid necrosis. By contrast, when autophagy is prolonged by
stress conditions, the essential components for cell survival are suppressed, causing cell
demise via apoptotic or necrotic/necroptotic cell death (Damme et al. 2014, Long & Ryan
2012).
DHA is the major Omega 3 polyunsaturated fatty acid (PUFA) component of
neuronal membranes in the gray matter of the cerebral cortex and in retinal
photoreceptors cells (Lauritzen et al. 2000 (Yehuda, 2002). DHA is highly unsaturated
and thus can increase the fluidity of neuronal membranes, thereby playing an essential
role in various neurochemical processes of the brain (Bazan et al. 2005) (Nishio et al.
2004). In a previous report we found that DHA inhibits PA-LTx-induced apoptosis in
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NGFDPC12 cells (Almaguel et al. 2009), protects NGFDPC12 cells against PA-induced
lysosomal and mitochondrial permeabilization (Almaguel et al. 2010), and attenuates
neuronal dysfunction following experimental spinal cord injury (Figueroa et al. 2012).
Further, DHA–derived metabolites have been associated with anti-nociceptive responses
after experimental spinal cord injury (Figueroa et al. 2012) (Figueroa et al. 2013a)
(Figueroa et al. 2013b). In this study, we report that DHA rescues NGFDPC12 cells from
PA-LTx-induced cell death by inhibiting apoptosis and necroptosis while enhancing
autophagy.

Materials and Methods
Materials
We purchased the following reagents from the appropriate suppliers: Ham’s F-12
medium with Kaighn’s modification (F-12K) was purchased from Mediatech, Inc.
(Manassas, VA); horse serum and fetal bovine serum were from Atlantic Biological
(Lawrenceville, GA); Nerve growth factor (NGF, Cat# N-100) was from Alomone Labs
(Jerusalem, Israel); fatty acid-free bovine serum albumin (Cat# 126575-10GM) was from
EMD Milipore Corp (Billerica, MA); PA (Cat# P0500-25G) and protease inhibitor
cocktail tablets (Cat# 4693124001) were from Sigma-Aldrich (St. Louis, MO); DHA
(Cat# 90310) was from Cayman Chemicals (Ann Arbor, MI); ZVAD (Cat# ALX-260020-M005) and Staurosporine (Cat# ALX-380-014-M001) were from Enzo Life Science
(Farmingdale, NY); and rapamycin (Cat# 9904S) was from Cell Signaling Technology
(Danvers, MA).

45

Cell Culture and Treatments
PC12 cells (rat pheochromocytoma cells, Cat# CRL-1721, ATCC, Manassas, VA)
were plated in F-12K medium with 15% horse serum, 2.5% fetal bovine serum (FBS),
and penicillin/streptomycin. After attaching to the plates, cells were then differentiated
with F-12K medium containing NGF (50 ng/mL) and 1% FBS and
penicillin/streptomycin (1% FBS-NGF medium). Medium was changed every 2-3 days
and cells were differentiated for 7-10 days before experimental treatments. Fully
differentiated PC12 cells showing long neurites that form an extensive network were used
in all experimental conditions.
PA-LTx treatment was performed as previously described (Ulloth et al. 2003) (Almaguel
et al. 2009). Briefly, a PA stock solution (300 mM in 100% ethanol) was diluted 1,000
fold in warm 1% FBS-NGF medium containing 0.15 mM fatty acid-free BSA resulting in
a complex of PA:BSA at 2:1 (0.3 mM: 0.15 mM) molar ratio. Previous analysis showed
that PA:BSA at 2:1 ratio leads to unbound free PA at low nM concentration throughout
the course of the experiment (Almaguel et al. 2009). DHA stock (100 mM or 50 mM)
was also prepared in 100% ethanol and diluted in 1% FBS-NGF medium containing 0.15
mM fatty acid-free BSA with or without PA. For control, cells were treated with 1%
FBS-NGF medium containing 0.15 mM fatty acid-free BSA and 0.1% ethanol. Cell
morphology after treatment was documented using a phase contrast Olympus microscope
equipped with a SPOT-Insight CMOS camera.
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Quantitative Real Time PCR Analysis
The procedures for total RNA extraction, cDNA synthesis and quantitative RTPCR were described previously (Almaguel et al. 2009, Padilla et al. 2011). The relative
amount of mRNA was calculated by the 2-ΔΔCT method, using β-actin as reference gene.
The primer sets used in the current study are as following:
HIF-1α, 5’-TCCATGTGACCATGAGGAAA-3’and 5’-CTTCCACGTTGCTGACTTGA-3’
BNIP3, 5’-CCAGAAAATGTTCCCCCCAAG-3’and 5’-TTGTCAGACGCCTTCCAATGTAG-3’
Atg7, 5’-CCCAAAGACATCAAGGGCTA-3’ and 5’-CCTGACTTTATGGCTTCCCA-3’
Atg12, 5’-CGTCTTCGGTTGCAGTTTC-3’ and 5’-CCAGTTTACCATCACTGCCA-3’
β-actin, 5’-GGGAAATCGTGCGTGACATT-3’ and 5’-GCGGCAGTGGCCATCTC-3’

Reactive Oxygen Species Analysis
Cellular ROS levels were measured by flow cytometry using the florescent
indicator 2’,7’dichlorodihydrofluorescein diacetate (H2DCFDA, Life Technologies).
After treatment, NGFDPC12 cells were incubated with 10 μM H2DCFDA in F-12K
medium for 25 min at 37°C. Cells were then detached by HyClone HyQtase (GE
Healthcare, Pittsburgh, PA), rinsed and analyzed with a Becton-Dickinson FACSCalibur
as described earlier (Almaguel et al. 2009, Padilla et al. 2011). NGFDPC12 cells treated
with 10 μM of DL-Buthionine-[S,R]-sulfoximine for 24 hrs. served as positive control.

Apoptosis Detection
After treatment, NGFDPC12 cells were detached from plates by HyQtase and
incubated with the apoptosis marker Annexin V-FITC for 20 min. Annexin V positive
cells were detected by flow cytometry as described previously (Padilla et al. 2011).
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Determination of Cell Viability
Cell viability after PA-LTx treatment was determined by crystal violet assay.
PC12 cells were seeded in 12- or 6-well plates at a density of 7,500 cells/cm2 and
differentiated with NGF. After treatment, cells were gently rinsed, fixed, and stained with
crystal violet solution as stated before (Padilla et al. 2011). Bound crystal violet was
dissolved with 10% acetic acid and the optical density (OD) at 570 nm was determined
using a Spectra Max i3X spectrophotometer (Molecular Devices, Sunnyvale, CA). Cell
viability was calculated as percent of the OD reading relative to control group.

Antibodies and Immunoblotting
DNA topoisomerase I (Topo I) and its cell death-associated cleavage fragments
were detected by immunoblotting using human scleroderma-associated autoantibodies as
described previously (Pacheco et al. 2005, Pacheco et al. 2014). LC3 (Cat# 4108S),
phospho-beclin-1 (Ser93, Cat# 14717S) and beclin-1 (Cat# 3495S) antibodies were
purchased from Cell Signaling Technology. We used Laemmli Sample Buffer (0.1 M
Tris-HCl, pH 6.8 containing 4% SDS, 10 % glycerol and protease inhibitors) to extract
total protein from cells. After quantification, 15-40 μg of cellular proteins were resolved
on a NuPAGE Bis-Tris Gel (Thermo Scientific) and transferred to nitrocellulose
membranes. Membranes were blocked and incubated with primary antibodies overnight
at 4°C. After washes, the membranes were incubated with appropriate horseradish
peroxidase-conjugated secondary antibodies for subsequent chemiluminescent detection
or with IRDye secondary antibody for subsequent Odyssey imaging (Li-Cor
Biotechnology, Lincoln, NE).
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Statistical Analysis
All measurements were done in triplicates in at least three independent
experiments. Data analysis was done by GraphPad Prism 6.0 (GraphPad Software, San
Diego, CA, USA). Identification of outliers was done and normality of data was assessed
with Kolmogorov-Smirnov test. Statistical comparison analysis for multi-group
experiments was performed by two-way ANOVA followed by Bonferroni multiple
comparison test. Experiments comparing two groups were analyzed by student’s t test.
Significance was accepted at p<0.05.

Results
PA-LTx Generates a Stress Response and Apoptosis in NGFDPC12 Cells
PA overload stimulates cellular ROS accumulation (Almaguel et al. 2009, Liu et
al. 2015). This increase in ROS levels leads to the activation of an array of cellular stress
response proteins, including hypoxia inducible factor 1 (HIF-1α). In the present study, we
did a time course measurement of HIF-1α mRNA expression following PA-LTx
treatment. As shown in Figure 1A, there is a significant increase in HIF-1α expression at
18 (3.2-fold), 24 (3.7-fold) and 48 (3.8-fold) hours after treatment. One of the
downstream effects of PA overload is the activation and increased expression of proapoptotic proteins like Bax, Bak and BNIP3 (BCL2/adenovirus E1B 19 kDa proteininteracting protein 3) (Almaguel et al. 2009). When BNIP3 mRNA was measured in the
time course experiments, we found a significant induction of BNIP3 at 12 (2-fold), 18
(3.5-fold), 24 (3.5-fold), and 48 hours (3.9-fold) (Fig. 1B). Our previous reports showed
that PA induces NGFDPC12 cell death with apoptotic features using DAPI staining
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which detects early and late apoptosis (Ulloth et al. 2003, Almaguel et al. 2009) (Liu et
al. 2008). In order to confirm that PA overload triggers significant early apoptosis in our
experimental conditions, we labeled cells with Annexin V to analyze early apoptotic cells
after PA treatment. Figure 1C shows that there was a 3-fold increase in Annexin V
labeling after a 24hrs exposure to PA-LTx compared to BSA-treated controls.
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Figure 1. PA-LTx stimulates HIF-1α and BNIP3 mRNA expression and apoptosis in
NGFDPC12 cells. NGFDPC12 cells were treated with BSA control medium (CTL) or
PA complexed with fatty acid-free BSA at 2:1 ratio (PA) for 12 to 48 hrs and the levels
of (A) HIF-1α and (B) BNIP3 mRNA were analyzed by real-time RT-PCR. (C)
NGFDPC12 cells were treated with PA for 24 hrs and apoptotic cells were identified by
Annexin V labeling. The percentage of Annexin V-tagged cells in a sample was
determined by flow cytometry. The results are expressed as fold-change relative to
control at 24 hrs and the data is shown as Mean±SEM, n=6. Statistical analysis was done
by two-way ANOVA followed by Bonferroni multiple comparison test for (A) and (B)
and by student’s t test for (C). Significance symbols: *=p<0.05. ****=p<0.0001.

51

PA-LTx Induces Necroptosis in NGFDPC12 Cells in The Presence of ZVAD
While PA-LTx induces loss of cell viability through apoptosis, treatment of
NGFDPC12 cells undergoing lipotoxicity with the pan-caspase inhibitor ZVAD triggers
caspase-independent cell death (Ulloth et al. 2003). Further, it has been observed that
lysosomal cathepsin L, implicated in TNF-induced necroptosis (Pacheco et al. 2014), is
also involved in PA-LTx-induced cell death (Almaguel et al. 2010). Based on these
findings we hypothesized that induction of necroptosis was a possible explanation for the
caspase-independent cell death induced by PA-LTx in the presence of ZVAD. To address
this hypothesis, we used a highly specific human autoantibody to nuclear protein
Topoisomerase I (Topo I) that discriminates between apoptosis and necrosis (primary,
secondary, and necroptosis) using immunoblotting of protein lysates from affected cells
(Casiano et al. 1996) (Casiano et al. 1998) (Pacheco et al. 2005) (Pacheco et al. 2014)
(Wu et al. 2001). These antibodies specifically recognize the Topo 1 70 and 45 kDa
cleavage fragments generated during necrosis or necroptosis, and the single Topo 1 70
kDA fragment signature of apoptosis. The first series of experiments were done to
validate these antibodies in our experimental system by treating NGFDPC12 cells
cultures with staurosporine and HgCl2, which are well established inducers of apoptosis
and necrosis respectively, and performed immunoblotting analysis using the cell’s lysates
to verify the distinct Topo I cleavage patterns for each condition. Given that primary
necrosis, secondary necrosis, and necroptosis converge into downstream cathepsinmediated proteolysis and exhibit identical patterns of Topo I cleavage in L929 fibroblasts
(Pacheco et al. 2005, Pacheco et al. 2014), we predicted to observe a similar pattern of
Topo I cleavage in NGFDPC12 cells undergoing necrosis or necroptosis. As shown in
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Figure 2A, the apoptotic 70 kDa fragment was observed after 6 h treatment with
staurosporine. The faint 45 kDa band was likely due to secondary necrosis (Wu et al.
2001, Silva 2010). In contrast, HgCl2 induced the necrosis-associated Topo I cleavage
pattern (70 and 45 kDa fragments) by 6 hrs and this pattern was sustained after 12 and 18
hrs. The 60 kDa band shown in all treatment groups is likely due to non-specific
autoantibody binding. Next, the induction of apoptosis in NGFDPC12 cells treated with
PA-LTx for 24 hours was confirmed by the appearance of the 70 kDa apoptotic cleavage
fragment of Topo I, with absence of the necrotic 45 kDa fragment (Fig. 2B). However,
when the pan-caspase inhibitor ZVAD was added to PA-LTx treatment (ZVAD+PA),
instead of inhibiting apoptosis-associated Topo I cleavage, we observed induction of the
necrosis-associated 45 kDa cleavage fragment, similar to the pattern observed during
treatment with the necrosis inducer HgCl2 (Fig. 2B). These results suggest that PA-LTx
primarily causes apoptosis in NGFDPC12 cells, but a necroptotic pathway is induced
following caspase inhibition with ZVAD.
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Figure 2. Cleavage pattern of Topo I in PA-LTx-treated NGFDPC12 cells in the
presence or absence of ZVAD.fmk. (A) The cleavage pattern of Topo I has been shown to
differentiate between apoptosis and necrosis or necroptosis. For validation of using this
method in NGFDPC12 cells, we treated cells with control medium (CTL), an apoptosis
inducer Staurosporin (Stau, 3 μM) or a necrosis inducer HgCl2 (50 μM) for 6, 12, and 18
hrs. Total cellular protein was extracted and Topo I immunoblot was performed using a
human serum carrying Topo I autoantibodies (1:250 dilution). (B) NGFDPC12 cells were
treated with BSA control medium (CTL) and PA-LTx (PA) in the presence or absence of
ZVAD (40μM) for 24 and 48 hrs. Cellular proteins were collected followed by Topo I
immunoblotting. These experiments were repeated at least three times and representative
blots are shown.

54

Crosstalk between Apoptosis and Necroptosis in NGFDPC12 Cells
Undergoing PA-LTx
In order to understand and successfully inhibit lipotoxicity, it is important to
identify potential crosstalk between the different cell death modalities. The next series of
experiments proceeded to use ZVAD to inhibit apoptosis, the RIP1 inhibitor Nec-1 to
inhibit necroptosis, and the mTOR inhibitor rapamycin to promote autophagy.
NGFDPC12 cells were treated with ZVAD, Nec-1 or Rapa for 48 hours in the presence
or absence of PA (Fig. 3A-C). NGFDPC12 cells treated with ZVAD alone showed a
significant 20% reduction in cell viability compared to control untreated cells (Fig. 3A).
PA treatment decreased the cell viability to 35% as expected. Confirming our previous
report (Ulloth et al. 2003), treatment with ZVAD did not rescue the cells from PA-LTx
(Fig. 3A). Nec-1 didn’t affect cell viability by itself but when cells were co-treated with
PA and Nec-1 there was a modest 27% increase in cell viability (Fig. 3B). The autophagy
promoter rapamycin was used in the following experiments. Figure 3C shows that Rapa
didn’t decrease or increase cell viability by itself and neither rescued cells when cotreated with PA. Therefore, inhibiting apoptosis or stimulating autophagy alone is not
enough to rescue NGFDPC12 from PA-LTx. Only Nec-1 treatment had a modest
protective effect.
We then proceeded to combine these inhibitors and inducers to evaluate the
effects of inhibiting apoptosis and necroptosis or inhibiting necroptosis and inducing
autophagy at the same time (Fig. 3D-F). As shown in Figure 3D, combinatory treatment
with ZVAD and Nec-1 increased the cell viability by 24% compared to control
suggesting that this treatment might stop the cell loss process which is constantly taking
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place in the culture. PA treatment decreased cell viability to 37% but the combinatory
treatment with ZVAD+Nec-1 increased the cell viability to 65%. These results are
consistent with our hypothesis that while PA-LTx primarily induces apoptotic cell death
in NGFDPC12 cells, addition of ZVAD, rather than rescuing the cells from PA-induced
apoptosis, shifts cell death to necroptosis, which can be inhibited with Nec-1. Thus,
inhibiting necroptosis, but not apoptosis, attenuates PA-LTx in NGFDPC12 cells. Next,
we examined the inhibition of necroptosis in combination with promoting autophagy.
Interestingly, the combinatory treatment of Nec-1 and Rapa rendered significant positive
effects on cell survival in NGFDPC12 cells (Fig. 3E). Co-treatment of Nec-1+Rapa
increased cell viability over control by 60% in the absence of PA-LTx. When Nec1+Rapa were co-treated with PA cell viability went back to 84%, which is not
significantly different from the control. This result indicates that the neuroprotection is
almost complete when necroptosis is inhibited and the autophagic flux is allowed to
continue. When ZVAD was added to Nec-1+Rapa during PA-LTx (Fig. 3F), the
protective effect was still significant but reduced to 60% compared to control. These data
revealed a dynamic interaction between autophagy and necroptosis where the protective
effects of autophagy seemed to be enhanced when necroptosis is inhibited. As expected,
treating cells with Nec-1 and Rapa fully reversed ZVAD-induced necroptosis (Fig. 3F).
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Figure 3. The effect of apoptosis and necroptosis inhibitors and autophagy inducer on
NGFDPC12 cells with or without PA-LTx. NGFDPC12 cells were treated with ZVAD at
40 μM (A), necrostatin 1 (Nec-1) at 50 µM (B), rapamycin (Rapa) at 100 nM (C),
ZVAD+Nec-1 (D), Nec-1+Rapa (E), and ZVAD+Nec-1+Rapa (F) in the presence or
absence of PA-LTx. Cell viability was determined at 48 hrs after treatment using crystal
violet assay. The results are expressed as percent of control and the data is shown as
Mean±SEM, n=4-6. Statistical analysis was done by two-way ANOVA followed by
Bonferroni multiple comparison test. Significance symbols: *=p<0.05. *** =p<0.001.
**** =p<0.0001
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DHA as a Neuroprotective Agent from PA-LTx
The next series of experiments examined the mechanism(s) by which DHA
rescues NGFDPC12 cells from PA-LTx. We assessed the effects of moderate
physiological concentrations of DHA (20-50 μM bound to fatty acid-free BSA, see
Methods) on rescuing NGFDPC12 cells from PA-LTx. Figure 4A shows that
NGFDPC12 cells treated with PA-LTx for 24 hours show dismantle morphology with
small/short neurites, but appear normal when co-treated with DHA. Quantitative cell
viability data indicated that DHA at 20, 30, 40 or 50 μM has no negative effect on cell
viability but is able to rescue NGFDPC12 cells from PA-LTx (Fig. 4B). Interestingly, a
protective effect was also observed if cells were pre-treated with 50 μM DHA ahead of
the PA-LTx treatment (Fig. 4B).
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Figure 4. DHA rescues PA-LTx-treated NGFDPC12 cells from lipotoxicity. (A)
Microscopic images show 48 hrs after treated with BSA control medium (CTL), DHA
(50 μM), PA-LTx (PA) and PA+DHA. (B) NGFDPC12 cells were treated with DHA
alone at concentrations from 20-50 μM or together with PA-LTx for 48 hrs and cell
viability was determined by crystal violet assay. For pre-treatment group, NGFDPC12
cells were treated with DHA (50 μM) for 24 hrs followed by PA-LTx without DHA for
another 48 hrs. The results are expressed as percent of control and the data is shown as
Mean±SEM, n=5-8. Statistical analysis was done by two-way ANOVA followed by
Bonferroni multiple comparison test. Significance symbols: **=p<0.01. *** =p<0.001.
**** =p<0.0001
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DHA Diminishes PA-LTx-Induced HIF-1α and BNIP3 but Not ROS
Subsequently, we quantified the expression of HIF-1α and BNIP3, which are upregulated during PA-LTx treatment, in the presence or absence of DHA. Figures 5A and
5B show that DHA alone did not alter HIF-1α and BNIP3 mRNA levels. However, the
PA-LTx-simulated gene upregulation of HIF-1α and BNIP3 was back to control level in
the presence of DHA. Intracellular ROS levels in NGFDPC12 cells are increased during
PA-LTx (Liu et al. 2015). To examine the possibility that high intracellular ROS levels
are associated with induction of BNIP3 and HIF-1α expression in NGFDPC12 cells, ROS
accumulation in the cells was measured for up to 18 hours after the appropriate
treatments using the DCF-flow cytometry method. Figure 5C shows PA-LTx increased
ROS levels by 3.4 and 2.9-fold at 12 and 18 hours respectively. Interestingly, cotreatment with PA+DHA showed an accumulation of ROS similar to that caused by PALTx alone (3.4, 3.1, and 4.2-fold at 6, 12, and 18 hours respectively) indicating that
inhibition of ROS is dispensable for DHA’s ability to rescue NGFDPC12 cells from the
detrimental effects of PA-LTx.

DHA Protects NGFDPC12 Cells against PA-LTx by Inhibiting Apoptosis and
Necroptosis and Enhancing Autophagy
We showed above that the effects of PA-LTx in NGFDPC12 cells are inhibited by
the necroptosis inhibitor necrostatin-1 and the autophagy promoter rapamycin (Fig. 3E).
We hypothesized that the neuroprotective effects of DHA in the presence of PA-LTx may
influence these cellular processes, and that DHA may have the ability to induce
autophagy as a protective mechanism. Beclin-1 is a master protein that when activated
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inhibits apoptosis and leads the cell to autophagy (Green & Levine 2014). As expected,
there was an increased phosphorylation of beclin-1 in cells treated with Rapa and DHA
(Fig. 6A). While total beclin-1 was not significantly altered upon PA-LTx treatment,
phosphobeclin-1 was greatly reduced at 48 hours in PA-treated cells but co-treatment of
DHA+PA restored its level (Fig. 6A). Next, we analyzed the conversion of light chain
protein 3 (LC3-I) to phosphatidyl ethanolamine (PE)-conjugated LC3 (LC3-II), a wellestablished biomarker for autophagy. The immunoblots show a significant increase in
LC3-II levels in DHA-treated but not in PA-treated cells (Fig. 6B). The lack of visible
induction of LC3-II levels by rapamycin alone could be attributed to increased
autophagic turnover that eliminates the accumulation of LC3-II (Marino et al. 2014).
However, when DHA or rapamycin were added to PA-LTx treated cells, the levels of
LC3-II were increased. These data confirmed that DHA is able to increase autophagy in
untreated or PA treated cells. To further analyze this autophagic process, the levels of
autophagy related genes Atg7 (Fig. 6C) and Atg12 (Fig. 6D) transcripts were
determined. Of importance, both Atg12 and Atg7 mRNA levels were reduced in PAtreated cells, but showed at control levels (Fig. 6C) or higher than control (Fig. 6D)
during co-treatment with PA and DHA.
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Figure 5. DHA diminishes PA-LTx-stimulated HIF-1α and BNIP3 but not PA-LTxstimulated ROS accumulation. NGFDPC12 cells were treated with BSA control medium
(CTL), DHA (50 μM), PA-LTx (PA) and PA+DHA. HIF-1α (A) and BNIP3 (B) mRNA
levels after 24 hrs treatment was determined by real-time RT-PCR. The results are
expressed as fold-change relative to control and the data is shown as Mean±SEM, n=9.
(C) ROS levels at 6 hrs (n=3), 12 hrs (n=7) and 18 hrs (n=7) after treatment was
determined by DCF flow cytometry. The results are expressed as fold- change relative to
control at 6 hrs and the data is shown as Mean±SEM. Statistical analysis was done by
two-way ANOVA followed by Bonferroni multiple comparison test. Significance
symbols: *=p<0.05. **=p<0.01. *** =p<0.001. **** =p<0.0001
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Figure 6. DHA stimulates autophagy pathway in NGFDPC12 cells. NGFDPC12 cells
were treated with BSA control medium (CTL), Rapamycin (100 nM), DHA (50 μM),
PA-LTx (PA) and PA-LTx together with Rapamycin or DHA for 24 hrs and cellular
protein was extracted. Immunoblotting analysis of (A) phosphorylated and total Beclin I
and (B) LC3 were performed. These experiments were repeated at least three times and
representative blots are shown. Meanwhile, NGFDPC12 cells were treated with BSA
control medium (CTL), DHA (50 μM), PA-LTx and PA+DHA for 24 hrs. Total cellular
RNA was extracted and mRNA level of Atg 7(C) and Atg 12 (D) was determined by
real-time RT-PCR. The results are expressed as fold-change relative to CTL and the data
is shown as Mean±SEM, n=3. Statistical analysis was done by two-way ANOVA
followed by Bonferroni multiple comparison test. Significance symbols: *=p<0.05.
**=p<0.01.
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In order to further determine the effects of DHA on necroptosis and autophagy we
added chloroquine (an autophagy inhibitor) and ZVAD to NGFDPC12 cells exposed to
DHA alone or to PA+DHA co-treatment. Figure 7A shows that cell viability in the
DHA+ZVAD treatment group was similar to that of control cells, suggesting that DHA is
able to reverse ZVAD-induced loss of cell viability (see Fig. 3A for comparison).
However, DHA’s protective effect against PA-LTx was diminished in the presence of
chloroquine (Fig. 7B), confirming the important role of autophagy in DHA-induced
protection against PA-LTx (Fig.7B and 7C). In addition, adding ZVAD and PA together
leads to diminished cell size and loss of neurites compared to treatment with PA alone
(Fig. 7C), consistent with the previous cell viability results (Fig. 3A).
Finally, it was previously shown that low concentrations of HgCl2 induce necrotic
cell death with autophagic features in hepatocytes (Chatterjee et al. 2014), suggesting a
cellular attempt to survive in the presence of this strong stressor. In order to address this
possibility in our PA-LTx model, we compared LC3-II expression in NGFDPC12 cells
under different treatments. Figure 8A shows that staurosporine, a well-established
apoptosis inducer, did not increase LC3-II expression compared to control cells. On the
other hand, treatment with HgCl2, a primary necrosis inducer, led to sustained increase in
the levels of LC3-II for up to 18 hours compared to control and staurosporine-treated
cells. Interestingly, when the Topo I cleavage pattern in DHA-treated NGFDPC12 cells
was examined by immunoblotting, the pattern was similar to that of HgCl2-treated cells
or ZVAD-treated cells (Fig. 8B), even though the cell fate was very different, i.e.,
autophagy induced by DHA, primary necrosis induced by HgCl2, and necroptosis induced
by ZVAD. Likewise, cells co-treated with PA+DHA or PA+ZVAD also showed a Topo
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I cleavage pattern similar to that of HgCl2-treated cells. These results suggested that
DHA-induced autophagy may activate the lysosomal cathepsins responsible for the
cleavage of Topo I (Pacheco et al. 2005), consistent with the recent observation that
autophagy mediates the degradation of nuclear proteins (Dou et al. 2015).
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Figure 7. The protective effect of DHA in the presence of ZVAD and chloroquine in
NGFDPC12 cells. NGFDPC12 cells were treated with BSA control medium (CTL),
DHA (50 μM), PA-LTx (PA) and PA+DHA in the presence or absence of ZVAD at 40
µM (A) and chloroquine (CQ, autophagy inhibitor, 20 µM) (B) for 48 hrs. Crystal violet
assay was performed to determine cell viability. The results are expressed as percent of
control and the data is shown as Mean±SEM, n=4-5. Statistical analysis was done by
two-way ANOVA followed by Bonferroni multiple comparison test. Significance
symbols: *** =p<0.001. **** =p<0.0001. (C) Representative microscopic images show
the morphology of NGFDPC12 cells 48 hrs after treatments.
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Figure 8. Autophagy and necroptosis pathways share common elements. (A) NGFDPC12
cells were treated with BSA control medium (CTL), staurosporine (Stau, 3 µM), or
HgCl2 (50 µM) for 6, 12, and 18 hrs. Total cellular protein was extracted and LC3
immunoblotting was performed. (B) NGFDPC12 cells were treated with BSA control
medium (CTL), PA, DHA and ZVAD, separately or in combinations. Total cellular
protein was extracted 24 hrs after treatment followed by Topo I immunoblotting. These
experiments were repeated at least three times and representative blots are shown.
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Discussion
The present study reports new insights into mechanisms by which lipotoxicity
induces cell death in differentiated PC12 cells, and shows for the first time that the
omega-3 fatty acid DHA inhibits this process by attenuating necroptosis and activating
autophagy. Lipotoxicity occurs in non-adipose cells, which lack the proper cell
machinery to manage the overload of saturated FFA like palmitic acid (Engin 2017).
Nerve cells are especially vulnerable to the lipotoxicity injury especially during trauma,
hypoxia and neurodegenerative pathologies (Lee 2012). Traumatic or ischemic-hypoxic
brain injury exhibits an elevation of FFAs in the CNS (Bazan 1970) (Dhillon et al. 1994)
(Dhillon et al. 1997) (Gewirtz et al. 1999). Activation of phospholipase-A2 (PLA-2), due
to excitatory amino acids and calcium release, acts on the internal leaflet of the plasma
membrane releasing FFAs to the cytosol (Farooqui & Horrocks 1998). The magnitude of
FFA accumulation correlates with the severity of the injury (Bazan et al. 1971) (Zhang &
Sun 1995). The main species of FFAs found elevated after traumatic and hypoxicischemic injury are stearic, palmitic, oleic and arachidonic acids (Dhillon et al. 1994)
(Dhillon et al. 1997), and NGFDPC12 cells exposed to high levels of stearic acid or PA
exhibit apoptotic cell death (Ulloth et al. 2003). Along these lines, during spinal cord
injury the fatty acid monoglycerides and fatty acid glycerophos-phoethanolamines are
substantially increased, especially for palmitic, steric and arachidonic acids (Figueroa et
al. 2013b). Supplementation of omega-3 PUFA in the diet promoted locomotion recovery
and reduced neuropathic pain following spinal cord injury suggest a role for FFA levels
and type in this process (Figueroa et al. 2013a) (Figueroa et al. 2013b) (Liu et al. 2015)
(Figueroa et al. 2016). Up-regulation of fatty acid binding protein 5 (FABP5) following
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nerve injury mitigates the detrimental effects of high levels of saturated FFA in the cell
(De Leon et al. 1996).
Treatment of NGFDPC12 cells undergoing PA-LTx with ZVAD lead to the
activation of caspase-independent cell death (Ulloth et al. 2003). Our findings in the
present study show for the first time that the necroptosis inhibitor Nec-1 attenuates cell
death induced in the presence of ZVAD and PA in these cells, suggesting necroptosis as
an important mechanism of cell death in this context. Necroptosis is a pro-inflammatory,
programmed form of cell death associated with loss of plasma membrane integrity,
mitochondrial dysfunction, and organelle swelling. It can be activated by ligands of death
receptors and stimuli that induce the expression of death receptor ligands under caspase-8
deficient conditions, including inhibition by pan-caspase inhibitors such as ZVAD (Khan
et al. 2014) (Zhou & Yuan 2014) (Galluzzi et al. 2014). In NGFDPC12 cells, both FAS
receptor and FAS ligand are up-regulated during PA-LTx treatment (Ulloth et al. 2003),
which could explain the necroptotic death activated in these cells when we attempted to
attenuate PA-induced apoptosis with ZVAD. It is also established that during necroptosis
there is ROS accumulation and cellular damage (Lin et al. 2004) (Shindo et al. 2013)
(Vanlangenakker et al. 2011) (Galluzzi et al. 2014). This is consistent with our finding
that PA treatment increases ROS levels in NGFDPC12 cells, which could accelerate
membrane damage and cellular destruction.
While PA induces primarily an apoptotic type of cell death in NGFDPC12 cells,
there was a significant increase of cell viability during PA treatment (in the absence of
ZVAD) when co-treated with Nec-1, a small molecule inhibitor of RIP1 (He et al. 2009)
(Degterev et al. 2008). RIP1, through its death domain, complexes with FADD (Fas-
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associated protein with death domain) and TRADD (tumor necrosis factor receptorassociated death domain) (Stanger et al. 1995) and binds caspase 8 to form the
ripoptosome which is necessary for the extrinsic apoptotic pathway (Khan et al. 2014).
Inhibition of RIP1 kinase activity by Nec-1 suppresses apoptosis by preventing the
formation of RIP1/FADD/caspase-8 cell death complex also known as Complex IIa
(Abhari et al. 2013) (Feoktistova et al. 2011). Rats treated with Nec-1 before spinal cord
injury showed a smaller lesion size, inhibition of cytokine release and decreased ROS
production (Wang et al. 2014). These outcomes were accompanied by a reduction in
caspase 3 and Bax and an activation of the anti-apoptotic and pro-autophagy protein Bcl2 (Wang et al. 2014). Since both extrinsic (Fas-mediated) and intrinsic (mitochondrialmediated) apoptosis pathways are evident in PA-LTx in NGFDPC12 cells (Ulloth et al.
2003) (Almaguel et al. 2009), we cannot rule out that Nec-1, in the absence of ZVAD,
increases cell viability under PA-LTx by attenuating Fas-mediated apoptosis, but the
effect is not enough to rescue cells to the levels of the control, untreated cells because PA
overload still triggers the intrinsic apoptosis pathway.
Our data show that co-treatment with Nec-1 and Rapamycin successfully rescued
NGFDPC12 cells undergoing PA-LTx, suggesting that activation of autophagy is critical
in neuroprotection against lipotoxicity. Rapamycin is a macrolide that inhibits mTOR, a
serine/threonine protein kinase that regulates autophagy, cell growth, and cell
proliferation (Mukherjee & Mukherjee 2009). When mTOR is inhibited by Rapamycin,
the ULK1 complex (UNC-51-like kinase 1+ATG17+ ATG13+ATG101) is free to
stimulate the autophagic cascade (Marino et al. 2014). Autophagy is particularly
important in neurons because they are non-dividing cells and are more sensitive to
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accumulation of toxic molecules (Hara et al. 2006). Furthermore, the brain needs a
constant supply of energy even under conditions of stress like ischemia, starvation or
infection. It is well known that inhibition of autophagy cause neurodegeneration in
mature neurons, indicating that autophagy may regulate neuronal homeostasis (Komatsu
et al. 2006).
There are a multiple stress signals, including PA-LTx, that can exhibit the
involvement of both autophagy and apoptosis (Tan et al. 2012) (Tu et al. 2014). Along
this line, the Bcl-2-binding factor Beclin-1 (ATG6) is the central protein regulating the
autophagy process. Beclin-1 associates with VPS34 (vacuolar protein sorting 34) and
initiates the isolation of double membrane to start autophagy. This Beclin-1/VPS34
complex is inhibited when bound by Bcl-2 family members (Bcl-2, Bcl-XL) (Green &
Levine 2014). Further, inhibition of Beclin-1 by Bcl-2 allows the cell to ensure that
neither autophagy nor apoptotic or necroptotic cell death take place under non-stress
conditions (Luo & Rubinsztein 2010) (Maiuri et al. 2007). In a T-cell model lacking
caspase-8 and FADD cells developed a hyperautophagic morphology but subsequently
died by necroptosis, which could be prevented with necroptosis inhibitors and deletion of
RIP3 (Lu et al. 2011). In addition, if the stress is sufficiently strong to overcome the
cellular capability of activating autophagy, then apoptosis-activated caspases may digest
essential autophagic proteins and disable the autophagy pathway (Long & Ryan 2012).
Thus, if the intracellular contents cannot be degraded during autophagy, the apoptotic or
necroptotic pathways may prevail.
A novel finding from this study is that the protective effects of DHA against PALTx are mediated by impacting multiple cellular pathways, i.e. inhibition of necroptosis
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and stimulation of autophagy. This finding is consistent with our previous results
showing that DHA inhibited mitochondrial membrane depolarization and lysosomal
membrane permeabilization (Almaguel et al. 2010). While we found that PA-LTx
induces the mRNA expression of HIF-1α and BNIP-3, treatment with DHA reduced the
transcript levels for both genes. HIF-1α, executing his role as cellular stress sensor,
induces the expression of cell survival genes and/or cell death genes (Guo 2017). While
HIF-1α can promote autophagy directly through the HIF-1α/BNIP3/Beclin-1 complex,
which involves the mTOR signaling (Xia et al. 2015), HIF-1α can also induce apoptosis
(da Rosa et al. 2015). In our cellular model, PA decreased Beclin-1 phosphorylation,
suggesting that it decreases autophagy and activates apoptosis through the induction of
HIF1α and BNIP3 gene expression. In contrast, treatment with DHA in the presence of
PA inhibited the expression of these two genes, suggesting that by inducing autophagy
DHA antagonizes cell death processes associated with increased HIF1α and BNIP3
expression and activity.
In our experimental model, DHA elicited a small and transient increase of ROS
accumulation and did not inhibit generation of ROS accumulation observed during PALTx conditions. Interestingly, studies performed in human retinal pigment epithelial cells
showed that DHA triggers a transient increase in ROS, and an increase in the levels and
nuclear translocation of NFE2L2, a transcription factor that regulates cellular redox status
(Johansson et al. 2015). Subsequently, DHA was shown to increase the levels of
SQSTM1, which selectively targets misfolded, ubiquitinated proteins for lysosomal
degradation by binding both to ubiquitinated cargos and to LC3 (Atg8) on the growing
phagophore membrane (Johansson et al. 2015). LC3-II, which is phosphatidyl
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ethanolamine (PE)-conjugated, is responsible for docking the autophagosome with the
lysosome vesicles. Thus, DHA-containing PE can facilitate this process as opposed to
saturated fatty acid-containing PE (Kim et al. 2004) (Garcia et al. 1998).
It has been well established that DHA increases membrane fluidity (Hashimoto et
al. 2017) (Stillwell & Wassall 2003) by selective incorporating into the sn-1 and sn-2
positions of the anionic phospholipids phosphatidyl serine (PS) and PE (Shaikh et al.
2009). The amount of PUFAs in the membrane becomes a determinant of a “DHA nonraft domain” in which the membrane becomes more fluid and thinner, cholesterol is
displaced, and there is a “liquid disorganized domain” where proteins can change
conformation easier than in cholestrerol rich “organized domains” (Grimm et al. 2011)
(Hou et al. 2016). For instance, treating NGFCPC12 cells in culture with unsaturated
long chain fatty acids enhances neurite extension during differentiation (Liu et al. 2015).
Also, supplementation of mitochondrial membranes with DHA increases the content of
DHA-enriched cardiolipin that is necessary for mitochondrial function and survival
(Stanley et al. 2012). DHA-induced increase in membrane fluidity has a direct impact in
both autophagy membrane elongation and more efficient activation of membrane binding
proteins (Bahrami et al. 2017). It is here where DHA induction of non-raft membrane
domains (Wassall & Stillwell 2008) seems to be a key mechanism where autophagy and
membrane fluidity intersect. Considering that autophagy requires extensive cell
membrane assembly, nucleation, expansion and docking, membrane fluidity is critical to
ensure efficient survival under PA-LTx.
Beclin-1 has a BH3 domain, a coil domain, and an evolutionary conserved
domain (ECD) that serves as a membrane binding protein (Huang et al. 2012). The BH3
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domain gives Beclin-1 the capacity to interact with Bcl-2. AMP-activated protein kinase
(AMPK) directly phosphorylates Beclin-1, which renders it able to detach from Bcl-2 and
interact with VPS34 to induce autophagy. We suggest that DHA is important in this step
for the following reasons. First, Beclin-1 anchored with its ECD within the mitochondrial
membrane travels more efficiently through the non-raft domains when membranes are
more fluid in the presence of DHA enriched phospholipids. Second, a DHA metabolite,
docosahexaenoyl ethanolamine (DHEA), has been shown to induce phosphorylation of
Bcl-2, which results in its dissociation from Beclin-1 and initiates the autophagy process
(Rovito et al. 2013). Third, once Beclin-1 is freed from Bcl-2 it is easier for the Beclin1/VPS34 complex to conjugate LC3 with DHA-enriched PE for a faster and more
efficient phagophore formation.
In summary, the findings reported in this study show for the first time that
autophagy is a key cellular mechanism by which DHA rescues cells undergoing PA-LTx.
Omega 3 PUFA have been proposed to play various neuroprotective roles during
traumatic injuries in the nervous system and neurodegenerative diseases. We propose that
these neuroprotective DHA actions may involve the activation of survival autophagic
pathways concomitant to a reduction of necroptosis.
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Abstract
Epidermal-fatty acid binding protein (E-FABP/ FABP5/DA11) binds and
transport long-chain fatty acids in the cytoplasm and may play a protecting role during
neuronal injury. We examined whether E-FABP protects nerve growth factor
differentiated PC12 cells (NGFDPC12 cells) from lipotoxic injury observed after palmitic
acid (C16:0; PAM) overload. NGFDPC12 cells cultures treated with PAM/BSA at 0.3
mM/0.15 mM show PAM-induced lipotoxicity (PAM-LTx) and apoptosis. The apoptosis
was preceded by a cellular accumulation of reactive oxygen species (ROS) and higher
levels of E-FABP. Antioxidants MCI-186 and N-acetyl cysteine prevented E-FABP’s
induction in expression by PAM-LTx while tert-butyl hydroperoxide increased ROS and
E-FABP expression. Non-metabolized methyl ester of PAM, methyl palmitic acid failed
to increase cellular ROS, E-FABP gene expression or trigger apoptosis. Treatment of
NGFDPC12 cultures with siE-FABP showed reduced E-FABP levels correlating with
higher accumulation of ROS and cell death after exposure to PAM. In contrast,
increasing E-FABP cellular levels by pre-loading the cells with recombinant E-FABP
diminished the PAM-induced ROS and cell death. Finally, agonists for PPARβ
(GW0742) or PPARγ (GW1929) increased E-FABP expression and enhanced the
resistance of NGFDPC12 cells to PAM-LTx. We conclude that E-FABP protects
NGFDPC12 cells from lipotoxic injury through mechanisms that involve reduction of
ROS.
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Introduction
Epidermal-fatty acid binding protein (E-FABP/ FABP5/DA11) belongs to a
family of low molecular weight (14-15 kDa) cytosolic proteins that bind long chain free
fatty acids. The members of the FABP family share similar tertiary structure which
consists of two short α-helical segments and a fatty acid binding cavity surrounded by
two five-stranded antiparallel β-sheets (Gutierrez-Gonzalez et al. 2002). FABPs are
thought to play a prominent role in trafficking of long-chain free fatty acids to respective
final metabolic or regulatory sites within the cell. Compared to other members of FABPs
in the family, E-FABP has particularly wide tissue distribution, suggesting its diversified
functions. E-FABP was first isolated from human epidermal cells (Siegenthaler et al.
1994), and the rat version (DA11) was later cloned from injured dorsal root ganglion
cells (De Leon et al. 1996). E-FABP is also found expressed in tissues such as
vasculature endothelial cells (Masouye et al. 1997), mammary tissue (Buhlmann et al.
1999), adipose tissue (Coe et al. 1999), pancreatic islets (Hyder et al. 2010),
macrophages (Owada et al. 2001) in addition to all nerve cells studied. An analysis of the
temporal and spatial expression profiles in the developing brain shows that E-FABP
exhibits a robust expression during embryonic neurogenesis, axonal growth, neuronal
migration and terminal differentiation (Liu et al. 1997, Liu et al. 2000). It is highly
expressed (more than 100-fold compared to adult) as early as E14 in the rat, and the high
level of expression is sustained during the first three weeks postnatal followed by a lower
expression in the adult brain and spinal cord (Liu et al. 2000, Owada et al. 1996b). EFABP is up-regulated by nerve growth factor (NGF) and is required for NGF-induced
and polyunsaturated fatty acid-potentiated neurite outgrowth in PC12 cells (Allen et al.
2000, Liu et al. 2008). E-FABP co-localizes with growth-associated protein 43 in
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differentiating PC12 cells and in retinal ganglion cells (Allen et al. 2000, Allen et al.
2001). Furthermore, we and others have reported that E-FABP is induced in motor
neurons after peripheral nerve axonal injury (De Leon et al. 1996, Owada et al. 1997).
Similarly, E-FABP expression is up-regulated in the hippocampus in response to kainic
acid-induced seizure (Owada et al. 1996a) and in the cerebellum and hippocampus after
experimental brain ischemia (Boneva et al. 2010, Ma et al. 2010). In addition, hypoxia
causes elevated expression of E-FABP in aortic endothelial cells (Han et al. 2010) and
PC12 cells (unpublished data). These results suggest a role of E-FABP during stress
injury in the nerve cells, but its neuroprotective characteristics in the nervous system have
not been addressed in the literature.
Neuronal tissue holds a larger amount of membrane lipids compared to other
tissues and contains a high concentration of polyunsaturated fatty acids that are
susceptible to lipid peroxidation, leading to oxidative damage. Modulation lipid
metabolism plays an important role during neuronal injuries and neuronal disorders.
Several studies have shown that traumatic injury and hypoxic-ischemic brain injury lead
to activation of phospholipase A2 and sphingomyelinease that release fatty acids and
ceramide from membrane phospholipids and sphingolipids respectively (Dhillon et al.
1997, Liu et al. 2006, Yu et al. 2000). The increase of arachidonic acid and ceramide
initiates the cascade of inflammatory response (Farooqui et al. 2007, Nixon 2009), and
the accumulation of free fatty acids, especially saturated fatty acids, can cause
lipotoxicity (Scheff & Dhillon 2004). All of these events contribute to a great extent to
the prolonged-phase of secondary degenerative damage by various pathways, including
generation of free radicals and lipid peroxidation, eventually leading to cell death (Hall &
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Braughler 1989, Lok et al. 2011). Further, there is growing evidence suggesting that
sustained elevation of saturated fatty acids in the circulation due to high calorie intake
results in lipotoxicity, inflammation and increased oxidative stress, which are believed to
take part in the development of neurodegenerative diseases such as Alzheimer’s disease
and Parkinson’s disease (Adibhatla & Hatcher 2008, Gupta et al. 2012, Middleton &
Yaffe 2009), and metabolic disorders such as type 2 diabetes and nonalcoholic fatty liver
disease (Unger & Orci 2001, Wang et al. 2006).
Our laboratory has been investigating the lipotoxic effect of palmitic acid (C16:0;
PAM) in the nervous system. Pathophysiological concentration of PAM causes caspasedependent and caspase-independent apoptotic cell death in NGF-differentiated PC12
(NGFDPC12) cells and Schwann cells (Padilla et al. 2011, Ulloth et al. 2003). The injury
cascade starts with increasing intracellular calcium concentration and reactive oxygen
species (ROS) generation (Almaguel et al. 2009, Padilla et al. 2011). Meanwhile, ER
stress genes (CHOP, Xbp1 and GRP78) and apoptosis genes (BNIP3, Bax) have been
shown to be involved in the process (Almaguel et al. 2009, Padilla et al. 2011, Ulloth et
al. 2003), and Fas receptor and Fas ligand are dramatically increased (Almaguel et al.
2009, Ulloth et al. 2003). In NGFDPC12 cells, lysosomal membrane permealization
precedes mitochondrial membrane permealization, and cathepsin L seems to be a key
player of this lysosomal-mitochondrial crosstalk in PAM-induced lipotoxicity (PAMLTx) (Almaguel et al. 2010). The present study uses an NGFDPC12 cell model to
evaluate whether E-FABP is a stress response protein that plays a protective role
counteracting the ROS accumulation observed during PAM-LTx.
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Materials and Methods
Materials
Rat pheochromocytoma (PC12) cells were obtained from American Type Culture
Collection (Manassas, VA, USA) and all experiments were performed within seven
passages. Cell culture medium was acquired from Mediatech (Manassas, VA, USA)
while horse serum and fetal bovine serum (FBS) were purchased from Atlantic Biological
(Lawrenceville, GA, USA). Nerve growth factor (NGF) is a product from Alomone Labs
(Jerusalem, Israel). Fatty acid-free bovine serum albumin (BSA) was from EMD
Millipore Corp. (Billerica, MA, USA) and palmitic acid (PAM), methyl- palmitic acid
(mPAM), N-acetyl cysteine (NAC), and tert-butyl hydroperoxise (TBHP) were from
Sigma-Aldrich (St. Louis, MO, USA). Antioxidant MCI-186 was purchased from Biomol
Research Laboratories (Plymouth Meeting, PA, USA) and NF-ĸB SN50 cell permeable
inhibitory peptide and control peptide SN50M were from Enzo Life Sciences
(Farmingdale, NY, USA). All of the PPAR agonists were bought from R&D Systems
(Minneapolis, MN, USA).

Cell Culture and PAM Treatment
PC12 cells were propagated with F-12K medium (Ham’s F-12 Nutrient Mixture,
Kaighn’s Modification with glutamine) containing 15% horse serum, 2.5 % FBS, and
penicillin (100 units/mL)/streptomycin (100 μg/mL) (Full serum-medium). The cells
were then reseeded in 6-well plates at the density of 70,000 cells/well and differentiated
with 50 ng/mL of NGF in F-12K medium with 1% FBS and penicillin/streptomycin (1%
FBS-NGF medium). The medium was replaced every 3 days and PC12 cells were
differentiated for 7-10 days before treatments.
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PAM was delivered to the cell culture in complex with fatty acid-free BSA at
PAM to BSA molar ratio of 2:1, 1:1 or 0.5:1. Following previously described procedures
(Almaguel et al. 2009, Ulloth et al. 2003), PAM was first dissolved in 100% ethanol to
make 300 mM stock solution and then diluted into warm 1% FBS-NGF medium
containing 150 µM fatty acid-free BSA to make 300 µM (2:1), 150 µM (1:1) and 75 µM
(0.5:1) working solution. The final concentration of ethanol was less than 0.1%. With
this method, the concentration of unbound free PAM in the medium was about 11 nM in
the 300 µM PAM medium throughout the course of experiment. For control, the cells
were treated with 1% FBS-NGF medium containing 150 µM fatty acid-free BSA and
0.1% ethanol, designated as “control medium.”

Cell Morphology Analysis
Cell morphology changes were monitored by phase contrast microscopy at
different time points while nuclear morphology of control and PAM-treated NGFDPC12
cells were assessed by staining with fluorescent dye Hoechst 33342 (Life Technologies,
Carlsbad, CA, USA). Hoechst dye was added to the culture medium at 1 ng/ml and
incubated for 10 min at 37°C. Nuclear morphology was visualized under fluorescent
microscopy. Apoptotic cells were identified by the presence of highly condensed
chromatin or fragmented nuclei.

Cell Viability Assay
At the end of experimental treatments, test medium was replaced by one ml/well
of plain F-12K medium containing 50 μl of cell proliferation/viability reagent WST-1
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(Roche Applied Science, Indianapolis, IN, USA). After 30 min incubation in the cell
culture incubator, 100 μl aliquots were transferred to 96-well plate and optical density at
450 nm was determined by µQuant plate reader (Bio-Teck Instruments, Winooski, VT,
USA). WST-1 solution without incubating with cells was served as the blank. Cell
viability was expressed as relative optical density of experimental group opposed to that
of control group. For comparison, crystal violet cell viability assay was also performed
using the same procedure described previously (Padilla et al. 2011).

Reactive Oxygen Species (ROS) Analysis
The ROS levels in NGFDPC12 cells were evaluated by a florescent indicator 2’,
7’ dichlorodihydrofluorescein diacetate (H2DCFDA, Life Technologies). After
treatments, the cells were changed to plain F-12K medium with 10 μM H2DCFDA and
incubated for 25 min in cell culture incubator. Cells were then detached and analyzed
using a FACSCalibur flow cytometer and Flow-Jo software as described before
(Almaguel et al. 2009, Padilla et al. 2011).

siRNA Transfection
To knockdown E-FABP in NGFDPC12 cells, we selected Ambion In Vivo siRNA
system. Rat FABP5 siRNA (s139047) and negative control siRNA with scrambled
sequences were acquired (Life Technologies) and introduced into cells by X-tremeGENE
siRNA transfection reagent (Roche Applied Science). The siRNA transfection, following
the manufacturer’s instruction, was performed as below: siE-FABP or siControl stock
was prepared at 100 μM in water and 2 μl of stock was diluted with 250 μl of Opti-MEM.
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Transfection reagent (10 μl) was also diluted with 250 μl of Opti-MEM. Diluted siRNA
and transfection reagent were combined and incubated for 20 min. Three daydifferentiated PC12 cells in 6-well plates were change to antibiotics-free medium
(1.5ml/well) and then transfection solution (0.5 ml) was added to the well. After 24 hrs,
the medium was changed to 1% FBS-NGF medium for continual differentiation for
another 3-5 days. The transfected NGFDPC12 cells were treated with PAM accordingly.

Deliver Recombinant E-FABP to NGFDPC12 Cells
Recombinant rat E-FABP protein was produced using IMPACT kit (New England
Biolabs, Beverly, MA, USA) and delipidated by Lipidex 1000 method as reported before
(Liu et al. 2008). To increase the level of E-FABP in NGFDPC12 cells, recombinant EFABP protein was delivered to the cells by BioPORTER Quik Ease kit (Gene Therapy
Systems, San Diego, CA, USA). Dried BioPORTER reagent in the vials was hydrated
with PBS and then incubated with recombinant E-FABP at room temperature for 5 min.
Recombinant E-FABP/BioPORTER complex solution was diluted with plain F-12
medium before added to NGFDPC12 cells in 6-well plates (10μg protein/well).
BioPORTER reagent alone and BioPORTER complexed with a non-related protein, βgalactosidase, were used as controls. After 3-4 hrs incubation, full serum medium was
added to the wells to let cells recover for 4 hrs and then the medium was changed to 1%
FBS-NGF medium. The cells were treated with PAM accordingly on the following day.

Real-Time RT-PCR Analysis
Total cellular RNA was extracted using TRI reagent (Molecular Research Center,
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Cincinnati, OH) and quantified by measuring the OD at 260 nm. RNA samples (800 ng)
were first reversed transcribed to cDNA using iSCRIPT cDNA synthesis kit (Bio-Rad
Laboratories, Hercules, CA, USA). E-FABP gene as well as another five FABP genes:
intestinal type FABP (I-FABP), heart type FABP (H-FABP), adipocyte FABP (AFABP), brain type FABP (B-FABP) and myelin FABP (M-FABP) were quantified by
real-time PCR using CFX96 system (Bio-Rad). GAPDH was used as the reference gene.
Table 1 lists primer sequences used in real-time PCR. Reactions were performed in three
replicates with a 25 µl mixture containing cDNA samples, primers and iQ Sybr Green
supermix (Bio-Rad). The relative amount of mRNA in experimental cells was calculated
using 2−ΔΔCT method. In addition, the sizes of final PCR products were verified with a 4%
agarose gel followed by ethidium bromide staining.
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Table 1. Primer Sequences for Real Time PCR to amplify selected FABPs

Western Blots
The polyclonal antibodies against E-FABP were generated in rabbits against
recombinant E-FABP produced in the laboratory. After treatment, cells were pelleted and
extracted with lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 5%
glycerol, 1mM EDTA, 100 µM PMSF, 1mM DTT, and protease inhibitor cocktail from
Roche Applied Science). Protein extracts of NGFDPC12 cells (10 μg) were resolved on a
NuPAGE Bis-Tris gel (Life Technologies) and transferred to a nitrocellulose membrane.
After blocking with 7.5% milk in Tris-buffered saline with 0.05% Tween 20, pH 7.4
(TTBS), the membrane was incubated with E-FABP antiserum and anti β-actin (clone
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AC-15, Sigma-Aldrich) in 5% milk TTBS at 4°C overnight. Subsequently, the membrane
was washed with TTBS, incubated with horseradish peroxidase-goat anti-rabbit IgG and goat anti-mouse IgG for 1 hr, and washed again. The signal was then detected by
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL).
The relative amount of protein was quantified by densitometry analysis of the
autoradiographs using Alpha Innotech (Protein Simple, Santa Clara, CA).

Immunofluorescent Staining
PC12 cells were seeded in collagen-coated 4-well culture slides (BD Biosciences,
Bedford, MA) and differentiated with NGF. After PA-LTx treatments, cells were fixed
with 4% paraformaldehyde. After washed with PBS, the cells were incubated with
blocking solution that consists of 20% normal donkey serum (NDS) in PBST (PBS with
0.1% Tween 20) for 2 hrs. Primary antibody, anti-E-FABP antiserum, was prepared in
3% NDS with PBST and incubated with the cells overnight at 4°C. Next day, the slides
were washed with PBST and incubated with secondary antibody, Alexa Fluor488 antirabbit (Life Technologies), for 2 hrs. Afterward, cells were counter-stained with Texas
red-phalloidin (Liu et al. 2008) and examined with fluorescent microscopy.

Statistical Analysis
All the experiments were repeated independently at least 3 times. Statistical
comparisons were made using Student’s t test. Significance was accepted at p<0.05.

94

Results
Lipotoxicity Caused by Palmitic Acid (PAM) Induces Apoptosis in NGFDPC12 Cells
The first series of experiments confirmed the effect of PAM-induced lipotoxicity
(PAM-LTx) in NGFDPC12 cells. Figures 1A-1C show the morphological appearances
of NGFDPC12 cells after PAM treatment for up to 48 hrs. The extensive neurite network
seen in control non-treated cells started to disintegrate after 24 hrs and was largely absent
after 36 and 48 hrs of treatment (Fig. 1A). The loss of neurites coincided with round up
cell bodies (Fig. 1A) and typical apoptotic nuclei in PAM-treated cells (Fig. 1B).
Immunocytochemistry analysis of E-FABP revealed that there is an accumulation of EFABP in the neurite region after PAM treatment in NGFDPC12 cells (Fig. 1C).
Quantitative cell viability assays indicated a time-dependent decrease loss of NGFDPC12
cells following PAM treatment as shown in WST-1 assay and crystal violet assay (Fig.
1D and 1E).
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Figure 1. Palmitic Acid (PAM) induces apoptotic cell death in NGFDPC12 cells. Cells
were treated with control medium (CTL) or 300 µM PAM for different time period (1248 hrs). (A) Representative cellular morphological images were acquired by phase
contrast microscopy. (B) Representative nuclear morphological images were analyzed
with Hoechst staining and fluorescent microscopy. Arrows indicate chromatin
condensation and fragmentation. (C) Representative immunofluorescent images are
shown to exhibit intracellular E-FABP in green and cytoskeleton in red. (D) Cell viability
of NGFDPC12 cells was determined by WST-1 assay. (E) Cell viability of NGFDPC12
cells was determined by crystal violet assay. The data represent mean ± SEM of three
independent experiments. Significance symbol: ***=p<0.001 (compared to control
group).
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E-FABP Is Up-Regulated under PAM-LTx in NGFDPC12 Cells
In the next series of experiments, we determined the E-FABP mRNA levels in
NGFDPC12 cells at various time points after cells were treated with 75 µM, 150 µM and
300 µM PAM (Fig. 2A). When near physiological concentration of PAM was used (75
µM), mRNA level of E-FABP did not change for up to 48 hrs. However, at
pathophysiological concentration (150 µM), E-FABP mRNA showed a maximum
increase of 2.5 fold at 18 hrs and dropped back to control level at 24 and 48 hrs. When
NGFDPC12 cells were cultured with even higher PAM concentration of 300 µM, an
earlier and a stronger response of E-FABP mRNA up-regulation was observed. Under
such conditions, E-FABP mRNA level reached a maximum 3.5 fold at 12 hrs, followed
by a lower stimulation at 18 hrs (3 fold) and 24 hrs (2 fold). Western blot analysis
showed that E-FABP protein level in NGFDPC12 cells was increased continuously up to
24 hrs by 300 µM PAM while there are no significant changes observed up to 24 hrs
when treated with 150 µM PAM (Fig. 2B and 2C). In addition to E-FABP, mRNA levels
of the other five FABPs (I-FABP, H-FABP, A-FABP, B-FABP and M-FABP) in
NGFDPC12 cells were also analyzed and the results are summarized in Table 2. The data
show that E-FABP is the most abundant FABP in NGFDPC12 cells by two to three
orders of magnitude higher and it was significantly increased by PAM exposure. PAM
appears to also stimulate A-FABP expression but it exhibits only very low expression in
NGFDPC12 cells.
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Figure 2. E-FABP is up-regulated under PAM-induced lipotoxicity (PAM-LTx) in
NGFDPC12 cells. (A) Cells were treated with control medium (CTL) or PAM at the
concentration of 75 µM, 150 µM or 300 µM for 6 to 48 hrs. Quantification of E-FABP
mRNA levels was performed by real-time RT-PCR. (B) Cells were treated with CTL or
300 µM PAM for 6 to 24 hrs. Quantification of E-FABP protein levels was done by
Western blots followed by densitometry analysis, using β-actin as the loading control.
(C) A representative Western blot for E-FABP (15kDa) and β-actin (42kDa) of
NGFDPC12 cells treated with 300 µM or 150 µM PAM for 6 to 24 hrs. The data
represent mean ± SEM of three independent experiments. Significance symbols:
**=p<0.01 and ***=p<0.001 (compared to control group).
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Table 2. Relative expression of FABPs and their relative changes in response to PA-LTx
in NGFDPC12 cells.

E-FABP Up-Regulation by PAM-LTx in NGFDPC12 Cells Is Mediated through
Reactive Oxygen Species (ROS) Accumulation
The accumulation of ROS in NGFDPC12 cells after PAM treatment was analyzed
using H2DCFDA assay. The results indicate that PAM caused a dose- and timedependent increase of ROS levels in NGFDPC12 cells (Fig. 3A). The increase of ROS by
300 µM and 150 µM PAM occurred as early as 6 hrs after treatment, which precedes the
up-regulation of E-FABP mRNA seen in the same conditions (18 hrs, Fig. 2A). Their
ROS accumulation reached the highest level at 12 hrs and returned to control level at 24
hrs. Furthermore, ROS levels were not increased when NGFDPC12 cells were treated
with 75 µM PAM, which condition did not affect E-FABP mRNA levels (Fig. 2A).
Therefore, we hypothesized that the stimulation of E-FABP could be mediated through
ROS generation. To test this hypothesis, antioxidants MCI-186 (100 µM) or N-acetyl
cysteine (NAC, 100 µM) were added to NGFDPC12 cultures during PAM-LTx
treatment. The results are shown in Figure 3B. MCI-186 and NAC by themselves did not
affect E-FABP expression but were able to partially (MCI-186) or completely (NAC)
abolish the up-regulation of E-FABP caused by PAM. In addition, NGFDPC12 cells were
treated with free radical tert-butyl hydroperoxise (TBHP, 100 µM), and the result showed
that NGFDPC12 cells elicited a 2.5 to 3 fold induction of E-FABP mRNA expression
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after 12-24 hrs (Fig. 3C), which is comparable to the stimulation seen by 300 µM PAM
(Fig. 2A). These results confirmed that E-FABP is induced via ROS generated by PAMLTx.
ROS have been shown to activate a number of cellular signal transduction
pathways that could mediate the increase of E-FABP gene expression observed during
lipotoxic injury. Considering that E-FABP gene has two putative NF-ĸB binding sites in
the promoter region (Fig. 4A) that mediate the up-regulation of E-FABP in MCF-7 cells
(Kannan-Thulasiraman et al. 2010), we proceeded to further explore the interactions of
ROS and E-FABP regulation in cultures treated with SN50, which blocks nucleus
translocation of NF-ĸB. Figure 4B shows that the increase of E-FABP mRNA by PAM
was significantly lower in cells co-treated with SN50. Determination of cellular ROS
levels at a later time showed that cells co-treated with SN50 and PAM exhibited higher
ROS level than cells treated with PAM alone while the control peptide, SN50M, did not
affect the ROS levels in NGFDPC12 cells (Fig. 4C). In an additional experiment we also
examined if MAP kinase mediates the up-regulation of E-FABP by PAM-LTx. Figure
4D indicates that in the presence or absence of the MAP kinase inhibitor, U0126, EFABP mRNA was stimulated to similar level upon PAM treatment.
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Figure 3. Cellular accumulation of Reactive Oxygen Species (ROS) mediates PAM-LTxtriggered E-FABP up-regulation in NGFDPC12 cells. (A) Cells were treated with control
medium (CTL) or PAM at the concentration of 75 µM, 150 µM or 300 µM for 3, 6, 12,
and 24 hrs and cellular ROS level was measured with H2DCFDA method. (B) Cells were
pretreated with antioxidants MCI-186 (100 µM in control medium) or N-acetyl-cysteine
(NAC, 100 µM in control medium) for 12 hrs and then incubated with 300 µM PAM in
the presence of the same antioxidant for another12 hrs. For comparison, cells were
treated with CTL, 300 µM PAM or antioxidants alone for 12 hrs. Relative E-FABP
mRNA levels were determined by real-time RT-PCR. (C) Cells were treated with CTL or
tert-butyl hydroperoxide (TBHP, 100 µM in control medium) for 6, 12, 18 and 24 hrs and
relative E-FABP mRNA levels were determined. The data represent mean ± SEM of
three independent experiments. Significance symbols: *=p < 0.05, **=p<0.01 and
***=p<0.001 (compared to control group).
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Figure 4. NF-ĸB inhibitor affects PAM-LTx-induced E-FABP expression and ROS accumulation
in NGFDPC12 cells. (A) The putative binding sites of NF-kB on regulatory region of mouse EFABP predicted by PROMO program (Farre et al. 2003). (B) Cells were treated with control
medium (CTL), NF-kB inhibitor SN50 at 50µg/ml in control medium (SN50), 300 µM PAM
(PAM) or PAM together with SN50 (PAM+SN50) for 12 hrs and E-FABP mRNA levels were
determined by real-time RT-PCR. (C) Cells were treated with control medium, SN50 or control
peptide SN50M with or without 300 µM PAM for 18 hrs and ROS level was measured with
H2DCFDA method. (D) Cells were treated with 20 µM of U0126 or control medium with 0.1%
DMSO with or without 300 µM PAM for 12 hrs and E-FABP mRNA levels were determined by
real-time RT-PCR. The data represent mean ± SEM of three independent experiments.
Significance symbols: *=p < 0.05, **=p<0.01 and ***=p<0.001. Significance symbols are shown
above bars when compared to control group and are shown above lines when compared between
two linked groups.
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E-FABP Up-Regulation by PAM-LTx in NGFDPC12 Cells May Involve PAM
Metabolism
In order to determine whether metabolized PAM is essential for producing
lipotoxicity, a non-metabolized methyl ester of PAM, methyl palmitic acid (mPAM), was
tested (Parker et al. 2003). Our results revealed that mPAM does not alter either the EFABP mRNA (Fig. 5A) or ROS level (Fig. 5B) and NGFDPC12 cells did not lose their
morphological integrity as they did with PAM treatment (Fig. 5C). Hence, PAM
activation and metabolism are prerequisite in the lipotoxicity process.
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Figure 5. Non-metabolized PAM, methyl palmitic acid (mPAM), does not cause
lipotoxicity in NGFDPC12 cells. (A) Cells were treated with control medium (CTL), 300
µM PAM or mPAM at the concentration of 75 µM, 150 µM or 300 µM for 12 hrs.
Relative E-FABP mRNA levels were determined by real-time RT-PCR. (B) Cells were
treated with control medium (CTL), 300 µM PAM for 12 hrs or 300 µM mPAM for 6,
12, and 24 hrs and ROS level was measured with H2DCFDA method. The data represent
mean ± SEM of three independent experiments. Significance symbols: ***=p<0.001
(compared to control group). (C) Representative morphological photographs of
NGFDPC12 cells 48 hrs after being treated as in (A).
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Cellular Levels of E-FABP Affect ROS Concentration and NGFDPC12 Cells Viability
during PAM-LTx
To investigate the significance of E-FABP up-regulation during lipotoxicity, we
tested lipotoxicity effects on NGFDPC12 cells having decreased or increased intracellular
E-FABP protein levels.
By transfecting siRNA, both the E-FABP protein level and mRNA level in
NGFDPC12 cells was significantly reduced when compared to siControl-treated cells
(Fig. 6A). PAM treatment resulted in elevated E-FABP mRNA in siE-FABP cells and
siConrol cells, but E-FABP in siE-FABP cells were significant lower than that in
siControl cells 12 hr and 18 hr after PAM-LTx (Fig. 6A). The effect of decreased EFABP in NGFDPC12 cells on intracellular ROS is shown on Figure 6B. In the absence
of PAM, siE-FABP cells showed higher basal level of ROS than siControl cells,
presumably due to lacking ROS-buffering effect from E-FABP. PAM-LTx caused timedependent increase of ROS accumulation at 12 and 18 hrs. As expected, siE-FABP cells
exhibited higher ROS than siControl did (Fig. 6B). Cell viability assay showed no
difference between siControl and siE-FABP cells without PAM (Fig. 6C). However, a
significant higher loss of cell viability in siE-FABP transfected cells during lipotoxicity
was found when compared to that of siControl (Fig. 6C). These results suggest that the
E-FABP can reduce ROS accumulation and protect NGFDPC12 cells from apoptosis
during PAM-LTx.
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Figure 6. Lowering E-FABP levels in NGFDPC12 cells by siRNA increases ROS
accumulation and PAM-LTx-induced cell death. (A) Left: Three-day-differentiated PC12
cells were transfected with siControl or siE-FABP for 5 days. A representative E-FABP
Western blot is shown. Right: siControl and siE-FABP transfected cells were treated with
control medium or 300 µM PAM for 12 and 18 hrs. Relative E-FABP mRNA levels were
determined by real-time RT-PCR. (B) Cellular ROS levels of transfection reagent
(vehicle), siControl and siE-FABP treated cells were measured by H2DCFDA method at
12 and 18 hrs after PAM (or control medium) treatment. (C) Cell viability of siControl
and siE-FABP cells were measured by WST-1 assay at 24 and 48 hrs after PAM
treatment. CTL: control medium at 48 hrs. The data represent mean ± SEM of three
independent experiments. Significance symbols: *=p < 0.05, **=p<0.01 and
***=p<0.001. Significance symbols are shown above bars when compared to control
group and are shown above lines when compared between two linked groups.
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In a previous report we showed that increasing cellular levels of E-FABP
significantly potentiated neurite extension in differentiating PC12 cells (Liu et al. 2008).
Using a similar approach, we delivered recombinant E-FABP protein to NGFDPC12 cells
before exposure to PAM overload. Figure 7A indicates that NGFDPC12 cells receiving
recombinant E-FABP protein showed higher E-FABP levels at both basal and lipotoxic
condition. Upon PAM treatment, the cells loaded with recombinant E-FABP protein did
not show significant elevation of ROS as seen in vehicle-treated cells (Fig. 7B). Further,
this ROS-reducing effect appears to be specific to E-FABP because cells loaded with
vehicle (BioPORTER) or unrelated protein (β-galactosidase) still displayed increased
ROS level after PAM treatment (Fig. 7B). Figure 7C shows that the PAM+E-FABP
group, which exhibits lower ROS levels, had more viable cells than the other three groups
at the end of PAM treatment.
E-FABP has been shown to be regulated by peroxisome proliferator-activated
receptors (PPARs) (Hyder et al. 2010). We used specific PPAR agonists WY14643 (for
PPARα), GW0742 (for PPARβ/δ) and GW1929 (for PPARγ) to further examine the
effect of increased levels of E-FAPB during PAM-LTx. Among the PPAR agonists tested
(Fig. 8A), PPARβ/δ agonist, GW0742, elicited 6-fold stimulation, and PPARγ agonist,
GW1929, produced 2-fold stimulation of E-FABP expression at 24 hrs but not at 12 hrs.
Based on this result, we pretreated NGFDPC12 cells with PPAR β/δ agonist and PPARγ
agonist to increase E-FABP levels before PAM-LTx experiment. Consistent with our
hypothesis, elevated cellular levels of E-FABP in NGFDPC12 culture resulting from
treatment with PPARβ/δ and PPARγ agonists increased cell resistance to lipotoxic insult
(Fig. 8B). Furthermore, the protecting effect provided by PPARβ/δ and PPARγ agonists
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was abolished in siE-FABP-transfected cells (Fig. 8C), confirming the important role of
E-FABP in the PPAR agonists-initiated resistance during PAM-LTx.
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Figure 7. Preloading NGFDPC12 cells with recombinant E-FABP decreases PAM-LTxinduced cellular ROS accumulation and cell death. Recombinant proteins were delivered
to NGFDPC12 cells one day before the addition of 300 µM PAM to the cell culture. (A)
E-FABP Western blot was performed 24 hrs after treatment and a representative blot is
shown. Veh: control medium added to vehicle-loaded cells; PAM+Veh: PAM added to
vehicle-loaded cells; E-FABP: control medium added to E-FABP-loaded cells; PAM+EFABP: PAM added to E-FABP-loaded cells. (B) Cellular ROS level was evaluated by
DCF method at 12 hrs after PAM treatment. CTL: control medium added to vehicleloaded cells, PAM: PAM added to untreated cells, PAM+Veh: PAM added to vehicleloaded cells, PAM+β-gal: PAM added to β-galactosidase-loaded cells and PAM+EFABP: PAM added to E-FABP loaded cells. (C) Cell viability was determined by WST-1
assay at 48 hrs after PAM treatment. Significance symbols: *=p < 0.05, **=p<0.01 and
***=p<0.001. Significance symbols are shown above bars when compared to control
group and are shown above lines when compared between two linked groups.
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Figure 8. PPAR agonists stimulate E-FABP expression and protect NGFDPC12 cells from
PAM-LTx. (A) Cells were treated with 10 µM of PPARα agonist (WY14643), PPARβ agonist
(GW0742) and PPARγ agonist (GW1929) in control medium for 12 and 24 hrs. Relative EFABP mRNA levels of cells upon treatments were determined at 12 and 24 hrs. (B)
NGFDPC12 cells were treated with 300 µM PAM without PPAR agonists pretreatment
(PAM), with GW0742 pretreatment (PAM+ PPAR-β), or with GW1929 pretreatment (PAM+
PPAR-γ) for 2 days. Each group was also treated with control medium without PAM. Cell
viability was determined by WST-1 assay at 48 hrs. (C) siControl and siE-FABP transfected
cells were treated with 10 µM GW0742 or GW0742 for 2 days before PAM-LTx experiment.
Cell viability was determined by WST-1 assay at 48 hrs. The data represent mean ± SEM of
three independent experiments. Significance symbols: *=p<0.05 and ***=p<0.001.
Significance symbols are shown above bars when compared to control group and are shown
above lines when compared between two linked groups.
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Discussion
The present study provides new experimental evidence that E-FABP is an
oxidative stress response protein that plays a protective role as an antioxidant in
NGFDPC12 cells exposed to PAM-LTx injury. We demonstrate that experimental
conditions that increase cellular levels of E-FABP (administration of E-FABP
recombinant protein and treatment with PPAR agonists) lower ROS levels and improve
cell survival in PAM-injured NGFDPC12 cells. Inhibition of E-FABP gene expression
using E-FABP siRNA magnifies the detrimental effects of PAM-LTx by increasing ROS
accumulation and cell death. Thus, E-FABP levels in the cell can regulate the outcome of
PAM-LTx.
Previous work from our laboratory showed that the detrimental effects of PAMLTx can be inhibited by antioxidant treatment (Almaguel et al. 2009, Padilla et al. 2011),
suggesting that cellular ROS accumulation is an integral part of this PAM-LTx process.
The mitochondrial electron transport chain (ETC) has been recognized as one of the
major sites to generate ROS in the cell, mainly from enzyme complexes Complex I and
Complex III. Long-chain nonesterified fatty acids modulate mitochondrial ROS
production by interacting or uncoupling of the ETC (Schonfeld & Wojtczak 2008). For
PAM, in particular, has been shown to increase mitochondrial superoxide generation in
cardiomyocytes and INS-1 beta cells (Fauconnier et al. 2007, Lin et al. 2012). Palmitoylcarnitine that serves as the substrate for β-oxidation releases significant amount of H2O2
(St-Pierre et al. 2002). Further, the mitochondrial H2O2 emission rates in permeabilized
muscle fibers are higher during respiration by palmitoyl-carnitine oxidation (fatty acid
metabolism) than by pyruvate oxidation (glucose metabolism) (Anderson et al. 2007).
Palmitoyl-CoA was shown to inhibit directly (without β-oxidation) adenine nucleotide
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translocator and results in reduction in the extramitochondrial ATP/ADP ratio and
increased ROS production in liver mitochondria (Ciapaite et al. 2006). On the other hand,
succinate-dependent ROS release from Complex I is decreased by palmitoyl-CoA in
heart mitochondria (Bortolami et al. 2008). PAM can also be metabolized in peroxisome
and the balance between H2O2 production (by acyl-CoA oxidases) and H2O2 reduction
(by catalase) controls the net H2O2 output from peroxisome. Recently, peroxisomal ROS
generation has also been suggested to mediate the PAM-LTx in insulin-producing cells
(Elsner et al. 2011). While the present study demonstrates that PAM activation is
required for generating ROS and producing lipotoxicity, further studies are required to
assess the respective contributions of metabolic oxidation and the generation of lipidderived signals in the cytosol.
ROS can be toxic to the cells, due to their strong reactivity with proteins, lipids
and nucleic acids that causes deleterious modification of these macromolecules (Aruoma
et al. 1991, Kramer et al. 1994; Radi et al. 1991). High intracellular accumulation of
ROS can also regulate gene expression as seen in the redox-sensitive NF-ĸB signaling
pathway (Morgan & Liu 2011). NF-ĸB proteins regulate expression of many genes
involved in inflammation, immune response, cell growth/differentiation and apoptosis.
Our findings showing SN50 reduces the increase of E-FABP gene expression in
NGFDPC12 cells during lipotoxicity points to a potential contribution of the NF-ĸB
pathway in this process, which leads to future studies to examine the role of this
important signaling pathway. The NF-ĸB proteins are composed of dimers of the Rel
family that bind 10-base pair ĸB sites. NF-ĸB dimers are sequestered in the cytosol by
inhibitor proteins IĸBs. The activity of IĸBs is controlled through phosphorylation by IĸB
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kinases (IKKs). Upon phosphorylation, IĸBs become ubiquitinated and degraded in
proteosomes that allow NF-ĸB dimers to translocate to the nucleus, bind to ĸB motif and
activate gene transcription. ROS have both stimulatory and inhibitory effects in NF-ĸB
signaling pathway (Byun et al. 2002). Mitochondrial ROS generated during
hypoxia/reoxygenation activate NF-ĸB through phosphorylation of IĸBα at alternative
phosphorylation site tyrosine 42 (Fan et al. 2003). Tyrosine 42-phosphorylated IĸBα is
bound by regulatory subunit of PI3-kinase, which consequently unmasks NF-ĸB and
allows it to translocate to the nucleus (Beraud et al. 1999). On the other hand, H2O2
reduces NF-ĸB signaling by inhibiting inflammatory-stimulated IKK (Reynaert et al.
2006). Further, IKK is known to be phosphorylated and activated by upstream kinase
NIK (NF-ĸB-inducing kinase), and this activity is also modulated by H2O2 (Li &
Engelhardt 2006). Along these lines, PAM can regulate genes such as interleukin 6 in the
skeletal muscle (Weigert et al. 2004) and adipocytes (Ajuwon & Spurlock 2005) through
NF-ĸB activation. PAM has been shown to stimulate DNA binding of NF-ĸB, decrease
cytosolic IĸBα, and increase nuclear levels of p65/RalA in L6 myotubes, which is the
pathway implicated in fatty acid-induced insulin resistance in skeletal muscle (Sinha et
al. 2004).
The fact that treating NGFDPC12 cultures with PPAR agonists is followed by
induction of E-FABP suggests an important role of these proteins in protecting cells
during PAM-LTx. PPARs, comprising three isotypes PPARα, PPARβ/δ and PPARγ, are
transcription factors activated by a wide range of naturally occurring or metabolized
lipids derived from the diet or from intracellular signaling pathways and subsequently
modulate lipid-related gene expression (Feige et al. 2006). PPARs serve as a lipid signal
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sensor in the cell and play a crucial role to integrate various pathways involved in lipid
metabolism, inflammation, cellular proliferation and differentiation (Feige et al. 2006).
Elevated plasma saturated fatty acid due to over nutrition as well as traumatic/ischemic
CNS injury lead to activation of inflammatory cascades, as NF-ĸB the key regulator of
inflammation (Cai 2013, Fleming et al. 2006). PPARs are shown to suppress NF-ĸB
through various mechanisms (Wahli & Michalik 2012) and PPARγ is considered a
promising neuroprotective strategy mainly through its anti-neuroinflammatory activity
(Heneka et al. 2011, Munhoz et al. 2008). FABPs are able to facilitate this
neuroprotective pathway through channeling lipid ligands to respective PPAR ligand
binding domain (Velkov 2013). Members of the FABP family are regulated by PPARs.
Adipocyte-FABP and liver-FABP are among the best characterized PPAR target genes
(Mochizuki et al. 2001, Poirier et al. 1997, Tontonoz et al. 1994). The impressive upregulation of E-FABP by PPARβ/δ agonist observed in the present study is similar to the
effect of PPARβ/δ in prostate cancer (Morgan et al. 2010). In addition, the neuronal
differentiating activity of PPARβ/δ can occur through modulating MAP kinase pathway
(D'Angelo et al. 2011), which is consistent with our previous study showing that MAP
kinase mediates the NGF-induced up-regulation of E-FABP gene in PC12 cells (Liu et al.
2008). However, data presented in current study suggest that PAM-stimulated E-FABP
gene expression is dependent on NF-ĸB but not MAP kinase. Our data agree with the
notion that the expression of E-FABP may be at the center of neuronal differentiating and
injury processes (De Leon et al. 1996, Liu et al. 1997, Liu et al. 2000, Liu et al. 2008).
Multiple lines of evidence support an antioxidant role of FABPs as function of
their demonstrated fatty acid/lipid binding properties (Terrasa et al. 1998, Wang et al.
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2005, Wang et al. 2007). For instance, Ek et al. (1997) showed that FABPs can serve as
an intracellular fatty acids buffer that can alter their availability for cell metabolic
functions. Therefore, the increase in the level of E-FABP by PAM-LTx observed in our
study may reduce the effective amount of PAM to generate additional ROS. Further,
FABPs can also bind to long-chain fatty acid oxidation derivatives (Raza et al. 1989) and,
thus, may neutralize their potential toxic effect. In addition, FABPs are known to directly
involve PPAR-mediated gene control by transporting PPAR ligands to the nucleus
(Kaczocha et al. 2009, Wolfrum et al. 2001), and PPARs regulate the balance between
cell survival and apoptosis (Feige et al. 2006). Along these lines, Tan et al. (2002)
reported that E-FABP and adipocyte FABP can transport selective ligands to PPARβ/δ
and PPARγ, respectively, to enhance their transcriptional activity. For instance, in breast
cancer, retinoic acid either inhibits or promotes cell growth depending on how FABPs,
i.e. CRABP-II and E-FABP, channel it to either the nuclear retinoic acid receptor or
PPARβ/δ, respectively (Schug et al. 2008). In another series of studies, FABPs have been
shown to serve as antioxidant proteins through modification of their amino acid residues
not through their ligand binding. For example, E-FABP protein has the highest number of
cysteine residue among all FABPs (Odani et al. 2000). Disulfide bonds may be formed
between spatially close cysteine pairs: Cys-120/Cys-127 and Cys-67/Cys-87 in the case
of rat E-FABP, and they seem not to be directly involved in fatty acid binding. That the
cysteine pairs form disulfide bonds or remain free thiols is affected by the cellular redox
state suggests that E-FABP can serve as an intracellular free radical scavenger (Odani et
al. 2000). The protective role of E-FABP was also evident in the study by BennaarsEdien et al. (2002) showing that Cys-120 and Cys-127, to a lesser extent, are covalently
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modified by 4-hydroxynonenal (4-HNE), a toxic lipid peroxidation product, and the 4HNE modification is potentiated by fatty acid binding. The 4-HNE modification of
cysteine side chains were later reported for adipocyte FABP and liver FABP (Grimsrud et
al. 2007, Smathers et al. 2012). Besides cysteine residue, oxidative modification of
methionine residues was also identified in liver FABP, but the antioxidant effect was
reduced after fatty acid binding (Yan et al. 2009). The mechanism by which E-FABP
diminishes ROS produced by PAM-LTx demonstrated in this study needs further
investigation. However, it is reasonable to suggest that the protective role of E-FABP in
PAM-LTx may have important clinical implications in neuronal injuries that involve
oxidative stress or lipid peroxidation.
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Abstract
Hypoxia is at the core of neuronal death during traumatic brain injury, spinal cord
injury and stroke. We subjected nerve growth factor differentiated pheochromocytoma
cell line 12 (NGFDPC12) to .5% [O2] for 24 to 48hrs. The mRNA levels of the stress
response protein HIF-1α went up 3.5, 5 and 6 fold of control at 18, 24 and 48hrs,
respectively. Pro-apoptotic protein BNIP3 went up 2.5 and 3.5 fold of control at 18 and
24hrs, respectively. Hypoxia treatment also induced a 2.5 fold increase in ROS after
24hrs and that increase in ROS could be prevented with antioxidant MCI-186 at 50 and
100 μM concentration. In addition, hypoxia increased Annexin V conjugation 2.5 fold of
control at 24hrs. Treatment with docosahexaenoic acid (DHA) or the autophagy
promoter, rapamycin, during hypoxia increased cell viability and brought back the levels
of Annexin V to control level. Interestingly, pre-treat cells with DHA for 24 hours before
hypoxic insult also increased cell survival. We found that DHA increased the levels of
conjugated LC3 at 24 hrs under hypoxic condition, suggesting that autophagy is involved
in DHA-induced neuroprotection. Hypoxia also induced the up-regulation of EFABP and
that expression was decreased when an antioxidant was added during hypoxia. The
inhibition of EFABP expression during hypoxia decreased the cell viability and the
hypoxia-stimulated EFABP mRNA expression was reduced when an antagonist of
PPARγ was added. We propose that addition of DHA or expression of EFABP inhibits
apoptosis and protects NGFDPC12 cells from .5% [O2] hypoxia. DHA also has the
added benefit of stimulating autophagy and decreases stress response protein expression.
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Introduction
According to the CDC (https://www.cdc.gov/nchs/fastats/stroke.htm accessed
May-2018) neuronal injury in stroke, traumatic brain injury and spinal cord injury is the
first cause of disability and the fourth cause of death in USA. With an incidence of
750,000 a year stroke is the fifth cause of death in United States with more than 140,323
deaths every year. Apart for smoking and drinking alcohol, risk factors for stroke are
mainly related to metabolic syndrome where high blood pressure, insulin resistance,
overweight and dyslipidemia account for the majority of cases. The hallmark of this type
of neuronal injury is hypoxia and ischemia. The classical description of CNS injury
during hypoxia (Dirnagl et al. 1999) is a sharp decrease in pH, glutamate excitotoxicity,
production of oxygen free radicals and oxidative stress, with acute necrosis with
inflammation followed by prolonged periods of delayed cell death by apoptosis.
Mitochondria respiratory dysfunction results in decreased ATP and the formation of
reactive oxygen species (Nathaniel et al. 2015). The main mediator of hypoxia induced
endotoxicity is the activation of HIF-1α (hypoxia inducible factor-1α) that triggers the
activation of stress response proteins or cell death pathways.
DHA is a highly polyunsaturated fatty acid of the ω-3 series with 22 carbon atoms
and six cis double bonds. This chemical arrangement gives DHA the curved (kinked or
bent) structure that is key to its capacity to increase the fluidity of membranes (Stillwell
& Wassall 2003, Hashimoto et al. 1999). In a diverse array of experiments increasing
membrane fluidity resulted in increased drug permeability (Roach et al. 2004), carrier
mediated transport (Wu & Robinson 1999), activities of membrane-bound enzymes
(Keeffe et al. 1980), and enhanced neurotransmission (Clarke et al. 1999). We reported
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in a previous work (chapter 3 of this study) that DHA enhances the extension and
thickness of neurites in the model of NGFDPC12 cells (Liu et al. 2015). Almaguel et al
reported that NGFDPC12 cells co-treated with PA and DHA (PA+DHA) from the start
exhibited increased cell viability. DHA decreased the morphological features of
apoptosis, inhibited the PA-induced apoptotic cleavage of PARP and Lamin-B, and
stabilized mitochondrial membrane potential (Almaguel et al. 2009). DHA also keeps
the integrity of lysosomal membranes during PA-LTx and prevents cathepsin-L over
spilling from the lysosomes (Almaguel et al. 2010).
Epidermal fatty acid binding protein (EFABP/ FABP5/DA11) is part of the 1415kDa cytosolic family of proteins that transport long-chain free fatty acid in the aqueous
milieu of the cytoplasm (Gutierrez-Gonzalez et al. 2002). After peripheral motor nerve
injury of the dorsal root ganglia (De Leon et al. 1996) or hypoglossal motor neurons
following nerve crush (Owada et al. 1997) EFABP is induced many folds of control.
Further, EFABP is increased in the cerebellum and hippocampus after ischemia and it’s
been identified in activated microglia (Boneva et al. 2010). Ma et al. (Ma et al. 2010)
showed that FABP5 expression is increased in neurons of the cornu ammonis 1 (CA1) of
the hippocampus and remains stable within the dentate gyrus (DG) after ischemia. In
addition, hypoxia causes elevated expression of FABP5 in human aortic endothelial cells
(Han et al. 2010).
In this study, we examined the cellular events in NGFDPC12 cells undergoing
hypoxia insult and identified cellular mechanisms associated with neuroprotective
function of docosahexaenoic acid and EFABP in the perspective of hypoxic injury.
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Materials and Methods
Materials
We purchased the following reagents from the appropriate suppliers: Ham’s F-12
medium with Kaighn’s modification (F-12K) was purchased from Mediatech, Inc.
(Manassas, VA); horse serum and fetal bovine serum were from Atlantic Biological
(Lawrenceville, GA); Nerve growth factor (NGF, Cat# N-100) was from Alomone Labs
(Jerusalem, Israel); fatty acid-free bovine serum albumin (Cat# 126575-10GM) was from
EMD Milipore Corp (Billerica, MA); DHA (Cat# 90310) was from Cayman Chemicals
(Ann Arbor, MI); PA (Cat# P0500-25G), EPA (Cat#E2011-10MG), and protease
inhibitor cocktail tablets (Cat# 4693124001) were from Sigma-Aldrich (St. Louis, MO);
and rapamycin (Cat# 9904S) was from Cell Signaling Technology (Danvers, MA).
Peroxisome proliferator-activated receptor (PPAR) agonist WY14643 (Cat#1312) and
antagonist GW9662 (Cat#1508) were bought from R&D Systems (Minneapolis, MN).

Cell Culture and Treatments
PC12 cells (rat pheochromocytoma cells RRID:CVCL_0481, ATTC Cat# CRL1721, Manassas, VA) were plated in F-12K medium with 15% horse serum, 2.5% fetal
bovine serum (FBS), and penicillin/streptomycin. After attaching to the plates, cells were
then differentiated with F-12K medium containing NGF (50 ng/mL) and 1% FBS and
penicillin/streptomycin (1% FBS-NGF medium). Medium was changed every 2-3 days
and cells were differentiated for 7-10 days before experimental treatments. Fully
differentiated PC12 cells showing long neurites that form an extensive network were used
in all experimental conditions.

130

PA-LTx treatment was performed as previously described (Ulloth et al. 2003,
Almaguel et al. 2009). Briefly, a PA stock solution (300 mM in 100% ethanol) was
diluted 1,000 fold in warm 1% FBS-NGF medium containing 0.15 mM fatty acid-free
BSA resulting in a complex of PA:BSA at 2:1 (0.3 mM: 0.15 mM) molar ratio. Previous
analysis showed that PA:BSA at 2:1 ratio leads to unbound free PA at low nM
concentration throughout the course of the experiment (Almaguel et al. 2009). DHA
stock (100 mM or 50 mM) was also prepared in 100% ethanol and diluted in 1% FBSNGF medium containing 0.15 mM fatty acid-free BSA with or without PA. For control,
cells were treated with 1% FBS-NGF medium containing 0.15 mM fatty acid-free BSA
and 0.1% ethanol. Cell morphology after treatment was documented using a phase
contrast Olympus microscope equipped with a SPOT-Insight CMOS camera.
For hypoxia experiments, a Galaxy 48R CO2 Incubator equipped with O2
controller was purchased from Eppendorf (Hauppauge, NY). The incubator was
maintained at 37 °C with an atmosphere of 5% CO2, 0.5% O2 and balanced with N2 gas
for 12 hours before incubating with cells. NGFDPC12 cells were cultured in the hypoxic
atmosphere for 12 to 48 hours before subsequent analysis and cells were cultured with
5% CO2 and 95% air as the normoxic controls. For DHA and EPA pre-treatment study,
NGFDPC12 cells were incubated with 1% FBS-NGF medium containing 150 μM fatty
acid-free BSA in the presence or absence of 30 μM DHA (or EPA) for 12 hours and
changed back to 1% FBS-NGF medium before hypoxic treatment.

Quantitative Real Time PCR Analysis
The procedures for total RNA extraction, cDNA synthesis and quantitative RT-
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PCR were described previously (Almaguel et al. 2009, Padilla et al. 2011). The relative
amount of mRNA was calculated by the 2-ΔΔCT method, using β-actin as reference gene.
The primer sets used in the current study are as following:
HIF-1α, 5’-TCCATGTGACCATGAGGAAA-3’and 5’-CTTCCACGTTGCTGACTTGA-3’
BNIP3, 5’-CCAGAAAATGTTCCCCCCAAG-3’and 5’-TTGTCAGACGCCTTCCAATGTAG-3’
E-FABP, 5’-TTACCCTCGACGGCAACAA-3’and 5’- CCATCAGCTGTGGTTTCATCA-3’
β-actin, 5’-GGGAAATCGTGCGTGACATT-3’ and 5’-GCGGCAGTGGCCATCTC-3’

Reactive Oxygen Species Analysis
Cellular ROS levels were measured by flow cytometry using the florescent
indicator 2’,7’dichlorodihydrofluorescein diacetate (H2DCFDA, Life Technologies).
After treatment, NGFDPC12 cells were incubated with 10 μM H2DCFDA in F-12K
medium for 25 min at 37°C. Cells were then detached by HyClone HyQtase (GE
Healthcare, Pittsburgh, PA), rinsed and analyzed with a Becton-Dickinson FACSCalibur
as described earlier (Almaguel et al. 2009, Padilla et al. 2011). NGFDPC12 cells treated with
10 μM of DL-Buthionine-[S,R]-sulfoximine for 24 hrs. served as positive control.

Apoptosis Detection
After treatment, NGFDPC12 cells were detached from plates by HyQtase and
incubated with the apoptosis marker Annexin V-FITC for 20 min. Annexin V positive
cells were detected by flow cytometry as described previously (Padilla et al. 2011).

Determination of Cell Viability
Cell viability after hypoxic treatment was determined by crystal violet assay.
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PC12 cells were seeded in 12- or 6-well plates at a density of 7,500 cells/cm2 and
differentiated with NGF. After treatment, cells were gently rinsed, fixed, and stained with
crystal violet solution as stated before (Padilla et al. 2011). Bound crystal violet was
dissolved with 10% acetic acid and the optical density (OD) at 570 nm was determined
using a Spectra Max i3X spectrophotometer (Molecular Devices, Sunnyvale, CA). Cell
viability was calculated as percent of the OD reading relative to control group.

Antibodies and Immunoblotting
DNA topoisomerase I (Topo I) and its cell death-associated cleavage fragments
were detected by immunoblotting using human scleroderma-associated autoantibodies as
described previously (Pacheco et al. 2005, Pacheco et al. 2014). PARP (Cat# 9542S) and
LC3 (Cat# 4108S) antibodies were purchase from Cell Signaling Technology. The
polyclonal antibodies against E-FABP were generated in rabbits against recombinant EFABP produced in the laboratory. We used Laemmli Sample Buffer (0.1 M Tris-HCl,
pH 6.8 containing 4% SDS, 10 % glycerol and protease inhibitors) to extract total protein
from cells. After quantification, 15-40 μg of cellular proteins were resolved on a
NuPAGE Bis-Tris Gel (Thermo Scientific) and transferred to nitrocellulose membranes.
Membranes were blocked and incubated with primary antibodies overnight at 4°C. After
washes, the membranes were incubated with appropriate horseradish peroxidaseconjugated secondary antibodies for subsequent chemiluminescent detection or with
IRDye secondary antibody for subsequent Odyssey imaging (Li-Cor Biotechnology,
Lincoln, NE).
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siRNA Transfection
To knockdown E-FABP in NGFDPC12 cells, we selected Ambion In Vivo siRNA
system. Rat FABP5 siRNA (s139047) and negative control siRNA with scrambled
sequences were acquired (Life Technologies) and introduced into cells by X-tremeGENE
siRNA transfection reagent (Roche Applied Science). The siRNA transfection, following
the manufacturer’s instruction, was performed as below: siE-FABP or siControl stock
was prepared at 100 μM in water and 2 μl of stock was diluted with 250 μl of Opti-MEM.
Transfection reagent (10 μl) was also diluted with 250 μl of Opti-MEM. Diluted siRNA
and transfection reagent were combined and incubated for 20 min. Three daydifferentiated PC12 cells in 6-well plates were change to antibiotics-free medium
(1.5ml/well) and then transfection solution (0.5 ml) was added to the well. After 24 hrs,
the medium was changed to 1% FBS-NGF medium for continual differentiation for
another 3-5 days. The transfected NGFDPC12 cells were subjected to .5% [O2]
accordingly.

Statistical Analysis
All measurements were done in triplicates in at least three independent
experiments. Statistical comparison was analyzed by student’s t test. Significance was
accepted at p<0.05.
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Results
Hypoxia Induces Up-Regulation of HIF-1α and BNIP3, ROS Accumulation and
Apoptotic Features in NGFDPC12 Cells
Hypoxia triggers the gene expression of hypoxia-inducible factor-1α and
increases its nuclear translocation in different tissues (Feng et al. 2016, Zhao et al. 2017).
Therefore, we wanted to explore if NGFDPC12 cells at an oxygen tension of .5%, (.5%
[O2]) would show a similar response. Indeed, Figure 1A shows that .5% [O2] increased
the level of hypoxia inducible factor-1α significantly 2.47-fold of control at 12 hours,
3.87-fold of control at 18 hours, 5.47-fold of control at 24 hours and 6-fold of control at
48 hours. One of the downstream effect of HIF-1α expression and activation under any
stress condition is the expression of BNIP3 to activate either defense mechanisms like
autophagy or to trigger the apoptotic cascade to decrease inflammation. BNIP3
(BCL2/adenovirus E1B 19 kDa protein-interacting protein) activation under a strong
insult activates pro-apoptotic protein like Bak and Bax with the subsequent formation of
mitochondrial pores and release of cytochrome C from the mitochondria and execution of
apoptosis. We measured the gene expression of BNIP3 at different time points in
NGFDPC12 cells under .5% [O2]. Figure 1B shows BNIP3 mRNA expression was 2.3fold of control at 12 hours, 2.6-fold of control at 18 hours, 3.37-fold of control at 24
hours and 2.9-fold of control at 48 hours.
At 48 hours after hypoxic treatment, we also observed a 2.6-fold increase in
Annexin V labeling (Fig.1C), a measurement of early apoptosis. In summary, hypoxiainduced injury and PA-LTx-induced injury (see Chapter 2) elicit similar cellular
responses in NGFDPC12 cells.
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We showed in chapter 2 and 3 that PA-LTx induces reactive oxygen species
(ROS) accumulation in the cells. The amount of ROS is directly related with the
expression of HIF-1α and BNIP3 and apoptotic cell death. We proposed that as in PALTx, ROS could be the mechanism that triggers the fatal response in hypoxia. We put
NGFDPC12 cells in .5% [O2] incubator and measured ROS levels at 24 hours. As shown
in Figure 1D, the hypoxia-induced ROS levels is 2.2 fold of normoxia control. Adding
antioxidant MCI-186 at 50 μM concentration diminished ROS levels from 2.2 to 1.6 fold
of control. Increasing the concentration of MCI-186 to 100 μM decreased the ROS levels
to 1.4 fold of control, an almost 40% reduction.

Figure 1. Hypoxia induces up-regulation of HIF-1α and BNIP3, ROS accumulation and
apoptotic features in NGFDPC12 cells. Cells were exposed to hypoxia condition (.5 %
[O2]) for 12-48 hrs and the levels of (A) HIF-1α and (B) BNIP3 mRNA were analyzed by
real-time RT-PCR.
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Figure 1. Continued. Hypoxia induces up-regulation of HIF-1α and BNIP3, ROS
accumulation and apoptotic features in NGFDPC12 cells. Cells were exposed to hypoxia
condition (.5 % [O2]) for 12-48 hrs and the levels of (A) HIF-1α and (B) BNIP3 mRNA
were analyzed by real-time RT-PCR. (C) NGFDPC12 cells were exposed to hypoxia
condition for 24 hrs and apoptotic cells were identified by Annexin V labeling. The
percentage of Annexin V-tagged cells in a sample was determined by flow cytometry.
(D) NGFDPC12 cells were exposed to normoxia or hypoxia conditions for 24 hrs with or
without 50 or 100 μM antioxidant MCI-186 and intracellular ROS was determined by
DCF flow cytometry. The results are expressed as fold-change relative to normoxia
control and the data is shown as Mean±SEM. Significance symbols: *=p<0.05.
**=p<0.01.
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DHA and Rapamycin Protect NGFDPC12 Cells from .5% [O2] Hypoxia
Our laboratory has shown that DHA is able to rescue cells from PA-LTx
(Almaguel et al. 2009) and dietary omega-3 polyunsaturated fatty acids improve the
outcomes of rats suffered from spinal cord injury (Figueroa et al. 2013). In addition, our
data suggests that DHA’s protective effect involves autophagy stimulation (Chapter 2).
Therefore, we set ourselves to test whether DHA or rapamycin, an mTOR inhibitor and
autophagy promotor, is able to rescue cells from hypoxic injury. Figure 2 panel A shows
that normoxia-BSA treated NGFDPC12 cells are round, cell membrane well defined with
neurites extensions forming a cellular network. In panel B normoxia cells pre-treated
with DHA show the same round body as the BSA treated cells but with longer and
thicker neurites. This is consistent with our previous studies (Liu et al. 2008) where both
EPA and DHA increased the size, extension and branching of the neurites in NGFDPC12
cells. Figure 2 panel C shows NGFPC12 cells in normoxia treated with rapamycin
showing quite similar characteristics as DHA-treated cells. Round big cell bodies could
be observed with long thick branching neurites and higher confluency. When cells were
subjected to .5% [O2] hypoxia (panel D) the cells lost their round body shape, neurite
connection, cell fragmentation can be seen and confluency is lost. In cells treated with
DHA (panel E) the cell viability, confluency and neurite extension were maintained
compared to control, despite the fact that neurites were thinner. When we compare
hypoxia DHA pre-treated cells with hypoxia rapamycin treated cells we can observe
similar results (panel F). Cell bodies were big, round with quite long neurite with good
branching. Quantitatively, cell viability assay (Fig. 3) demonstrates that both DHA and
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rapamycin provide significant protective effect on NGFDPC12 cells under hypoxic
insult.
Next, we measured the percentage of apoptotic cells after treatments using
Annexin V probe. In Figure 4, control cells were treated with BSA only. The usual
number of cells that constantly die irrespective of the treatment was used a reference
point. DHA at 20 μM concentration did not increase the levels of Annexin V which is
consistent with the microscopic observations. Rapamycin at 20 nM concentration did not
increase the levels of Annexin V either, consistent also with the microscopic
observations. When cells were subjected to .5% [O2] hypoxia annexin V levels went up
3.5 fold of control at 48 hours. But co-treated the cells with DHA (20-40 μM) and
rapamycin (20 and 30 nM) dramatically reduced the level of Annexin V-positive cells.
We speculate that the induction of autophagy by rapamycin and DHA are the key
mechanism by which NGFDPC12 cells are protected from hypoxia-induced apoptosis.
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Figure 2. DHA and rapamycin rescue NGFDPC12 cells from hypoxia injury-Cell
morphology. Representative microscopic images show NGFDPC12 cells exposed to
normoxia or hypoxia condition for 48 hrs with treatment of BSA control medium (A, D),
20 μM of DHA (B, E) or 20 nM of rapamycin (C, F).
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Figure 3. DHA and rapamycin rescue NGFDPC12 cells from hypoxia injury-Cell
Viability. NGFDPC12 cells were exposed to normoxia or hypoxia condition for 48 hrs
with treatment of BSA control medium (CTL), 20 μM or 30 μM of DHA or 30 nM of
rapamycin. Cell viability was determined by crystal violet assay. The results are
expressed as percentage to normoxia control and the data is shown as Mean±SEM.
Significance symbols: *=p<0.05. **=p<0.01. *** =p<0.001. Significance symbols are
shown above bars when comparing normoxia CTL and are shown above lines when
comparing two linked groups.
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Figure 4. DHA and rapamycin attenuate hypoxia-induced apoptosis. NGFDPC12 cells
were exposed to normoxia or hypoxia condition for 24 hrs with treatment of BSA control
medium (CTL), 20 μM or 30 μM of DHA (20-40 μM) or of rapamycin (20, 30 nM). The
level of apoptotic cells was identified by Annexin V labeling followed by flow
cytometry. The results are expressed as fold-change relative to normoxia control.

142

Pre-Treatment with DHA or EPA Recues NGFDPC12 Cells from Hypoxia-Induced
Cell Death
One concept of injury under hypoxia is the activation of phospholipases with
release of saturated fatty acids inducing lipotoxicity and the release of ω-6 fatty acids like
arachidonic acid to induce inflammation. The key aspect of this metabolic process is the
fact that those fatty acids were already part of the cell membrane. We speculate that
enriching the membranes during differentiation with ω-3 fatty acids like DHA or EPA
(eicosapentanoic acid) will serve as substrate for phospholipases and will be released
during hypoxia injury giving protection to the cell.
We pre-treated the cells with DHA or EPA during the last 3 days of
differentiation and then expose the cells to .5% [O2] hypoxia. Figure 5 shows that when
NGFDPC12 cells were subjected to hypoxia cell viability diminished to less than 40% of
control. Treat cells with DHA or EPA in normoxia condition did not significantly alter
the cell viability but cells pre-treated with 30 μM DHA and then subjected to hypoxia cell
viability remained at 80% when compared to control. Similarly, cells pre-treated with 30
μM EPA and subjected to hypoxia showed a cell viability of 70% when compared to
normoxia BSA-control. Therefore, having a high concentration of ω-3 fatty acids in the
membrane composition is sufficient to induce the neuroprotective effects.
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Figure 5. Pre-treatment of DHA or EPA rescues NGFDPC12 cells from hypoxia-induced
cell death. NGFDPC12 cells were exposed to normoxia or hypoxia condition for 48 hrs
with or without pre-treatment with DHA or EPA and cell viability was determined by
crystal violet assay. . The results are expressed as percentage to normoxia control and the
data is shown as Mean±SEM. Significance symbols: *=p<0.05. **=p<0.01. ***
=p<0.001. Significance symbols are shown above bars when comparing normoxia CTL
and are shown above lines when comparing two linked groups.
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DHA Increases Autophagy to Rescue NGFDPC12 Cells from .5% [O2] Hypoxia
In chapter 2 we used a highly specific human autoantibody to nuclear protein
Topoisomerase I (Topo I) to distinguishes between apoptosis and necrosis (be it primary,
secondary, and necroptosis) in NGFDPC12 cells during PA-LTx (see Figure 2A in
chapter 2). We have also shown that DHA induces the same Topo I cleavage pattern as
HgCl2 (a necrosis inducer) in the presence or absence of PA-LTx (refer to figure 8B in
chapter 2). We interpret that even though DHA and PA-LTx + DHA treatment showed
the same Topo I cleavage pattern as HgCl2 it was not due to necrosis or necroptosis but
due to cathepsin activation within the lysosomal compartment as a result of DHAinduced enhancement of autophagy.
A representative Topo I immunoblot is shown in Figure 6. HgCl2 induced the 70
and 45 kDa band of Topo I at 24 hours. Palmitic acid at 24 and 48 hours showed only the
70 kDa band indicative of apoptosis. But when we added the pan-caspase inhibitor
ZVAD to PA treatment the third 45 kDa band appeared indicating that apoptosis was
inhibited and necrosis or necroptosis was induced at 24 or 48 hours. These verified
pattern of Topo I in lipotoxicity serves as a reference for the cellular responses in
NGFDPC12 cells during .5% [O2] hypoxia. Both normoxia and hypoxia conditions
include three groups: NGFDPC12 cells without pretreatment (1% FBS), cells with BSA
pretreatment or cells with DHA pretreatment (see Method section for details). The 70
kDa band can be seen in those three lanes even though the cell viability was high for
those conditions. Lane 12 shows that after 48 hours of .5% [O2] hypoxia, pre-treatment
with DHA induced the 45 kDa band indicative of necrosis/ necroptosis or in the case of
DHA cathepsins activation within the lysosome. This is of several experiments where the
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difference between the bands when comparing 1% FBS, BSA and Pre-DHA treatments is
obvious for the 45kDa band but the 70 kDa band is present in almost all the lanes. This
70 kDa band seems to suggest that the cells were passing through apoptosis. The
explanation could be that the cells were exogenous phenotypically healthy enough to
keep attached to the flask but already endogenously going through apoptosis and
eventually detachment from the flask.
Another way to measure apoptosis by immunoblotting is by probing the cleavage
pattern of poly-ADP-ribose polymerase (PARP) with antibodies formed in autoimmune
diseases (Casiano et al. 1996) (Casiano et al. 1998). The native protein has a molecular
weight of 110 kDa that is indicative of the presence of the protein. When cells are dying
by apoptosis a second 85 kDa band appears indicating that the protein has been cleaved at
specific sites by caspases. If caspases are inhibited or the cells turn from apoptosis to
secondary necrosis, a 50 kDa band appears indicating that cathepsins instead were
activated. In Figure 7 we can see the difference of the cleavage pattern of PARP between
1% FBA, BSA and Pre-DHA groups in .5% [O2] hypoxia. The 85 kDa band is noticeable
in the 1%FBS and BSA treatment groups. These two groups showed cell death
morphology under microscope and the 85 kDa band is consistent with apoptotic cell
death. However, the pre-DHA treatment group, exhibited healthier cell morphology
under microscope, showed a different PARP cleavage pattern. The caspase-related 85
kDa band is weaker and the cathepsin-related 50 kDa band is stronger in Pre-DHA cells
compared to those of 1%FBS or BSA groups. Again, we speculate that cathepsins are
activated within the confine of the lysosomes during autophagy induced by DHA.
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To confirm our speculation, the autophagy marker, LC3 II, was examined by
immunoblotting. As shown in Figure 8, a stronger LC3 II band can be seen in both DHA
and rapamycin treated cells in both normoxia and hypoxia conditions compared to BSAcontrol cells.
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Figure 6. Topo I cleavage pattern in NGFDPC12 cells under hypoxic condition. Lanes 16: NGFDPC12 cells were treated with BSA control medium (BSA), a necrosis inducer
HgCl2 (50 μM), PA-LTx (PA) in the presence or absence of ZVAD (40μM) for 24 and
48 hrs. Lanes 7-12: NGFDPC12 cells were exposed to normoxia or hypoxia condition
with treatment of differentiating medium (1% FBS), BSA control medium (BSA) or
pretreatment of DHA (50μM). Total cellular protein was extracted and Topo I
immunoblot was performed using a human serum carrying Topo I autoantibodies (1:250
dilution). These experiments were repeated at least three times and a representative blot is
shown.
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Figure 7. PARP cleavage pattern in NGFDPC12 cells under hypoxic condition.
NGFDPC12 cells were exposed to normoxia or hypoxia condition with treatment of
differentiating medium (1% FBS), BSA control medium (BSA) or pretreatment of DHA
(50μM). Total cellular protein was extracted and PARP immunoblot was performed. A
representative blot is shown.
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Figure 8

Figure 8. DHA increases autophagy in NGFDPC12 cells in normoxia and in hypoxia.
NGFDPC12 cells were exposed to normoxia or hypoxia condition with treatment of BSA
control medium (BSA), pretreatment of DHA (50μM) or Rapamycin (30 nM). Total
cellular protein was extracted and LC3 immunoblot was performed. A representative blot
is shown.
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EFABP Gene Expression and Protein Synthesis Are Induced during Hypoxia
Our data indicates that lipotoxicity and hypoxia stimulate similar stress responses
in NGFDPC12 cells. In chapter 3 we showed how epidermal fatty acid binding protein
(EFABP, FABP5) was more than just a fatty acid carrier protein. EFABP has the
capacity to buffer reactive oxygen species (ROS), serves as an antioxidant and increased
cell viability under PA-LTx. Knowing that hypoxia induces ROS we hypothesized that
.5% [O2] hypoxia would increase the expression of EFABP as a protective mechanism.
And indeed, as shown in Figure 9A, when cells were subjected to hypoxia for 24 and 48
hrs the gene expression as measured by real time RT-PCR was twofold of control at 24
hours and almost five fold of control at 48 hours. In Figure 9B, a representative EFABP
immunoblot is shown in a time line of 12, 24 and 48 hours after .5% [O2] hypoxia, using
β-Actin as a reference for protein loading. In accordance with mRNA results, EFABP
protein level is also increased. EFABP may function as a protective agent to buffer the
accumulated saturated fatty acid resulted from plasma and organelle membrane
degradations and also as an antioxidant molecule to neutralize the ROS coming from
malfunctioning mitochondria.
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Figure 9
A

B

Figure 9. Hypoxia induces up-regulation of EFABP. (A) NGFDPC12 cells were exposed
to normoxia or hypoxia condition for 24 and 48 hrs and the level of EFABP mRNA was
determined by real time RT-PCR. The results are expressed as fold-change relative to
normoxia control and the data is shown as Mean±SEM. Significance symbols: *=p<0.05.
(B) NGFDPC12 cells were exposed to normoxia or hypoxia condition for 12, 24 and 48
hrs and the level of EFABP protein was determined by immunoblots, using beta-acting as
a reference. A representative blot is shown.
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Antioxidant MCI-186 Reduces Hypoxia-Induced EFABP Gene Expression
After showing that hypoxia induces ROS and that those ROS can be decreased
with antioxidant treatment we set ourselves to test our hypothesis that hypoxia-stimulated
ROS stimulates FABP5 in NGFDPC12 cells. Again, we put the cells in .5 % [O2]
hypoxia for 24 hours with and without antioxidant MCI-186 and then collected the
mRNA to measure gene expression by RT-PCR. Figure 10 shows hypoxia induced the
gene expression of EFABP more than 3 fold of normoxia control and the EFABP upregulation was significantly reduced when antioxidant MCI-186 was added at 100 μM
concentration. It is interesting to note that a trend of increasing EFABP expression can be
seen in cells treated with MCI-186 under normoxia condition. We speculate that the
reducing environment caused by MCI-186 might offset the normal balance of the redox
status of the cell temporarily and the signal for protection is still triggered even in the
reduced state.

EFABP Protects NGFDPC12 Cells from Hypoxic Injury
We have shown that EFABP protects NGFDPC12 cells from PA-LTx. Next, we
examined the ability of EFABP to protect cells from hypoxic injury. For that, we
transfected NGFDPC12 cells with siRNA of EFABP to reduce cellular EFABP levels and
compared the cell viability of siControl cells and siEFABP cells after .5 % [O2] hypoxia.
As predicted, Figure 11 indicates that siEFABP cells showed significantly worse
outcome than siControl cells under hypoxia. We propose that EFABP’s protective
function in hypoxia may rely on its antioxidant and fatty acids buffering capability,
similar to the EFABP’s function we described in previous publications (Liu et al 2015).
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Figure 10

Figure 10. Antioxidant Reduces Hypoxia-stimulated E-FABP mRNA Expression.
NGFDPC12 cells were exposed to normoxia or hypoxia conditions for 24 hrs with or
without 50 or 100 μM antioxidant MCI-186 and the level of EFABP mRNA was
determined. The results are expressed as fold-change relative to normoxia control and the
data is shown as Mean±SEM. Significance symbols: *=p<0.05. Significance symbols are
shown above bars when comparing normoxia CTL and are shown above lines when
comparing two linked groups.
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Figure 11

Figure 11. Reduced cellular level of EFABP makes the cell survival worse in
NGFDPC12 cells after hypoxic insult. NGFDPC12 cells were transfected with siRNA of
EFABP or negative control siRNA with scrambled sequences. The transfected cells were
exposed to hypoxia condition for 48 hrs and cell viability was determined by crystal
violet assay. The results are expressed percent to normoxia control and the data is shown
as Mean±SEM. Significance symbols: *=p<0.05.
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FFABP Gene Expression Is Induced by Activation of PPAR
The peroxisome proliferator-activated receptors are a group of nuclear receptor
proteins that functions as transcription factors regulating the expression of genes involved
in cellular differentiation, development, metabolism of carbohydrates, lipid and proteins
and even in tumorigenesis (Feige et al. 2006, Berger & Moller 2002). The main ligands
for PPAR are lipids and free fatty acids metabolites like eicosanoids. As their name imply
one the effect of PPAR activation is the synthesis and assembly of peroxisomes. Very
long chain fatty acids are metabolized within the peroxisomes by β-oxidation which
increase in size and number when there is an increase load of fatty acids. Because FABPs
in general have a PPAR response element on their gene (Juge-Aubry et al. 1997,
Laprairie et al. 2017, Bando et al. 2017), we hypothesized that increase in FABP5
expression during hypoxia may mediate through PPAR due to elevated levels of fatty
acids, which is well established in the event of hypoxic injury (Dhillon et al. 1997). First,
we measured the effect of the PPAR family agonist WY-14643 on the gene expression of
FABP5. For that, NGFDPC12 cells were treated with three different concentrations of
WY-14643 for 24 hours under normoxia condition and EFABP mRNA as measured by
real-time RT-PCR. Figure 12 shows that EFABP mRNA expression increased to 3.7
fold by 100 μM of WY-14643 and to 2.6 fold by 200 μM WY-14643. At concentration of
400 μM, WY-14643 increased EFABP gene expression to 8.65 fold of control.
Next, we proceeded to inhibit PPARγ with antagonist GW9662 during hypoxia.
As seen in Figure 13, EFABP mRNA expression is increased to 2.75 fold of control 24
hours after .5% [O2] hypoxia. The up-regulation of EFABP mRNA reduced to 1.45 fold
in the presence of 5 μM GW9662 and to 1.65 fold in the presence of 10 μM GW9662.
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This result supports our hypothesis that the regulation of FABP5 expression is through
PPAR.

Figure 12

Figure 12. PPAR activator increases EFABP mRNA expression. NGFDPC12 cells were
treated with PPAR activator WY-14643 for 24 hrs and level of EFABP mRNA was
determined. The results are expressed as fold-change relative to control and the data is
shown as Mean±SEM. Significance symbols: *=p<0.05.
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Figure 13

Figure 13. PPAR gamma antagonist reduces hypoxia-stimulated EFABP mRNA
expression. NGFDPC12 cells were exposed to normoxia or hypoxia conditions for 24
hrs with or without treatment of PPAR gamma antagonist GW9662 and the level of
EFABP mRNA was determined. The results are expressed as fold-change relative to
normoxia control and the data is shown as Mean±SEM. Significance symbols: *=p<0.05.
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Discussion
The major pathway modulating the cellular response to hypoxia occurs at the
transcription level and is controlled through a number of key transcription factors, with
increased expression of genes involved in metabolism, stress response and survival, cell
division and even angiogenesis.
One of the most important oxygen tension sensor in the cell is the iron and
ascorbate-dependent interaction between the hypoxia responsive transcription factor HIF1α and its complement VHL. HIF-1α is part of the heterodimer Hypoxia Inducible
Factor (HIF). Under normoxia conditions HIF-1α is hydroxylated by proline
hydroxylases and targeted for proteasome degradation via von Hippel Lindau E3
ubiquitine ligase complex. Under hypoxia conditions, proline hydroxylase is not able to
hydroxylate HIF-1α rendering it stable and able to interact with HIF-β becoming a
heterodimer that stimulates the expression of hundreds of Hypoxia Response Elementscontaining genes (Bargiela et al. 2018).
Mammalian target of Rapamycin (mTOR) is a serine-threonine kinase that
regulates growth, differentiation, survival and energy by balancing anabolic and catabolic
processes for cellular homeostasis (Perez-Alvarez et al. 2018). mTOR controls many
cellular functions such as protein synthesis, energy metabolism, cell size, lipid
metabolism, autophagy, mitochondria, and lysosome biogenesis (Bockaert & Marin
2015). mTOR exist in two different complexes mTORC1 and mTORC2. They differ in
their composition and in their sensitivity to Rapamycin.
Autophagy is the catabolic mechanism by which dysfunctional or unnecessary
cellular components are degraded through the action of lysosomes (Mizushima &
Komatsu 2011). mTORC1 keeps autophagy in check by different routes. The first being
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phosphorylation of ULK1/2 and ATG13 with disassembly of the pro-autophagy complex
ULK1/2, ATG13, ATG101 and RB1-inducible coil-coil protein 1 (RB1CC1)/FIP200.
Besides mTORC1 can phosphorylate ATG14 and UVRAG, which inactivates
phosphatidylinositol 3-kinase class III (PI3KCIII) complex during initial (composed of
PIK3C3/Vps34, Becline-1PIK3R4/Vps15, ATG14 and AMBRA1) and maturing stages
(involving PIK3C3/Vps34, Beclin-1, PIK3R4/Vps15 and UVRAG) of autophagosomes
(Nakamura & Yoshimori 2017). On the other hand, both ULK and PI3KCIII complexes
are activated by AMPK-dependent phosphorylation (Kim et al. 2011, Kim et al. 2013).
The last mechanism we will mention involves mTORC1 phosphorylation of transcription
factor TFEB, which prevents its nuclear translocation and the transcription of several
ATG (autophagy) and lysosomal proteins (Perez-Alvarez et al. 2018).
During hypoxic or ischemic conditions, the CNS passes through a series of events
called the “ischemic cascade”. The description is extensive but the cascade includes
energy failure, glutamate excitotoxicity, inflammation and death by apoptosis in hours or
even days after the event (Perez-Alvarez & Wandosell 2016). It’s been described a
reduction of mTORC1 activity after brain ischemia due to decreased levels of oxygen,
glucose and growth factors. Increased inhibition of neuronal mTORC1 has been describe
after ischemia, by diminished activity of PI3K/Akt pathway both in vitro and in vivo
models (Mateos et al. 2016, Dutta et al. 2015).
As we stated before HIF-1α main effect is to shift from oxygen-consuming
oxidative phosphorylation to oxygen-independent glycolysis, to ensure a constant supply
of ATP during hypoxia (Chen et al. 2016). The connection between HIF-1α and the
mTOR pathway is not completely elucidated and contradictory outcomes have been
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reported in regard to neuronal cell viability.

It’s been reported that during glucose,

oxygen or nutrient deprivation the activation of AMPK resulted in HIF-1α stabilization
and expression via Akt/mTOR/p70S6K activation reducing neurological deficits, infarct
volume, brain edema and apoptosis after ischemia induction with isoflurane
preconditioning and inhibition of autophagy on a long run (Yan et al. 2016). On the other
hand, others have demonstrated that rapamycin up-regulation of autophagy reduces
infarct size and improves outcomes in both middle cerebral artery ligation (MCAL) and
embolic middle cerebral artery occlusion (MCAO), murine models of stroke (Buckley et
al. 2014, Chauhan et al. 2011).
It’s been hypothesized for many years (Lee et al. 2000) the “ischemic tolerance”
or “ischemic preconditioning” paradigm in the heart where sub lethal ischemic insults
prior to real damage may be protective, allowing defensive endogenous mechanisms
triggered after brain ischemia to make the tissue resistant to more severe ischemic injury.
The tuberous sclerosis complex 1(Tsc1 also known as hamartin) as part of the mTORC1
pathway has been proposed as a key player in mTOR induced up-regulation of autophagy
as preconditioning factor. Overexpression of Tsc1 rendered the hippocampal neurons
after OGD (oxygen glucose deprivation) resistant by maintaining effective autophagic
flux. Conversely, down regulation of Tsc1 resulted in autophagosome accumulation and
inhibited autophagic flux (Papadakis et al. 2013). This apparent contradiction of
induction and activation of mTORC1 complex to be protective in some cases and
inhibition of mTORC1 by rapamycin to be protective in others may be explained by time
and context dependent mechanisms. Autophagy induction before or just after ischemic
damage, results in beneficial effects measured as improvement of neurological score,
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reduction of infarct area or diminution of brain edema (Yin et al. 2012, Chauhan et al.
2015). When autophagy has been induced hours after ischemic damage opposite results
have been obtained (Guo et al. 2014, Jiang et al. 2017). It could be proposed that the
availability of ATP and growth factors would keep the PI3K/Akt/mTORC1 increased and
this will keep the cell in an anabolic state so that when autophagy is induced after the
injury toxic metabolites have already accumulated to lethal levels causing the cell to
default in hyperautophagy and cell death. It is here when inhibition of autophagy may be
more protective than induction of autophagy.
We can conclude that autophagy is an endogenous protective mechanism that is
activated during hypoxia damage mainly through inhibition of PI3K/Akt/mTORC1
pathway. When the insult is prolonged and autophagy is sustained longer than the
capacity of the cell to maintain energy hyperautophagy ensues and cell death is the
outcome. More studies ascertaining the duration as well as the severity of
nutrient/growth factors/oxygen deprivation are needed to elucidate the correct application
of autophagy modulation in brain ischemia.
Bcl-2 [B-cell leukemia\lymphoma 2]/adenovirus E1B19KD interacting protein3
(BNIP3) is an atypical BH3 (Bcl-2 homology 3) domain only containing protein that
interacts with BCL-2, BxL and adenovirus E1B-19K/EBV-BHRF protein (Yasuda et al.
1998). BNIP3 carboxy-terminal transmembrane (TM) domain (amino acids 164-184)
directs BNIP3 to mitochondria and is well known to be involved in its pro-apoptotic
activity (Chen et al. 1999). Overexpression of HIF-1α induces the expression of BNIP3
through the HIF response element (HRE) on BNIP3 (Guo et al. 2001). This
characteristic makes BNIP3 a stress-hypoxia response protein. We have reported
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previously that BNIP3 gene expression is increased during lipotoxicity (Montero et al.).
Increase BNIP3 and its interaction with Bax/Bak at the mitochondrial membrane
stimulates the induction of the mitochondria permeability transition pore (mPTP) and
release of cytochrome C (Vande Velde et al. 2000, Regula et al. 2002). Cells lacking
Bax/Bak are resistant towards BNIP3 mediated cell death and release of cytochrome C
from mitochondria is induced by BNIP3 (Kubli et al. 2007, Quinsay et al. 2010). Further
findings have shown that Z-VAD-fmk, a caspase inhibitor can suppress BNIP3 mediated
cell death in neonatal cardiac myocytes (Regula et al. 2002). Some have interpreted that
BNIP3-induced cell death shows characteristics of both necrosis and apoptosis as shown
by mPTP opening that is also considered a necrotic process and by activation of
Bax/Bak that is apoptotic primarily (Vasagiri & Kutala 2014).
Therefore, the effect of BNIP3 expression inducing apoptosis, necrosis or
autophagy is cell line and context dependent. It’s been reported that BNIP3 was
constitutively expressed in some cell lines whereas in most of the normal cell lines its
expression remains suppressed under regular conditions suggesting that it is maintained
in an inactive state and is regulated by post translational modifications (Vasagiri &
Kutala 2014). In some cases not the amount of BNIP3 but its phosphorylation status
determines the final outcome of the cell. BNIP3 phosphorylation was induced after
reoxygenation of hypoxia conditions and elevated levels of phosphorylated BNIP3
correlates with increased cell death (Graham et al. 2007). BNIP3 phosphorylation can
induce caspase independent cell death in knock down caspase 3, caspase 9 and Apa-1
mouse embryo fibroblast (Vande Velde et al. 2000). In rat cardiac myocyte BNIP3
overexpression resulted in autophagy and cell death after ischemia/reperfusion
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(Hamacher-Brady et al. 2007). In models of rat spinal cord injury BNIP3 in the
mitochondria interacted with microtubule-associated protein 1A/B-light chain 3 (LC3),
thus forming a mitochondria-BNIP3-LC3-autophagy complex resulting in mitophagy
(Yu et al. 2018). Moreover in CCL39 cells hypoxia induction of BNIP3 through its
HRE activation resulted in increased autophagy flux and increased in cell survival
(Bellot et al. 2009). Something that should call our attention is that the oxygen
concentration was 1% and the treatment was 24hours. This can explain that the
autophagy seen during this time point is a normal attempt of the cell for survival and that
BNIP3 at that amount and duration of stress is not enough to trigger cell death by the
mPTP formation and cytochrome c release.
EFABP (also known as skin type FABP, FABP5 cutaneous FABP or epidermal
FABP) is widely expressed through the body. It is the most distributed of all the fatty
acid binding proteins. Substantial levels are found in skin, macrophages, liver, neuronal
tissue, lung, and elsewhere. It is involved in systemic glucose and lipid homeostasis and
its expression is drastically increased in adipose tissue when another FABP (adipose
FABP) is knock down suggesting its importance in the body’s basic metabolism (Storch
& Corsico 2008). EFABP has been shown to bind and drastically increase the half-life of
the short-lived metabolite leukotriene A4 in rat basophilic leukemia cells and to increase
the availability of eicosanoids by stabilizing intermediate metabolites for further
conversion (Dickinson Zimmer et al. 2004). During neurogenesis, particularly in the
prenatal and postnatal period, EFABP is expressed at high concentration. Treatment of
PC12 cells by nerve Growth Factor increases its expression dramatically and knockdown
of its gene decreases neurite outgrowth compared to mock-transfected cells (Allen et al.
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2000). If we take into consideration that lipids constitute 50% of brain dry weight
(Edmond 2001, Rapoport et al. 2001) and that every metabolic reaction will take place
inside or across a membrane we can understand how important fatty acid binding and
transport proteins are in the nervous system. The relevance of FABPs could be observed
when deficiencies of the lipid cargo of FABPs, especially polyunsaturated fatty acids
(PUFA), have been associated in diseases like schizophrenia, depression, Parkinson’s and
Alzheimer dementia (Salvati et al. 2006, Watanabe et al. 2007, Iwayama et al. 2010). But
for our discussion about the effect on PUFAs, particularly DHA, what is important is the
increased in expression of FABPs as shuttles and conductors to the particular pathway
that PUFAs would follow during injury and neural repairing in the brain (Duplus &
Forest 2002).
From the perspective of hypoxia it has been shown that FABPs are expressed
abundantly under low oxygen concentrations in different tissues. In term human
placental trophoblast (Biron-Shental et al. 2007) hypoxia increased the expression of
FABPs and the accumulation of lipids droplets was observed in ex vivo placental human
trophoblasts suggesting a role for these FABPs in uptake and accumulation of lipids
during hypoxic stress (Biron-Shental et al. 2007). The authors didn’t comment on
whether the increase in fatty acids accumulation was for the purpose of fetal nervous
system development or for energy availability during a stress situation. But they
speculated that because FABPs went up at both protein and gene expression levels HIF1α surely played a role at transcription level (Kaelin 2002) because FABPs and EFABP
in particular have a Hypoxia Response Elements (HRE) on the promoter sequence
(Jadoon et al. 2015, Hu et al. 2015).
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DHA is the most abundant n-3 polyunsaturated fatty acids in the mammalian brain, and
it’s been shown that it plays important roles in neurogenesis, neurotransmission, and
protection against oxidative stress (Innis 2007). Studies have shown that DHA is
incorporated in neuronal membranes in a short time period (Connor et al. 1990) and the
effects of the incorporation can be measured at the microsomal, synaptosomal and
mitochondrial membranes after just 6 days (Suzuki et al. 1997). PUFA are known to
effect ion channels, neurotransmitter receptor and second messengers in the neuronal
membranes (Boneva et al. 2011), by increasing and preserving the fluidity that leads to
the optimum functioning of membranes proteins such as receptors, enzymes, ion
channels, and ion pumps. The conversion of ALA (α-linolenic acid) into DHA is very
efficient in the infant brain but decreases to negligible levels in the adult rat brain
(Rapoport et al. 2007, DeMar et al. 2006). It is important to mention that the conversion
of ALA into DHA is carried out by astroglia and endothelial cells of the blood vessels
and they supply this essential nutrient to neurons (Moore et al. 1991, Moore 1993).
The significant majority of DHA in the brain is supplied by plasma and the main
source is from the diet (Horrocks & Farooqui 2004). Most of the PUFAs in the western
diet is the n-6 arachidonic acid (ARA). The balance between these two PUFA seems to
very important (Simopoulos 2002). Because ARA metabolites are mediators of
inflammation (prostaglandin, leukotrienes, and other lipoxygenase or cyclooxygenase
products) and DHA and EPA derivatives are competitive substrates for ARA metabolites
it seems that a high ratio of n-3/n-6 PUFA is important for inflammation control in the
cell and in the CNS (Schmitz & Ecker 2008). Evidence for this observation has been
reviewed by Simopoulos addressing the levels of n-3 relative to n-6 levels on patients
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with cardiovascular disease, cancer, and inflammatory and autoimmune disease
(Simopoulos 2008). We can conclude that increased consumption of DHA-rich food and
decreased intake of ARA-rich food protects against brain stroke, and also prevents
chronic degenerative diseases. In the realm of cognition in humans, dietary deficiencies
of DHA are associated with increased risk for attention deficit disorder, dementia,
depression, bipolar disorder and schizophrenia (Gomez-Pinilla 2008). The importance of
DHA in the CNS especially in the brain cannot be over emphasize. The organ with the
highest lipid content in the human body is the brain, and 35% of the brain is composed
PUFA (Yehuda et al. 1999) such as DHA, EPA and ARA (Sastry 1985).
As we mentioned before, the brain has a limited capacity to synthesize its own
DHA, and therefore, plasma-derived DHA has to be transported across the blood-brain
barrier (BBB). FABP5 is also expressed by brain microvascular cells, and are responsible
for DHA transport across the BBB (Pan et al. 2015). Reduced BBB expression of FABP5
has been described in a mouse model of AD, and this was associated with decreased BBB
trafficking and brain content of DHA (Pan et al. 2016). Different approaches have been
tried to increased BBB expression of FABP5 and enhanced DHA trafficking. The
peroxisome proliferator-activated receptor (PPAR) signal transduction pathway has been
characterized as one important mechanism for FABP5 expression in hepatocytes (Rogue
et al. 2010). Therefore there is a positive feedback loop of fatty acids as natural ligands
of PPARs and upregulation of FABPs with increased transport to and inside the cells of
fatty acids. The complex formed by the FA and FABP stabilizes the nuclear localization
signal allowing it to translocate to the nucleus and activate the nuclear receptor PPAR.
(Armstrong et al. 2014). The FABP interaction with PPAR is somewhat specific. For
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example, FABP4 directs ligands to PPARγ, whereas FABP5 canalizes ligands to
PPARβ/δ (Tan et al. 2002). Moreover, FABP1 and FABP2 can differentially modulate
the activation of PPARα in a ligand-selective manner (Hughes et al. 2015). Our group
published that in a model of rats fed a DHA-enriched diet for 8 weeks spinal cord FABP5
gene expression was elevated compared to control (Figueroa et al. 2016). We can
conclude that DHA has the capacity to upregulate BBB expression of FABP5 and help
facilitate its own transport across the BBB (Pan et al. 2018).
Tacking together we propose that EFABP is neuroprotective in the context of
hypoxia because neuronal tissue has a large amount of membrane lipids compared to the
rest of the body and given its high concentration of polyunsaturated fatty acids in its
membrane is susceptible to lipid peroxidation. EFABP will hinder the increased
concentration of saturated fatty acids release from the membrane by phospholipase A2
during hypoxia (Dhillon et al. 1997) and will buffer the amount of ROS that are produced
under low oxygen tension and excessive oxidation of fatty acids. Besides EFABP might
direct the protective polyunsaturated fatty acids like DHA to where they are needed and
increase its effect as neuroprotective agents during hypoxia.
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CHAPTER FIVE
DISCUSSION

Summary of Dissertation Findings
Our general findings of this study are that PA induces the expression of stress
response genes, increases the accumulation of reactive oxygen species, and decreases cell
viability by apoptosis in NGFDPC12 cells. We found that even though PA induces
apoptosis, PA-induced cell death cannot be prevented by inhibition of apoptosis. The
PA-induced lipotoxicity can be prevented by inhibiting the apoptosome and
necroptosome with treatment of RIP1 inhibitor necrostatin-1 and enhanced even more by
the combination treatment of necrostatin-1 and the autophagy promoter rapamycin.
DHA rescues PA-induced cell death by inhibiting apoptosis and necroptosis and
promoting autophagy. DHA decreases the expression of PA-induced stress response
proteins but interestingly doesn’t decrease PA-induced ROS production. Besides DHA
stimulates the mRNA expression, phosphorylation and conjugation of autophagy
controlling proteins. Inhibiting the capacity of DHA to induce autophagy decreases DHA
capacity to rescue NGFDPC12 cells form PA-LTx.
We also observed that PA induces the mRNA expression and protein amount of EFABP
in a dose response manner. The PA-induced ROS accumulation is time and dose
dependent. ROS in turn stimulated the expression of EFABP and this expression could
be prevented when co-treating the cells with the antioxidant N-acetyl-cysteine during PALTx. Conversely lowering EFABP expression by siRNA increased the accumulation of
ROS and decreased cell viability. Lastly stimulating PPARβ and PPARγ with direct
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agonist increased the expression of EFABP and that expression correlated with increased
cell viability during PA-LTx.

Figure 1. Schematic diagram of protective pathways stimulated by DHA and EFABP in
NGFDPC12 cells during lipotoxic and hypoxic injury.
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As a parallel study .5% [O2] hypoxia induced the expression of stress response
genes and triggered apoptosis in NGFDPC12 cells just like PA-LTx. Hypoxia disrupts
the architecture of differentiated PC12 cells microscopically by diminishing the body
size, reducing the confluency, thinning the neurites and producing apoptotic bodies. The
decrease in cell viability can be prevented with an array of different concentration of
DHA and the autophagy promoter Rapamycin just like in PA-LTx. Pre-treatment of
NGFDPC12 cells with DHA and EPA (another PUFA) increased cell viability under
hypoxia. As in PA-LTx hypoxia also induces ROS and it can be prevented with
antioxidant MCI-186. The mRNA and protein level of FABP5 are also increased under
hypoxia in a time dependent manner and this increase in FABP5 can be prevented by
antioxidant treatment during hypoxia. Lastly the hypoxia-induced expression of FABP5
can be inhibited by treating the cells under hypoxia with PPARγ antagonist GW9966.

Discussion
The precise mechanisms of neuronal injury by lipotoxicity and the cellular events
that take place as a consequence of increased levels of saturated fatty acids are still a
work in progress. Saturated fatty acids affect the membrane fluidity, membrane capacity
for signal transduction, protein-protein interaction, activation of cell death and cell
survival machinery and a myriad of basal metabolic pathways that takes the cell out of
homeostasis. Saturated free fatty acid stimulates oxidative pathways that lead to the
production of ROS, destabilization of mitochondria with activation of the intrinsic
apoptotic pathway and cell death. The rational for this study is that FFA accumulate in
the brain after hypoxia-ischemia CNS injury (Bazan 1970, Homayoun et al. 1997)
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showing a 10 fold elevation in concentration (Dhillon et al. 1997) and a correlation
between PA levels and CNS injury.

Lipotoxicity
To start we treated NGFDPC12 cells with the pathological concentration of PA
after CNS injury. PA treatment showed to be toxic to NGFDPC12 cells. We first probed
the effect of PA on the gene expression of two key proteins involved in the response of a
tissue under stress, HIF-1α (hypoxia inducible factor- 1α) and BNIP3 (Bcl2/adenovirus
E1B 19kDa protein-interacting protein 3). As we mentioned in previous chapters these
two proteins complex with other proteins and depending on the severity of the injury and
energy availability induce increase protein and organelles turn over by activating
autophagy or trigger the activation of caspases resulting in apoptosis. That PA is enough
of an insult to trigger cell death was demonstrated by measuring the increased amount of
phosphatidylserine in the outer leaflet of the cytoplasmic membrane that occurs in
apoptosis using Annexin V levels by flowcytometry. PA treatment caused the normal
array of the neurite meshwork to be lost, diminished cell confluency, increased cell
shrinking, cell blebbing and chromatin and nucleus condensation.
As a way of confirmation we used the Topoisomerase I cleavage pattern during
cell death to differentiate between apoptosis and necrosis (Casiano et al. 1996, Casiano et
al. 1998) during PA lipotoxicity. Using staurosporine as our positive control we found
that PA at 24 and 48hrs will induce the 70kDa band characteristic of apoptosis. Trying to
understand how to rescue the cells from PA-induced apoptosis we blocked the caspases
with the pan-caspase inhibitor zVAD.fmk and the results were intriguing. Not only
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zVAD.fmk was not capable of rescuing the cell from PA-LTx but it also induced the cell
to die by the necrosis/necroptotic type of cell death. We observed that PA+zVAD
treatment induced the Topoisomerase I 45kDa band characteristic of necrosis.
Assuming that the cell has defaulted to another kind of regulated cell death when
zVAD.fmk was present we hypothesized that the event taking place was necroptosis and
proceeded to use inhibitors to inhibit necroptosis and apoptosis and to measure cell
viability by Crystal Violet assay. Treating NGFDPC12 cells with zVAD.fmk caused a
decreased in cell viability by itself. Needless to repeat in didn’t increased cell viability in
the presence of PA. We then proceeded to treat the cells using the RIP1 inhibitor
necrostatin-1 and it increased cell viability compared to control. Interesting necrostatin-1
increased the cell viability of PA-treated NGFDPC12 cells significantly. We also
measured the effect of the autophagy promoter rapamycin on cell viability during PALTx. It didn’t change the cell viability when applied by itself and didn’t increased the
cell viability when under PA-LTx. We moved on to combine these inhibitors and
promoters to see if there was an additive effect. We tried to inhibit apoptosis and
necroptosis at the same time. Inhibiting necroptosis and inducing autophagy with
necrostatin-1 and rapamycin respectively rendered the best outcome. This combination
increased cell viability dramatically over control cells and restored cell viability of cells
undergoing PA-LTx. Others have recently published that necrostain-1 inhibits cell death
from oxidative stress and mitochondrial damage induced-apoptosis (Chen et al. 2018a).
The addition of zVAD.fmk to necrostatin-1 and rapamycin took the benefit that inhibition
of necroptosis and induction autophagy had provided to the cells and brought it back to
the PA+zVAD.fmk+necrostain-1 level for cell viability. These findings allowed us to
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clarify previous observation done by Uloth et al. (Ulloth et al. 2003) when they tried to
inhibit PA-LTx induced cell death with zVAD.fmk but were not able to rescue the cells
and called the process caspase independent cell death.

DHA Neuroprotection in PA-LTx
We have found in previous works (Almaguel et al. 2009, Almaguel et al. 2010)
that DHA is protective to PA-LTX in NGFDPC12 cells. We proceeded to test the effect
of DHA regarding apoptosis, necroptosis and autophagy. Microscopically DHA-treated
cells promoted long and thick neurites extensions, healthy body shape and size and keep
the cells attached and confluent during PA-LTx. Different concentrations of DHA
ranging from 20 to 50uM protected NGFDPC12 cells from PA-LTx. Interesting pretreatment of DHA significantly also protected the cells and increased the cell viability
during PA lipotoxicity.
DHA not only increased cell viability but also decreased the gene expression as
measure by mRNA levels of HIF-1α and BNIP3 during PA-LTx indicating that the effect
of DHA in the cell is positive enough to bring the cell down to non-stress level. We were
expecting to see a decrease in PA-induced ROS when DHA was added to the media but
we didn’t see it. When DHA is added to PA ROS levels remain the same but DHA didn’t
increase the accumulation of ROS when applied by itself.
The most interesting part of the findings of this study was the fact that DHA
neuroprotection in part was due to the induction of autophagy. For the last ten to fifteen
years most of the literature in the field proposed autophagy as a cell death mechanism,
even calling it autophagic cell death (Azad et al. 2008) or going as far as calling it
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autophagic programmed cell death (Tsujimoto & Shimizu 2005). More recently a new
wave of articles has been published establishing a role for autophagy in cell survival and
neuroprotection (Li et al. 2018, Marino et al. 2014, Lee 2012). We treated PA-injured
cells with DHA and observed an increased in different molecular events characteristics of
autophagy. The first one was phosphorylation of beclin-1 at serine residue 93 as
demonstrated by Western Blot. Becline-1 (also known as ATG6) is the key protein in the
activation of autophagy (Marino et al. 2014). When beclin-1 is phosphorylated it
acquires the capacity to dissociate from Bcl-2 and starts its interaction with the Atg5-Atg7-Atg12 axis and conjugation of LC3. The autophagy promoter rapamycin was used as
positive control and it induced phosphorylation of beclin-1 in control cells. DHA also
induced the phosphorylation of becline-1 in control cells. PA treatment eradicated the
becline-1 phosphorylated band completely suggesting that PA-LTx by inducing apoptosis
even eliminates the basal autophagic flux necessary for normal metabolism. The
treatment of NGFDPC12 cells under PA-LTx restored and even increased above basal
level the phosphorylation of becline-1 at serine 93. This is key because when becline-1 is
phosphorylated Bcl-2 is not able to interact with beclin-1 and left to inhibit Bak and Bax
and prevent the formation of the mitochondrial permeability transition pore with
cytochrome c release with activation of caspases and apoptosis (Marino et al. 2014). The
two processes apoptosis and autophagy can’t occur together. This is a change in
paradigm because we can focus on what the cell needs to survive and relegate to a second
level what the cell is doing to die.
As additional evidence for DHA-induced autophagy taking place as a defense
versus PA-LTx we measured the gene expression of two proteins involved in the
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regulation of autophagy Atg7 and Atg12 (Glick et al. 2010). Atg7 is important for the
conjugation of LC3 and formation of the initial stages of the autophagosome called the
phagophore. Again DHA didn’t elevate the amount of mRNA as measured by PCR on
control cells. PA decreased to almost half the level of Atg7 mRNA at 24hrs of
lipotoxicity. When DHA was added to PA treated cells Atg7 mRNA levels were brought
back to normal levels. Something different but still interesting occurred with Atg12
mRNA levels as measured by PCR. PA again decreased the levels of Atg12 expression
but DHA this time not only brought back the levels to normal but increased the
expression of the gene 50% compared to control cells.
The last piece of evidence is the direct measured of the activity of Atg7 (a
conjugation and elongation protein) by showing the conjugation of LC3 with
phosphatidyl ethanolamine that is key for membrane assembly of the phagophore, the
formation of the protein conjugate that migrate at 14kDa during electrophoresis LC3-PE
or LC3II. DHA when applied by itself stimulated the formation of LC3II on control
cells. It’s worth noting that we have published that PUFA be it DHA or EPA increases
the cell viability, cell size, neurites length and neurites thickness compared to control
(Liu et al. 2008). We speculate that DHA ramps up autophagy in the cell and that
contribute to the degradation of oxidized molecules and more availability of growing
substrates. PA nullified completely any conjugation of LC3 but DHA when in the
presence of PA induced a strong conversion of LC3 to LC3-PE. The lysosomotropic
agent chloroquine which alters the autophagic flux by preventing acidification of
lysosomes nullified the DHA-induced neuroprotection during PA-LTx. Taken together
we think this is the highlight of the study because the applications can be myriads from
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stroke to diabetic neuropathy and every pathology where neuroregeneration is necessary
(Wang et al. 2018, He et al. 2017, Kesidou et al. 2013).
In order to answer the question whether DHA was able to recue NGFDPC12 from
caspase independent cell death we treated NGFDPC12 cells with DHA during PA-LTx +
zVAD.fmk and DHA was able to keep the cell viability to control levels. We understand
now that when cells are treated with zVAD.fmk in the presence of PA what we called
before caspase independent cell death is actually necroptosis. We showed in the present
study that HgCl2 (necroptosis inducer) induces the conjugation of LC3I but staurosporine
(apoptosis inducer) don’t. It means to us that autophagy or at least its machinery is used
during HgCl2-induced cell death or that autophagy is a failed attempt of survival that
eventually will succumb to necroptosis. Very interesting to us was the fact that DHA
induced the same Topoisomerase cleavage pattern as HgCl2, zVAD.fmk, PA+zVAD.fmk
in the presence or absence of PA suggesting that activation of cathepsins within the
confine of a stable lysosomal membrane as we would expect in autophagy is the major
contribution of DHA to rescue cells.

EFABP Neuroprotection in PA-LTx
Since a complete picture of DHA neuroprotection is still lacking and the
mechanisms involved remain to be elucidated, we decided to investigate possible
physiological interacting partners in lipotoxicity. Our lab is being at the forefront in the
understanding of fatty acids binding proteins. We showed that EFABP was important in
the protection of NGFDPC12 cells under PA-LTx. EFABP protein levels increased
significantly during PA-LTx at 24 and 48hrs and that increase in protein level was
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associated with an increase in mRNA levels that was responsive in a dose and time
manner. The pick for EFABP expression was at 12hrs under 300uM palmitic acid
concentration but still the increased expression could be seen at 18hrs during 150uM PA
concentration. The increase in EFABP was correlated with PA-induced ROS that could
be suppressed with two different antioxidants MCI-186 and N-acetyl-cysteine. The direct
induction of ROS with TBHP (tert-butyl- hydroperoxide) induced an almost four fold
expression of FABP5 mRNA levels as measured by RT-PCR. This results were
confirmed by modifying the promoter region of the FABP5 gene. Considering that
FABP5 gene has two putative NF-κB binding sites in the promoter region that mediate
the up-regulation of EFABP in MCF-7 cells (Kannan-Thulasiraman et al. 2010) we
explored the interactions of ROS and FABP5 regulation in cultures treated with SN50,
which blocks nucleus translocation of NF-κB. We observed that in PA+SN50 treated
cells EFABP mRNA expression was lower compared to control cells. Even more
inhibition of EFABP expression by preventing NF-κB translocation was correlated to a
dramatic increase in ROS levels.
To determine the necessity of palmitic acid metabolism as the causative agent of
ROS-induced EFABP expression in PA-LTx we used a non-metabolized methyl ester of
palmitic acid, methyl-palmitic acid (mPA). We observed that mPA at three different
concentrations does not alter either the EFABP mRNA expression or ROS levels and
NGFDPC12 cells did not lose their morphological integrity as it occurred with PA
treatment. Therefore PA activation and metabolism are required in the lipotoxic process.
We proposed in chapter 3 that the fundamental aspect of PA-LTx is an augmented state
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of oxidative stress and that minimizing or buffering that oxidative stress is the key to
protect from lipotoxicity.
In order to confirm that EFABP is key to the homeostasis of the cell during
saturated fatty acid injury we silenced the gene using siRNA technology. siRNA is a
specific, potent, and highly successful approach for loss-of-function studies. We used this
approach to evaluate the hypothesis that FABP5 is unequivocally necessary for
neuroprotection during PA-induced ROS injury. PA treatment in NGFDPC12 cells
resulted in elevated EFABP mRNA levels in siControl cells but a significant decrease in
EFABP mRNA expression in siFABP5+PA treated cells. Inhibiting EFABP by siEFABP
results in higher levels of ROS when compared to siControl cells. This suggests to us
that fatty acid binding protein in general do more than just trafficking fats around the
cytoplasm of the cell and are involved in keeping the oxidative environment of the cell in
check. When PA is added to siEFABP treated cells the amount of ROS is almost three
times that of siControl cells treated with PA that already was the double the amount of
ROS of the siControl. The most impacting result is the fact that silencing of EFABP
during PA-LTx decreased cell viability as measured by WST-1 assay when compared to
siControl. Doing the opposite, transfecting cells with recombinant EFABP and exposing
them to PA-LTx prevented the cells from increasing ROS when compared to PA +
vehicle. We emphasize that cells treated with recombinant EFABP and PA had higher
cell viability when compared with cells treated with the transfection vehicle and PA. It
tells us that by limiting the supply of saturated fatty acids to be metabolized by the
mitochondria or by buffering the ROS that will result from saturated fatty acid
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metabolism EFABP is necessary to avoid an augmented state of oxidative stress and cell
death.
As we mention in the introduction lipids are at the core of metabolic syndrome
and their effect can be seen in insulin resistance, diabetes, arthrosclerosis, ischemic
disease and stroke. In non-neuronal tissue like pancreatic islet cells, the chronic elevation
of plasma free fatty acids leads to lipotoxicity, which has been reported to be responsible
for the loss of β-cell function and plays a major role in the pathogenesis of diabetes (Lee
et al. 1994). EFABP has been shown to be regulated by PPARs (peroxisomesproliferator activated receptor) (Hyder et al. 2010) and the balance between PPARα and
PPARγ activities for example play a crucial role in determining the cell fat storage
(Auwerx 1999). Taken together the modulation of EFABP expression through PPAR’s
control seems to be another important factor in lipotoxicity. Using GW0742 (PPARβ
agonist) and GW1929 (PPARγ agonist) we measured the effect on EFABP mRNA
expression and observed a dramatic stimulation by GW0742 treatment and modest
stimulation by GW1929 treatment at 24hours. When PA was added in the presence of
these two agonists cell viability assays showed better resistance compared to PA
treatment alone. Furthermore, the protective effect provided by PPARβ and PPARγ was
abolished in siEFABP-transfected cells, confirming the important role of EFABP in the
PPAR agonist-initiated resistance during PA-LTx. Therefore by understanding the role
EFABP and its relation to PPARs we can modulate the metabolisms of fats that is so
important in most common chronic diseases.
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Hypoxia
Lipotoxicity seems to be involved in ischemic-hypoxic pathological processes in
different kinds of tissues from pancreatic, cardiac, nervous, hepatic and pulmonary (Petry
et al. 2018, Chen et al. 2018b, Gu et al. 2017, Rius et al. 2017, Yilmaz et al. 2015). With
this paradigm in mind we envisioned to seek cellular events that we observed take place
during PA-LTx in NGFDPC12 when these cells are subjected to hypoxia. Hypoxia in
our study was defined at .5% oxygen concentration. Not to our surprise hypoxia
increased the levels of mRNA expression of HIF-1α indicating the stress it imposes on
the cells. HIF-1α stimulates and complexes with BNIP3 to stimulates the cell for copying
with the challenge by ramping up cell survival mechanism or if the attempt fails to trigger
cellular demise through the cleaner and less inflammatory route. We remind the reader
that PA-LTx also induced the expression of HIF-1α and BNIP3.
Hypoxia also increased the levels of AnnexinV, a characteristic feature of cells
going into the early stages of apoptosis. Contrary to the tumor hypoxic environment
where cells “learn” how to survive in low oxygen tension (Chouaib et al. 2018, Joseph et
al. 2018, Lee et al. 2018), neurons are extremely sensitive to hypoxia (Beaudin et al.
2017) because they are already in a “below than average” oxygen environment
(Ndubuizu & LaManna 2007) and decreases in blood flow rapidly reach pathological
levels. We also observed an increased in ROS during hypoxia. This is another parallel
event common both to hypoxia and PA-LTx. We will repeat here that this “augmented
state of oxidative stress” is the essence of the cause for cell demise. All cell events
described in this study are activated in response to oxidation and are attempts at getting
rid of oxygen species and peroxidation. This increase in ROS during hypoxia can be
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buffered with MCI-186 antioxidant. This preliminary finding we hypothesize will serve
to answer the question whether decreasing ROS increases cell viability. As we showed in
chapter three an increase in ROS induced the expression of E-FABP and protected the
cell from lipotoxicity.

DHA Neuroprotection in Hypoxia
Another parallel finding between PA-LTx and hypoxia is that both can be
reversed with DHA treatment. This is the highlight finding of chapter four. DHA kept
the integrity of cell membranes, the extension of neurites, and the appropriate shape and
size of the NGFDPC12 cell bodies during hypoxia. As in chapter two induction of
autophagy seems to be protective for NGFDPC12 during hypoxia. We treated the cells
with autophagy promoter rapamycin and observed the same effect of protection as DHA.
The cell viability of DHA or rapamycin treated cells under hypoxia as measured by
crystal violet was a high as control cells in normoxia. Even more both DHA and
rapamycin at different concentrations decreased the levels of AnnexinV induced by
hypoxia. Both rapamycin and DHA stimulated autophagy as seen by the second 14kDa
band indicative of the conjugation of LC3 on WB. We speculate that the same events
that took place in DHA protection against lipotoxicity like beclin-1 phosphorylation and
Atg7 and Atg12 mRNA expression will be seen in DHA-protection during hypoxia.
These will be subject for future studies.
In a previous publication (Liu et al. 2008) we have reported that the
polyunsaturated fatty acid EPA give the same morphological characteristics of
neurogenesis to NGFDPC12 cells and neuroprotection. We pre-treated the cells with
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either DHA or EPA and exposed them to hypoxia. Both polyunsaturated fatty acids gave
protection to the cells almost as high as DHA co-treatment during hypoxia. As we
proposed in chapter 2, once a polyunsaturated fatty acid is incorporated in the cell
membrane phospholipases activated during hypoxia cleave the fatty acid free and use it in
the molecular process be it phagophore formation, membrane signaling or even LC3
conjugation (Stillwell et al. 2005, Stillwell & Wassall 2003).
Topoisomerase I cleavage pattern by western blot showed that pre-DHA induces
the 45kDa band characteristic of cathepsins activation and necrosis (Casiano et al. 1996,
Casiano et al. 1998). We proposed that DHA helps to keep the integrity of lysosomes
and allow for the autophagic flux to continue. Contrary to what be expected with this
necrosis pattern cell viability of DHA treated cells during hypoxia was high. A similar
finding was observed with the cleavage pattern of PARP protein (Casiano et al. 1996,
Casiano et al. 1998). Albeit the normoxia side of the blot presented in the result section
of chapter 4 shows the 50 kDa in all three conditions, it could be observed that the only
treatment showing this 50kD band in hypoxia was the pre-treatment with DHA. The two
hypoxia control groups didn’t show the band and the cell viability of this condition was
low.

EFABP Neuroprotection in Hypoxia
Another parallel of PA-LTx and hypoxia was the fact that EFABP expression
increases during hypoxia, even 5 fold increase at 48hrs. EFABP protein level also
increased during hypoxia and showed a constant increase from 12 to 48 hours. The
hypoxia-induced ROS accumulation lead the cell to increase the levels of EFABP
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mRNA. This hypoxia-induced ROS-mediated increase in EFABP mRNA level could be
blunted by buffering ROS using antioxidant MCI-186. We propose that EFABP is a
ROS scavenger and we hypothesize EFABP can be actually buffering saturated free fatty
acids from producing more ROS. Silencing of EFABP with siRNA resulted in a similar
outcome as silencing EFABP during lipotopxicity. It decreased the cell viability to half
the percent of normoxia cells. The PPARγ agonist WY14643 increased the EFABP
mRNA during normoxia condition. The PPARγ antagonist GW9966 decreased the
expression of EFABP during hypoxia. Futures studies will be done to test the correlation
of EFABP inhibition and cell viability during lipotoxicity. This is another fascinating
parallel between PA-LTx and hypoxia because it implies a role for lipotoxicity during
hypoxia. We expect that this work will be continued and the correlation established.
In summary, DHA mechanism of protection from lipotoxicity is due to inhibition
of apoptosis and necroptosis and activation of autophagy. The effect can be seen by cotreatment or pre-treatment suggesting the incorporation of DHA in cell membranes. The
present study cast light over the change of PA-LTx-induced cell death from apoptosis to
necroptosis in the presence of caspase inhibitors. Also DHA protection from hypoxia by
inhibiting apoptosis and stimulating autophagy and the role EFABP play in both PA-LTx
and hypoxia. We expect that lipids will continue emerging as important players in many
chronic diseases of the whole spectrum.
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